
    
<!DOCTYPE html>




<html lang="en" >
<head >
    <meta charset="UTF-8">
    <meta http-equiv="X-UA-Compatible" content="IE=edge">

    <!-- Mobile properties -->
    <meta name="HandheldFriendly" content="True">
    <meta name="MobileOptimized" content="320">
    <meta name="viewport" content="width=device-width, initial-scale=1.0">

  
    <!-- Stylesheets -->
    <link rel="stylesheet" href="/pmc/static/CACHE/css/output.cc84172e9e16.css" type="text/css">
  
  <link rel="stylesheet" href="/pmc/static/CACHE/css/output.b634933a977d.css" type="text/css"><link rel="stylesheet" href="/pmc/static/CACHE/css/output.913c7dcab8ff.css" type="text/css"><link rel="stylesheet" href="/pmc/static/CACHE/css/output.3766d7ad0d2d.css" type="text/css"><link rel="stylesheet" href="/pmc/static/CACHE/css/output.e3c3c2c84eb3.css" type="text/css">

  
    <link rel="stylesheet" href="https://maxcdn.bootstrapcdn.com/font-awesome/4.7.0/css/font-awesome.min.css"/>
  
<link type="text/css" href="/pmc/static/bundles/base/base.a2ef7ca69e4b20dff539.css" rel="stylesheet" />


    <link rel="stylesheet" href="/corehtml/pmc/css/fonts/stix/stixfonts.css" type="text/css" /><link rel="stylesheet" href="/corehtml/pmc/css/3.18/pmcrefs1.min.css" type="text/css" /><link rel="stylesheet" href="/corehtml/pmc/css/pmc2020_1.1/ncbi_web.min.css?_=a" type="text/css" /><style type="text/css">.pmc-wm {background:transparent repeat-y top left;background-image:url(/corehtml/pmc/pmcgifs/wm-journal.gif);background-size: auto, contain}</style><style type="text/css">.print-view{display:block}</style>

    <link type="text/css" href="/pmc/static/bundles/article/article.3c5d12ff2e4beea20136.css" rel="stylesheet" />
    <link type="text/css" href="/pmc/static/django_pmc_cite_box/lib/cite-box.css" rel="stylesheet" />


    <title>Molecular docking and antimalarial evaluation of novel N-(4-aminobenzoyl)-l-glutamic acid conjugated 1,3,5-triazine derivatives as Pf-DHFR inhibitors - PMC</title>

  
  <!-- Favicons -->
  <link rel="shortcut icon" type="image/ico" href="https://www.ncbi.nlm.nih.gov/coreutils/nwds/img/favicons/favicon.ico" />
  <link rel="icon" type="image/png" href="https://www.ncbi.nlm.nih.gov/coreutils/nwds/img/favicons/favicon.png" />

  <!-- 192x192, as recommended for Android
  http://updates.html5rocks.com/2014/11/Support-for-theme-color-in-Chrome-39-for-Android
  -->
  <link rel="icon" type="image/png" sizes="192x192" href="https://www.ncbi.nlm.nih.gov/coreutils/nwds/img/favicons/favicon-192.png" />

  <!-- 57x57 (precomposed) for iPhone 3GS, pre-2011 iPod Touch and older Android devices -->
  <link rel="apple-touch-icon-precomposed" href="https://www.ncbi.nlm.nih.gov/coreutils/nwds/img/favicons/favicon-57.png">
  <!-- 72x72 (precomposed) for 1st generation iPad, iPad 2 and iPad mini -->
  <link rel="apple-touch-icon-precomposed" sizes="72x72" href="https://www.ncbi.nlm.nih.gov/coreutils/nwds/img/favicons/favicon-72.png">
  <!-- 114x114 (precomposed) for iPhone 4, 4S, 5 and post-2011 iPod Touch -->
  <link rel="apple-touch-icon-precomposed" sizes="114x114" href="https://www.ncbi.nlm.nih.gov/coreutils/nwds/img/favicons/favicon-114.png">
  <!-- 144x144 (precomposed) for iPad 3rd and 4th generation -->
  <link rel="apple-touch-icon-precomposed" sizes="144x144" href="https://www.ncbi.nlm.nih.gov/coreutils/nwds/img/favicons/favicon-144.png">



    
        <!-- Logging params: Pinger defaults -->

<meta name="ncbi_app" content="pmc-frontend" />

<meta name="ncbi_db" content="pmc" />

<meta name="ncbi_phid" content="939BE807DB0F4BC50000268D09B0966C.1.m_2" />


        <!-- Logging params: Pinger custom -->

<meta name="ncbi_pdid" content="article" />

<meta name="ncbi_op" content="retrieved" />

<meta name="ncbi_app_version" content="0.0" />

<meta name="ncbi_domain" content="threebio" />

<meta name="ncbi_type" content="fulltext" />

<meta name="ncbi_pcid" content="/articles/PMC9649585/" />


    


    <script>
        
            var ncbiBaseUrl = "https://www.ncbi.nlm.nih.gov";
        
        var useOfficialGovtHeader = true;
    </script>


    <meta name="robots" content="INDEX,NOFOLLOW,NOARCHIVE" /><link rel="canonical" href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9649585/" /><link rel="schema.DC" href="http://purl.org/DC/elements/1.0/" /><meta name="citation_journal_title" content="3 Biotech" /><meta name="citation_title" content="Molecular docking and antimalarial evaluation of novel N-(4-aminobenzoyl)-l-glutamic acid conjugated 1,3,5-triazine derivatives as Pf-DHFR inhibitors" /><meta name="citation_author" content="Nayana Adhikari" /><meta name="citation_author_institution" content="Department of Pharmaceutical Sciences, Dibrugarh University, Dibrugarh, Assam 786004 India" /><meta name="citation_author" content="Ayesha Aktar Khanam Choudhury" /><meta name="citation_author_institution" content="Department of Pharmaceutical Sciences, Dibrugarh University, Dibrugarh, Assam 786004 India" /><meta name="citation_author" content="Anshul Shakya" /><meta name="citation_author_institution" content="Department of Pharmaceutical Sciences, Dibrugarh University, Dibrugarh, Assam 786004 India" /><meta name="citation_author" content="Surajit Kumar Ghosh" /><meta name="citation_author_institution" content="Department of Pharmaceutical Sciences, Dibrugarh University, Dibrugarh, Assam 786004 India" /><meta name="citation_author" content="Saurav Jyoti Patgiri" /><meta name="citation_author_institution" content="Regional Medical Research Centre, Indian Council of Medical Research (ICMR), Dibrugarh, Assam 786001 India" /><meta name="citation_author" content="Udaya Pratap Singh" /><meta name="citation_author_institution" content="Drug Design and Discovery Laboratory, Department of Pharmaceutical Sciences, Sam Higginbottom University of Agriculture, Technology and Sciences, Allahabad, Uttar Pradesh 211007 India" /><meta name="citation_author" content="Hans Raj Bhat" /><meta name="citation_author_institution" content="Department of Pharmaceutical Sciences, Dibrugarh University, Dibrugarh, Assam 786004 India" /><meta name="citation_publication_date" content="2022/12" /><meta name="citation_issue" content="12" /><meta name="citation_volume" content="12" /><meta name="citation_doi" content="10.1007/s13205-022-03400-2" /><meta name="citation_abstract_html_url" content="/pmc/articles/PMC9649585/?report=abstract" /><meta name="citation_fulltext_html_url" content="/pmc/articles/PMC9649585/" /><meta name="citation_pmid" content="36386564" /><meta name="DC.Title" content="Molecular docking and antimalarial evaluation of novel N-(4-aminobenzoyl)-l-glutamic acid conjugated 1,3,5-triazine derivatives as Pf-DHFR inhibitors" /><meta name="DC.Type" content="Text" /><meta name="DC.Publisher" content="Springer" /><meta name="DC.Contributor" content="Nayana Adhikari" /><meta name="DC.Contributor" content="Ayesha Aktar Khanam Choudhury" /><meta name="DC.Contributor" content="Anshul Shakya" /><meta name="DC.Contributor" content="Surajit Kumar Ghosh" /><meta name="DC.Contributor" content="Saurav Jyoti Patgiri" /><meta name="DC.Contributor" content="Udaya Pratap Singh" /><meta name="DC.Contributor" content="Hans Raj Bhat" /><meta name="DC.Date" content="2022 Dec" /><meta name="DC.Identifier" content="10.1007/s13205-022-03400-2" /><meta name="DC.Language" content="en" /><meta property="og:title" content="Molecular docking and antimalarial evaluation of novel N-(4-aminobenzoyl)-l-glutamic acid conjugated 1,3,5-triazine derivatives as Pf-DHFR inhibitors" /><meta property="og:type" content="article" /><meta property="og:description" content="Malaria has been a source of concern for humans for millennia; therefore in the present study we have utilized in-silico approach to generate diverse anti-malarial hit. Towards this, Molinspiration cheminformatics and Biovia Discovery Studio (DS) 2020 ..." /><meta property="og:url" content="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9649585/" /><meta property="og:site_name" content="PubMed Central (PMC)" /><meta property="og:image" content="https://www.ncbi.nlm.nih.gov/corehtml/pmc/pmcgifs/pmc-card-share.jpg?_=0" /><meta name="twitter:card" content="summary_large_image" /><meta name="twitter:site" content="@ncbi" /><meta name="ncbi_feature" content="associated_data" />


</head>
<body >

   
    
        <button
          class="back-to-top back-to-top--bottom"
          data-ga-category="pagination"
          data-ga-action="back_to_top">
          Back to Top
        </button>
    

    <a class="usa-skipnav" href="#main-content">Skip to main content</a>
    <!-- ========== BEGIN HEADER ========== -->
<section class="usa-banner" style="display: none;">
  <div class="usa-accordion">
    <header class="usa-banner-header">
      <div class="usa-grid usa-banner-inner">
        <img src="https://www.ncbi.nlm.nih.gov/coreutils/uswds/img/favicons/favicon-57.png" alt="U.S. flag" />
        <p>An official website of the United States government</p>
        <button
          class="usa-accordion-button usa-banner-button"
          aria-expanded="false"
          aria-controls="gov-banner-top"
        >
          <span class="usa-banner-button-text">Here's how you know</span>
        </button>
      </div>
    </header>
    <div
      class="usa-banner-content usa-grid usa-accordion-content"
      id="gov-banner-top"
    >
      <div class="usa-banner-guidance-gov usa-width-one-half">
        <img
          class="usa-banner-icon usa-media_block-img"
          src="https://www.ncbi.nlm.nih.gov/coreutils/uswds/img/icon-dot-gov.svg"
          alt="Dot gov"
        />
        <div class="usa-media_block-body">
          <p>
            <strong>The .gov means it’s official.</strong>
            <br />
            Federal government websites often end in .gov or .mil. Before
            sharing sensitive information, make sure you’re on a federal
            government site.
          </p>
        </div>
      </div>
      <div class="usa-banner-guidance-ssl usa-width-one-half">
        <img
          class="usa-banner-icon usa-media_block-img"
          src="https://www.ncbi.nlm.nih.gov/coreutils/uswds/img/icon-https.svg"
          alt="Https"
        />
        <div class="usa-media_block-body">
          <p>
            <strong>The site is secure.</strong>
            <br />
            The <strong>https://</strong> ensures that you are connecting to the
            official website and that any information you provide is encrypted
            and transmitted securely.
          </p>
        </div>
      </div>
    </div>
  </div>
</section>
<div class="usa-overlay"></div>
<header class="ncbi-header" role="banner" data-section="Header">

	<div class="usa-grid">
		<div class="usa-width-one-whole">

            <div class="ncbi-header__logo">
                <a href="https://www.ncbi.nlm.nih.gov/" class="logo" aria-label="NCBI Logo" data-ga-action="click_image" data-ga-label="NIH NLM Logo">
                  <img src="https://www.ncbi.nlm.nih.gov/coreutils/nwds/img/logos/AgencyLogo.svg" alt="NIH NLM Logo" />
                </a>
            </div>

			<div class="ncbi-header__account">
				<a id="account_login" href="https://account.ncbi.nlm.nih.gov" class="usa-button header-button" style="display:none" data-ga-action="open_menu" data-ga-label="account_menu">Log in</a>
				<button id="account_info" class="header-button" style="display:none"
						aria-controls="account_popup">
					<span class="fa fa-user" aria-hidden="true"></span>
					<span class="username desktop-only" aria-hidden="true" id="uname_short"></span>
					<span class="sr-only">Show account info</span>
				</button>
			</div>

			<div class="ncbi-popup-anchor">
				<div class="ncbi-popup account-popup" id="account_popup" aria-hidden="true">
					<div class="ncbi-popup-head">
						<button class="ncbi-close-button" data-ga-action="close_menu" data-ga-label="account_menu"><span class="fa fa-times"></span><span class="usa-sr-only">Close</span></button>
						<h4>Account</h4>
					</div>
					<div class="account-user-info">
						Logged in as:<br/>
						<b><span class="username" id="uname_long">username</span></b>
					</div>
					<div class="account-links">
						<ul class="usa-unstyled-list">
							<li><a id="account_myncbi" href="/myncbi/" class="set-base-url" data-ga-action="click_menu_item" data-ga-label="account_myncbi">Dashboard</a></li>
							<li><a id="account_pubs" href="/myncbi/collections/bibliography/" class="set-base-url" data-ga-action="click_menu_item" data-ga-label="account_pubs">Publications</a></li>
							<li><a id="account_settings" href="/account/settings/" class="set-base-url" data-ga-action="click_menu_item" data-ga-label="account_settings">Account settings</a></li>
							<li><a id="account_logout" href="/account/signout/" class="set-base-url" data-ga-action="click_menu_item" data-ga-label="account_logout">Log out</a></li>
						</ul>
					</div>
				</div>
			</div>

		</div>
	</div>
</header>
<div role="navigation" aria-label="access keys">
<a id="nws_header_accesskey_0" href="https://www.ncbi.nlm.nih.gov/guide/browsers/#ncbi_accesskeys" class="usa-sr-only" accesskey="0" tabindex="-1">Access keys</a>
<a id="nws_header_accesskey_1" href="https://www.ncbi.nlm.nih.gov" class="usa-sr-only" accesskey="1" tabindex="-1">NCBI Homepage</a>
<a id="nws_header_accesskey_2" href="/myncbi/" class="set-base-url usa-sr-only" accesskey="2" tabindex="-1">MyNCBI Homepage</a>
<a id="nws_header_accesskey_3" href="#maincontent" class="usa-sr-only" accesskey="3" tabindex="-1">Main Content</a>
<a id="nws_header_accesskey_4" href="#" class="usa-sr-only" accesskey="4" tabindex="-1">Main Navigation</a>
</div>
<section data-section="Alerts">
	<div class="ncbi-alerts-placeholder"></div>
</section>
<!-- ========== END HEADER ========== -->

    
    


    
        

<section class="pmc-alerts">
    
    <div role="alert" class="pmc-alert pmc-alert--info" role="region" aria-label="Alert" aria-hidden="false"  data-key="pmc-alert-welcome">
        <div class="pmc-alert__body pmc-alert--ncbi-icon">
            <div class="pmc-alert__content">
                <p>
                    <strong>
                        Preview improvements coming to the PMC website in October 2024.
                        <a href="https://ncbiinsights.ncbi.nlm.nih.gov/2024/03/14/preview-pmc-improvements/" data-ga-category="cloud_beta_banner" data-ga-label="learn_more" data-ga-action="on_pmc2020">Learn More</a> or
                        <a href="https://pmc.ncbi.nlm.nih.gov/articles/PMC9649585/" data-ga-category="cloud_beta_banner" data-ga-action="on_pmc2020" data-ga-label="go_to_cloud">Try it out now</a>.
                    </strong>
                </p>
            </div>
        </div>
    </div>
    
</section>
    

    
    
        
        <header class="pmc-header usa-header-extended" role="banner">
    <div class="pmc-header__bar">
        <div class="pmc-header__control usa-accordion">
            
                <button class="usa-menu-btn pmc-header--button pmc-header--left">
                    <i class="fa fa-ellipsis-v" aria-hidden="true"></i>
                </button>
            

            <div class="usa-logo pmc-header__logo pmc-header--stretch
                
               " id="extended-mega-logo">
                <div class="usa-logo-text">
                    <a href="/pmc/" title="Home" aria-label="Home" ></a>
                </div>
            </div>
            <button class="usa-accordion-button pmc-header--right pmc-header--button pmc-header__search--control pmc-header--right" aria-expanded="false" aria-controls="a1">
                <i class="fa fa-search" aria-hidden="true"></i>
                <i class="fa fa-times" aria-hidden="true"></i>
            </button>
        </div>
        <div class="pmc-header__search usa-accordion-content" id="a1">
            <div role="search"  class="pmc-header--stretch"  >
    <form class="usa-search " autocomplete="off">
        <div>
              <label class="usa-sr-only" for="pmc-search">Search PMC Full-Text Archive</label>
              <span class="clearable">
                <input
                  required="required"
                  autocomplete-url="/pmc/autocomplete/pmc/"
                  placeholder="Search PMC Full-Text Archive"
                  id="pmc-search" type="search" name="term"/>
                  <i class="clear-btn" ></i>
              </span>
              <button type="submit" formaction="/pmc/">
                <span class="usa-search-submit-text">Search in PMC</span>
              </button>
        </div>
    </form>
</div>


            <ul class="usa-unstyled-list usa-nav-secondary-links pmc-header--offset-two">
                    <li>
                        <a href="https://www.ncbi.nlm.nih.gov/pmc/advanced" data-ga-action="featured_link" data-ga-label="advanced_search">
                            Advanced Search
                        </a>
                    </li>
                    <li>
                        <a  href="/pmc/about/userguide/" data-ga-action="featured_link"
                        data-ga-label="user guide">
                            User Guide
                        </a>
                    </li>
            </ul>
        </div>
    </div>
     <nav role="navigation" class="usa-nav ">
        <button class="usa-nav-close">
            <i class="fa fa-times" aria-hidden="true"></i>
        </button>
        <div class="usa-breadcrumb usa-breadcrumb--wrap usa-breadcrumb--hack">
             
    <ul class="usa-breadcrumb__list">
            
                <li class="usa-breadcrumb__list-item"
                    >
                    <a href="/pmc/journals/" class="navlink">Journal List</a>
                </li>
            
                <li class="usa-breadcrumb__list-item"
                    >
                    <a class="navlink" href="/pmc/journals/1811/">3 Biotech</a>
                </li>
            
                <li class="usa-breadcrumb__list-item"
                    >
                    <a class="navlink" href="/pmc/issues/419667/">v.12(12); 2022 Dec</a>
                </li>
            
                <li class="usa-breadcrumb__list-item"
                     aria-current="page" >
                    PMC9649585
                </li>
            
    </ul>
 

        </div>
        
        
            <div class="pmc-sidebar pmc-sidebar-hack">
                

<div class="scroller">

    
        <section>
                <h6>Other Formats</h6>
                <ul class="pmc-sidebar__formats">
                  <li class="pdf-link other_item"><a href="/pmc/articles/PMC9649585/pdf/13205_2022_Article_3400.pdf" class="int-view">PDF (3.4M)</a></li>
                </ul>
        </section>
    
    <section>
        <h6>Actions</h6>
        <ul class="pmc-sidebar__actions">
            <li>
                <button role="button" class="citation-button citation-dialog-trigger ctxp"
                        aria-label="Open dialog with citation text in different styles" data-ga-category="save_share" data-ga-action="cite" data-ga-label="open"
                        data-all-citations-url="/pmc/resources/citations/9649585/"
                        data-citation-style="nlm"
                        data-download-format-link="/pmc/resources/citations/9649585/export/"
                >
                    <span class="button-label">Cite</span>
                </button>
            </li>
            <li>
                
                    

<link type="text/css" href="ncbi-overlay-block/src/overlay-block.css">
<div class="collections-button-container" data-article-id="9649585" data-article-db="pmc">
  <button class="collections-button collections-dialog-trigger"
          aria-label="Save article in MyNCBI collections."
          data-ga-category="collections_button"
          data-ga-action="click"
          data-ga-label="collections_button"
          data-collections-open-dialog-enabled="false"
          data-collections-open-dialog-url="https://www.ncbi.nlm.nih.gov/account?back_url=https%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC9649585%2F%23open-collections-dialog"
          data-in-collections="false">
      <span class="button-label">Collections</span>
  </button>
  <div class="overlay" role="dialog">
  <div id="collections-action-dialog"
       class="dialog collections-dialog"
       aria-hidden="true">
    <div class="title">Add to Collections</div>
    <div class="collections-action-panel action-panel">
      


<form id="collections-action-dialog-form"
      class="collections-action-panel-form action-panel-content action-form action-panel-smaller-selectors"
      data-existing-collections-url="/pmc/list-existing-collections/"
      data-add-to-existing-collection-url="/pmc/add-to-existing-collection/"
      data-create-and-add-to-new-collection-url="/pmc/create-and-add-to-new-collection/"
      data-myncbi-max-collection-name-length="100"
      data-collections-root-url="https://www.ncbi.nlm.nih.gov/myncbi/collections/">

  <input type="hidden" name="csrfmiddlewaretoken" value="yfGWKaQo2ErPSez4RQOlX7UeoTWiqI6eSV84UtRTYujMPYoGGcqIZWYpRnOIdIZL">

  

  <div class="choice-group" role="radiogroup">
    <ul class="radio-group-items">
      <li>
        <input type="radio"
               id="collections-action-dialog-new-header "
               class="collections-new"
               name="collections"
               value="new"
               data-ga-category="collections_button"
               data-ga-action="click"
               data-ga-label="collections_radio_new">
        <label for="collections-action-dialog-new-header ">Create a new collection</label>
      </li>
      <li>
        <input type="radio"
               id="collections-action-dialog-existing-header "
               class="collections-existing"
               name="collections"
               value="existing"
               checked="true"
               data-ga-category="collections_button"
               data-ga-action="click"
               data-ga-label="collections_radio_existing">
        <label for="collections-action-dialog-existing-header ">Add to an existing collection</label>
      </li>
    </ul>
  </div>

  <div class="controls-wrapper">
    <div class="action-panel-control-wrap new-collections-controls">
      <label for="collections-action-dialog-add-to-new" class="action-panel-label required-field-asterisk">
        Name your collection:
      </label>
      <input
        type="text"
        name="add-to-new-collection"
        id="collections-action-dialog-add-to-new"
        class="collections-action-add-to-new"
        pattern="[^&quot;&amp;=&lt;&gt;/]*" title="The following characters are not allowed in the Name field: &quot;&amp;=&lt;&gt;/"
        maxlength=""
        data-ga-category="collections_button"
        data-ga-action="create_collection"
        data-ga-label="non_favorties_collection">
      <div class="collections-new-name-too-long usa-input-error-message selection-validation-message">
        Name must be less than  characters
      </div>
    </div>
    <div class="action-panel-control-wrap existing-collections-controls">
      <label for="collections-action-dialog-add-to-existing" class="action-panel-label">
        Choose a collection:
      </label>
      <select id="collections-action-dialog-add-to-existing"
              class="action-panel-selector collections-action-add-to-existing"
              data-ga-category="collections_button"
              data-ga-action="select_collection"
              data-ga-label="($('.collections-action-add-to-existing').val() === 'Favorites') ? 'Favorites' : 'non_favorites_collection'">
      </select>
      <div class="collections-retry-load-on-error usa-input-error-message selection-validation-message">
        Unable to load your collection due to an error<br>
        <a href="#">Please try again</a>
      </div>
    </div>
  </div>

  <div class="action-panel-actions">
    <button class="action-panel-submit"
            type="submit"
            data-loading-label="Adding..."
            data-pinger-ignore
            data-ga-category="collections_button"
            data-ga-action="click"
            data-ga-label="add">
      Add
    </button>
    <button class="action-panel-cancel"
            aria-label="Close 'Add to Collections' panel"
            ref="linksrc=close_collections_panel"
            aria-controls="collections-action-panel"
            aria-expanded="false"
            data-ga-category="collections_button"
            data-ga-action="click"
            data-ga-label="cancel">
      Cancel
    </button>
  </div>
</form>
    </div>
  </div>
</div>
</div>
                
            </li>

        </ul>
    </section>
    
        <section class="social-sharing">
            <h6>Share</h6>
            <ul class="pmc-sidebar__share">
                <li><a class="fa-stack fa-lg" target="_blank" rel="noopener noreferrer" role="button" href="https://twitter.com/intent/tweet?url=https%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC9649585%2F&amp;text=Molecular%20docking%20and%20antimalarial%20evaluation%20of%20novel%20N-(4-aminobenzoyl)-l-glutamic%20acid%20conjugated%201%2C3%2C5-triazine%20..." alt="Share on Twitter"><i class="fa fa-twitter fa-stack-1x">&#160;</i></a></li> 
<li><a class="fa-stack fa-lg" target="_blank" rel="noopener noreferrer" role="button" href="https://www.facebook.com/sharer/sharer.php?u=https%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC9649585%2F" alt="Share on Facebook"><i class="fa fa-facebook fa-stack-1x">&#160;</i></a></li>
                <li>
                    <div class="share-permalink">
                        <button class="trigger"  alt="Show article permalink" aria-expanded="false" aria-haspopup="true">
                            <i class="fa-stack fa-lg" >
                                <i class="fa fa-link fa-stack-1x">&nbsp;</i>
                            </i>
                        </button>
                        <div class="dropdown dropdown-container" hidden>
                              <div class="title">
                                Permalink
                              </div>
                              <div class="content">
                                  <input type="text" class="permalink-text" value="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9649585/" aria-label="Article permalink"><button class="permalink-copy-button usa-button-primary" title="Copy article permalink" data-ga-category="save_share" data-ga-action="link" data-ga-label="copy_link">
                                      <span class="button-title">Copy</span>
                                  </button>
                              </div>
                        </div>
                    </div>
                </li>
            </ul>
        </section>
    
    <section>
        <h6>RESOURCES</h6>
        <ul class="pmc-sidebar__resources">
        
            <li>
                <div class="usa-accordion">
                    <button
                            data-ga-category="resources_accordion"
                            data-ga-action="open_similar_articles"
                            data-ga-label="/pmc/articles/PMC9649585/"
                            class="usa-accordion-button"
                            aria-controls="similar-articles-accordion-header"
                            aria-expanded="false"
                            data-action-open="open_similar_articles"
                            data-action-close="close_similar_articles"
                    >
                        Similar articles
                    </button>
                    <div
                            
                                data-source-url="/pmc/resources/similar-article-links/36386564/"
                            

                         class="usa-accordion-content pmc-sidebar__resources--citations" id="similar-articles-accordion-header" aria-hidden="true">
                        
                    </div>
                </div>
            </li>
            <li>
                <div class="usa-accordion">
                    <button
                            data-ga-category="resources_accordion"
                            data-ga-action="open_cited_by"
                            data-ga-label="/pmc/articles/PMC9649585/"
                            class="usa-accordion-button"
                            aria-controls="cited-by-accordion-header"
                            aria-expanded="false"
                            data-action-open="open_cited_by"
                            data-action-close="close_cited_by"
                    >
                        Cited by other articles
                    </button>
                    <div
                            
                                data-source-url="/pmc/resources/cited-by-links/36386564/"
                            
                            class="usa-accordion-content pmc-sidebar__resources--citations"
                            id="cited-by-accordion-header"
                            aria-hidden="true"
                    >
                        
                    </div>
                </div>
            </li>
            <li>
                <div class="usa-accordion">
                    <button
                            data-ga-category="resources_accordion"
                            data-ga-action="open_NCBI_links"
                            data-ga-label="/pmc/articles/PMC9649585/"
                            class="usa-accordion-button"
                            aria-controls="links-accordion-header"
                            aria-expanded="false"
                            data-action-open="open_NCBI_links"
                            data-action-close="close_NCBI_link"
                    >
                        Links to NCBI Databases
                    </button>
                    <div data-source-url="/pmc/resources/db-links/9649585/" class="usa-accordion-content" id="links-accordion-header" aria-hidden="true"></div>
                </div>
            </li>

            
        
        </ul>
    </section>

 </div>
            </div>
        

    </nav>

</header>

    
    

    <div class="usa-overlay"></div>
    
<main id="main-content" class="usa-grid usa-layout-docs pmc-main">
    <article class="usa-width-three-fourths usa-layout-docs-main_content pmc-article">
        <section class="usa-breadcrumb usa-breadcrumb--wrap">
         
    <ul class="usa-breadcrumb__list">
            
                <li class="usa-breadcrumb__list-item"
                    >
                    <a href="/pmc/journals/" class="navlink">Journal List</a>
                </li>
            
                <li class="usa-breadcrumb__list-item"
                    >
                    <a class="navlink" href="/pmc/journals/1811/">3 Biotech</a>
                </li>
            
                <li class="usa-breadcrumb__list-item"
                    >
                    <a class="navlink" href="/pmc/issues/419667/">v.12(12); 2022 Dec</a>
                </li>
            
                <li class="usa-breadcrumb__list-item"
                     aria-current="page" >
                    PMC9649585
                </li>
            
    </ul>
 

        </section>
        
  <div class="pmc-article__disclaimer" role="complementary" aria-label="Disclaimer note">
    As a library, NLM provides access to scientific literature. Inclusion in an NLM database does not imply endorsement of, or agreement with,
    the contents by NLM or the National Institutes of Health.<br/>
    Learn more:
    <a data-ga-category="Link click" data-ga-action="Disclaimer" data-ga-label="New disclaimer box" href="/pmc/about/disclaimer/">PMC Disclaimer</a>
    |
    <a data-ga-category="Link click" data-ga-action="PMC Copyright Notice" data-ga-label="New disclaimer box" href="/pmc/about/copyright/">
        PMC Copyright Notice
    </a>
</div>

        <section class="pmc-page-banner" role="banner">
            
                
                    <div><img src="/corehtml/pmc/pmcgifs/logo-threebio.jpg" alt="Logo of threebio" usemap="#logo-imagemap" /><map id="logo-imagemap" name="logo-imagemap"><area target="pmc_ext" rel="noopener noreferrer" shape="rect" href="http://www.springer.com/" ref="reftype=publisher&amp;article-id=9649585&amp;issue-id=419667&amp;journal-id=1811&amp;FROM=Article%7CBanner&amp;TO=Publisher%7COther%7CN/A" /></map></div> 
                
            
        </section>
        <section  role="document">
            
                <div id="mc" class=" article lit-style content pmc-wm slang-all page-box"><!--main-content--><div class="jig-ncbiinpagenav" data-jigconfig="smoothScroll: false, allHeadingLevels: ['h2'], headingExclude: ':hidden,.nomenu'"><div class="fm-sec half_rhythm no_top_margin"><div class="fm-flexbox"><div class="fm-citation"><div class="citation-default"><div class="part1"><span id="pmcmata">3 Biotech.</span> 2022 Dec; 12(12): 347. </div><div class="part2"><span class="fm-vol-iss-date">Published online 2022 Nov 10. </span>  <span class="doi"><span>doi: </span><a href="//doi.org/10.1007%2Fs13205-022-03400-2" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=9649585&amp;issue-id=419667&amp;journal-id=1811&amp;FROM=Article%7CFront%20Matter&amp;TO=Content%20Provider%7CCrosslink%7CDOI">10.1007/s13205-022-03400-2</a></span></div></div></div><div class="fm-ids"><div class="fm-citation-pmcid"><span class="fm-citation-ids-label">PMCID: </span><span>PMC9649585</span></div><div class="fm-citation-pmid">PMID: <a href="https://pubmed.ncbi.nlm.nih.gov/36386564">36386564</a></div></div></div><h1 class="content-title">Molecular docking and antimalarial evaluation of novel <em>N</em>-(4-aminobenzoyl)-<span class="small-caps">l</span>-glutamic acid conjugated 1,3,5-triazine derivatives as <em>Pf</em>-DHFR inhibitors</h1><div class="half_rhythm"><div class="contrib-group fm-author"><a href="https://pubmed.ncbi.nlm.nih.gov/?term=Adhikari%20N%5BAuthor%5D" class="affpopup" co-rid="_co_idm140311570960608" co-class="co-affbox">Nayana Adhikari</a>,<sup>1</sup> <a href="https://pubmed.ncbi.nlm.nih.gov/?term=Choudhury%20AA%5BAuthor%5D" class="affpopup" co-rid="_co_idm140311567248224" co-class="co-affbox">Ayesha Aktar Khanam Choudhury</a>,<sup>1</sup> <a href="https://pubmed.ncbi.nlm.nih.gov/?term=Shakya%20A%5BAuthor%5D" class="affpopup" co-rid="_co_idm140311570956912" co-class="co-affbox">Anshul Shakya</a>,<sup>1</sup> <a href="https://pubmed.ncbi.nlm.nih.gov/?term=Ghosh%20SK%5BAuthor%5D" class="affpopup" co-rid="_co_idm140311570954880" co-class="co-affbox">Surajit Kumar Ghosh</a>,<sup>1</sup> <a href="https://pubmed.ncbi.nlm.nih.gov/?term=Patgiri%20SJ%5BAuthor%5D" class="affpopup" co-rid="_co_idm140311568393024" co-class="co-affbox">Saurav Jyoti Patgiri</a>,<sup>2</sup> <a href="https://pubmed.ncbi.nlm.nih.gov/?term=Singh%20UP%5BAuthor%5D" class="affpopup" co-rid="_co_idm140311568390944" co-class="co-affbox">Udaya Pratap Singh</a>,<sup>3</sup> and  <a href="https://pubmed.ncbi.nlm.nih.gov/?term=Bhat%20HR%5BAuthor%5D" class="affpopup" co-rid="_co_idm140311568388864" co-class="co-affbox">Hans Raj Bhat</a><sup><img src="/corehtml/pmc/pmcgifs/corrauth.gif" alt="corresponding author" /></sup><sup>1</sup></div><div style="display:none" class="contrib-group aff-tip"><div id="_co_idm140311570960608"><h3 class="no_margin">Nayana Adhikari</h3><p><sup>1</sup>Department of Pharmaceutical Sciences, Dibrugarh University, Dibrugarh, Assam 786004 India </p><div>Find articles by <a href="https://pubmed.ncbi.nlm.nih.gov/?term=Adhikari%20N%5BAuthor%5D">Nayana Adhikari</a></div></div><div id="_co_idm140311567248224"><h3 class="no_margin">Ayesha Aktar Khanam Choudhury</h3><p><sup>1</sup>Department of Pharmaceutical Sciences, Dibrugarh University, Dibrugarh, Assam 786004 India </p><div>Find articles by <a href="https://pubmed.ncbi.nlm.nih.gov/?term=Choudhury%20AA%5BAuthor%5D">Ayesha Aktar Khanam Choudhury</a></div></div><div id="_co_idm140311570956912"><h3 class="no_margin">Anshul Shakya</h3><p><sup>1</sup>Department of Pharmaceutical Sciences, Dibrugarh University, Dibrugarh, Assam 786004 India </p><div>Find articles by <a href="https://pubmed.ncbi.nlm.nih.gov/?term=Shakya%20A%5BAuthor%5D">Anshul Shakya</a></div></div><div id="_co_idm140311570954880"><h3 class="no_margin">Surajit Kumar Ghosh</h3><p><sup>1</sup>Department of Pharmaceutical Sciences, Dibrugarh University, Dibrugarh, Assam 786004 India </p><div>Find articles by <a href="https://pubmed.ncbi.nlm.nih.gov/?term=Ghosh%20SK%5BAuthor%5D">Surajit Kumar Ghosh</a></div></div><div id="_co_idm140311568393024"><h3 class="no_margin">Saurav Jyoti Patgiri</h3><p><sup>2</sup>Regional Medical Research Centre, Indian Council of Medical Research (ICMR), Dibrugarh, Assam 786001 India </p><div>Find articles by <a href="https://pubmed.ncbi.nlm.nih.gov/?term=Patgiri%20SJ%5BAuthor%5D">Saurav Jyoti Patgiri</a></div></div><div id="_co_idm140311568390944"><h3 class="no_margin">Udaya Pratap Singh</h3><p><sup>3</sup>Drug Design and Discovery Laboratory, Department of Pharmaceutical Sciences, Sam Higginbottom University of Agriculture, Technology and Sciences, Allahabad, Uttar Pradesh 211007 India </p><div>Find articles by <a href="https://pubmed.ncbi.nlm.nih.gov/?term=Singh%20UP%5BAuthor%5D">Udaya Pratap Singh</a></div></div><div id="_co_idm140311568388864"><h3 class="no_margin">Hans Raj Bhat</h3><p><sup>1</sup>Department of Pharmaceutical Sciences, Dibrugarh University, Dibrugarh, Assam 786004 India </p><div>Find articles by <a href="https://pubmed.ncbi.nlm.nih.gov/?term=Bhat%20HR%5BAuthor%5D">Hans Raj Bhat</a></div></div></div></div><div class="half_rhythm"><div class="togglers fm-copyright-license"><a href="#" class="pmctoggle" rid="idm140311566991872_ai">Author information</a> <a href="#" class="pmctoggle" rid="idm140311566991872_an">Article notes</a> <a href="#" class="pmctoggle" rid="idm140311566991872_cpl">Copyright and License information</a> <a href="/pmc/about/disclaimer/" style="margin-left: 1em">PMC Disclaimer</a></div><div class="fm-authors-info hide half_rhythm" id="idm140311566991872_ai" style="display:none"><div class="fm-affl" id="Aff1"><sup>1</sup>Department of Pharmaceutical Sciences, Dibrugarh University, Dibrugarh, Assam 786004 India </div><div class="fm-affl" id="Aff2"><sup>2</sup>Regional Medical Research Centre, Indian Council of Medical Research (ICMR), Dibrugarh, Assam 786001 India </div><div class="fm-affl" id="Aff3"><sup>3</sup>Drug Design and Discovery Laboratory, Department of Pharmaceutical Sciences, Sam Higginbottom University of Agriculture, Technology and Sciences, Allahabad, Uttar Pradesh 211007 India </div><div><span class="fm-affl">Hans Raj Bhat, </span><span class="fm-affl"><span class="email-label">Email: </span><a href="mailto:dev@null" data-email="moc.liamg@snahamrahp" class="oemail">moc.liamg@snahamrahp</a></span>.</div><div><sup><img src="/corehtml/pmc/pmcgifs/corrauth.gif" alt="corresponding author" /></sup>Corresponding author.</div></div><div class="fm-article-notes hide half_rhythm" id="idm140311566991872_an" style="display:none"><div class="fm-pubdate half_rhythm">Received 2022 Jan 30; Accepted 2022 Oct 12.</div></div><div class="permissions half_rhythm hide" id="idm140311566991872_cpl" style="display:none"><div class="fm-copyright half_rhythm"><a href="/pmc/about/copyright/">Copyright</a> &#x000a9; King Abdulaziz City for Science and Technology 2022, Springer Nature or its licensor (e.g. a society or other partner) holds exclusive rights to this article under a publishing agreement with the author(s) or other rightsholder(s); author self-archiving of the accepted manuscript version of this article is solely governed by the terms of such publishing agreement and applicable law.</div></div></div><div id="pmclinksbox" class="links-box whole_rhythm hidden" role="complementary" aria-label="Related or updated information about this article."></div></div><div class="sec"></div><div id="ass-data" class="tsec fm-sec whole_rhythm" data-section="Featured_PMC_Datacitation"><h2 class="nomenu">Associated Data</h2><dl data-count="1" class="box-data-suppmats whole_rhythm no_bottom_margin"><dt><a href="#" rid="data-suppmats" data-ga-action="click_feat_toggler" data-ga-label="Supplementary Materials" class="pmctoggle">Supplementary Materials</a></dt><dd id="data-suppmats" style="display: none;"><div class="half_rhythm"><div class="caption half_rhythm no_bottom_margin">Supplementary file1 (DOCX 2394 KB)</div><div><a href="/pmc/articles/PMC9649585/bin/13205_2022_3400_MOESM1_ESM.docx" data-ga-action="click_feat_suppl">13205_2022_3400_MOESM1_ESM.docx</a><span style="color:gray"> (2.3M)</span></div><div class="small guid">GUID: A395E296-0EED-4DA9-85E7-B1086C3BB181</div></div></dd></dl></div><div id="Abs1" lang="en" class="tsec sec"><h2 class="head no_bottom_margin" id="Abs1title">Abstract</h2><!--article-meta--><div><p id="Par1" class="p p-first">Malaria has been a source of concern for humans for millennia; therefore in the present study we have utilized in-silico approach to generate diverse anti-malarial hit. Towards this, Molinspiration cheminformatics and Biovia Discovery Studio (DS) 2020 were used to conduct molecular modelling studies on 120 designed compounds. Furthermore, the TOPKAT module was used to evaluate the toxicity of the screened compounds. The CDOCKER docking technology was used to investigate protein&#x02013;ligand docking against the <em>Pf-</em>DHFR-TS protein (PDB ID: 1J3I and 1J3K). These compounds were synthesized using a conventional and microwave-assisted nucleophilic substitution reaction, and they were characterized using a variety of physicochemical and spectroscopic methods. Among the ten compounds tested, Df3 had the highest antimalarial activity against the chloroquine-resistant (Dd2) strain, with an IC<sub>50</sub> value of 9.54&#x000a0;&#x003bc;g&#x000a0;mL<sup>&#x02212;1</sup> and further demonstrate, molecular dynamics (MD) simulation studies and estimation of MM-PBSA-based free binding energies of docked complexes with 1J3I and 1J3K were carried out. The discovery of a novel class of <em>Pf-</em>DHFR inhibitors can be accomplished using this hybrid scaffold.</p><div id="sec-a.u.b.n.b" class="sec"><h3 id="sec-a.u.b.n.btitle">Supplementary Information</h3><p class="p p-first-last">The online version contains supplementary material available at 10.1007/s13205-022-03400-2.</p></div></div><div class="sec"><strong class="kwd-title">Keywords: </strong><span class="kwd-text">1,3,5-triazine; <em>N</em>-(4-aminobenzoyl)-<span class="small-caps">l</span>-glutamic acid; <em>Pf</em>-DHFR-TS; Docking; Antimalarial; Molecular dynamics</span></div></div><div id="Sec1" class="tsec sec"><h2 class="head no_bottom_margin" id="Sec1title">Introduction</h2><p id="Par2" class="p p-first">Malaria has been a source of concern for humans for millennia. The WHO has predicted 14 million more malaria cases and 47,000 more fatalities, and over the previous 20&#x000a0;years, the illness claimed more young lives (WMR <a href="#CR33" rid="CR33" class=" bibr popnode">2020</a>). There were 241 million malaria cases worldwide in 2020, up from 227 million in 2019, with 85 countries with endemic malaria, primarily in the WHO&#x02019;s African region. Malaria mortality in the WHO Eastern Mediterranean region increased by 49% between 2016 and 2020, with <em>Plasmodium falciparum</em> (<em>Pf</em>) accounting for 80% of infections (WMR <a href="#CR34" rid="CR34" class=" bibr popnode">2021</a>).
</p><p id="Par3">The majority of malaria cases in Africa and Southeast Asia are caused by <em>Pf</em>, the most virulent of the protozoal species that cause human malaria. Resistance to currently used antimalarial medications, such as pyrimethamine, halofantrine, mefloquine, and quinine, has hampered the decade-long effort to curb the menace of the disease. Therefore, it is necessary to generate armamentarium of novel antimalarial agents endowed with unique chemical structure and mode of action (Nzila et al. <a href="#CR22" rid="CR22" class=" bibr popnode">2005</a>; Yuthavong et al. <a href="#CR35" rid="CR35" class=" bibr popnode">2012</a>).</p><p id="Par4">A purposeful approach to selective chemotherapy can often be seen in studies of the metabolic and biochemical distinctions between parasite and host cells. It has been found advantageous to target specific metabolic processes necessary for parasite growth, to prevent damage to host cell. Studies have shown that malarial parasite synthesizes folate factor from scratch and that <em>para</em>-amino benzoic acid (PABA) is crucial in the parasite's folate metabolic pathway using PABA dependent auxotrophic mutants (Kr&#x000e1;tk&#x000fd; et al. <a href="#CR15" rid="CR15" class=" bibr popnode">2019</a>). The amino acid PABA, which is frequently utilized in biochemistry and medical science, has a wide range of commercial applications. It is now understood that the majority of human illnesses have it as a key component (L&#x000f6;dige and Hiersch <a href="#CR18" rid="CR18" class=" bibr popnode">2015</a>).</p><p id="Par5">1,3,5-Triazine is another pharmacophore, and its derivatives have generated interest for their biological activity against bacteria (Kashyap et al. <a href="#CR14" rid="CR14" class=" bibr popnode">2018</a>), cancer (Dansena et al. <a href="#CR8" rid="CR8" class=" bibr popnode">2015</a>), mycobacteria (Dubey et al. <a href="#CR9" rid="CR9" class=" bibr popnode">2012</a>), protozoa (Gahtori et al. <a href="#CR10" rid="CR10" class=" bibr popnode">2012</a>), fungi (Singh et al. <a href="#CR28" rid="CR28" class=" bibr popnode">2012</a>), and viruses (Singh et al. <a href="#CR28" rid="CR28" class=" bibr popnode">2012</a>; Sakakibara et al. <a href="#CR27" rid="CR27" class=" bibr popnode">2015</a>). The antimalarial activity of 1,3,5-triazine has been discovered to be highly impacted by a number of bioactive pharmacophores, including hybrid PABA-1,3,5-triazine (Adhikari et al. <a href="#CR1" rid="CR1" class=" bibr popnode">2020</a>), 4-aminoquinoline 1,3,5-triazine (Bhat et al. <a href="#CR4" rid="CR4" class=" bibr popnode">2013a</a>, <a href="#CR5" rid="CR5" class=" bibr popnode">b</a>), thiazole-1,3,5-triazine (Singh et al. <a href="#CR29" rid="CR29" class=" bibr popnode">2013</a>), pyrazole-1,3,5-triazine (Gogoi et al. <a href="#CR12" rid="CR12" class=" bibr popnode">2021</a>), and pyrimidine-1,3,5-triazine derivatives (Choudhury et al. <a href="#CR6" rid="CR6" class=" bibr popnode">2022</a>).</p><p id="Par6" class="p p-last">A combinatorial library of 120 compounds was generated in this study, which included the two-pharmacophores 4-aminobenzoyl-<span class="small-caps">l</span>-glutamic acid and 1,3,5-triazine. Following that, ten compounds were selected using computational screening techniques such as molecular property analysis, toxicity assessment, and molecular docking. These screened compounds were synthesized using a microwave synthesizer. The compounds were tested for antimalarial activity in vitro against 3D7 (chloroquine-sensitive) and Dd2 (chloroquine-resistant) strains of <em>P. falciparum</em> as <em>Pf</em>-DHFR inhibitor.</p></div><div id="Sec2" class="tsec sec"><h2 class="head no_bottom_margin" id="Sec2title">Results and discussion</h2><div id="Sec3" class="sec sec-first"><h3 id="Sec3title">In silico screening</h3><div id="Sec4" class="sec sec-first"><p></p><h4 id="Sec4title" class="inline">Compound library </h4><p id="Par7" class="p p-first-last">The compound library consists of different functional groups belonging to primary/secondary amines with aliphatic chains or aromatic rings on the core scaffold of <span class="small-caps">l</span>-glutamic acid conjugated 1,3,5-triazines. All 120 compounds were categorized into three series, such as Dd1 to Dd40, De1 to De40 and Df1 to Df40). Table <a href="/pmc/articles/PMC9649585/table/Tab1/" target="table" class="fig-table-link figpopup" rid-figpopup="Tab1" rid-ob="ob-Tab1" co-legend-rid=""><span style="position: relative;text-decoration:none;">&#x200B;<span class="figpopup-sensitive-area" style="left: -2.5em;">Table1</span></span><span>1</span></a> showed that all three series contained the same chemical scaffolds: <em>N</em>-(4-aminobenzoyl)-<span class="small-caps">l</span>-glutamic acid conjugated 1,3,5-triazine.</p><!--table ft1--><!--table-wrap mode="anchored" t5--><div class="table-wrap anchored whole_rhythm" id="Tab1"><h3>Table 1</h3><!--caption a7--><div class="caption"><p>Chemical library of all designed compounds</p></div><div class="xtable"><table frame="hsides" rules="groups" class="rendered small default_table"><thead><tr><th align="left" colspan="5" rowspan="1">
<img loading="lazy" alt="An external file that holds a picture, illustration, etc.&#10;Object name is 13205_2022_3400_Figa_HTML.gif" src="/pmc/articles/PMC9649585/bin/13205_2022_3400_Figa_HTML.gif" /></th></tr><tr><th align="left" rowspan="2" colspan="1">Serial No.</th><th align="left" rowspan="2" colspan="1">Y</th><th align="left" colspan="3" rowspan="1">X</th></tr><tr><th align="left" rowspan="1" colspan="1">
<img loading="lazy" alt="An external file that holds a picture, illustration, etc.&#10;Object name is 13205_2022_3400_Figb_HTML.gif" src="/pmc/articles/PMC9649585/bin/13205_2022_3400_Figb_HTML.gif" /></th><th align="left" rowspan="1" colspan="1">
<img loading="lazy" alt="An external file that holds a picture, illustration, etc.&#10;Object name is 13205_2022_3400_Figc_HTML.gif" src="/pmc/articles/PMC9649585/bin/13205_2022_3400_Figc_HTML.gif" /></th><th align="left" rowspan="1" colspan="1">
<img loading="lazy" alt="An external file that holds a picture, illustration, etc.&#10;Object name is 13205_2022_3400_Figd_HTML.gif" src="/pmc/articles/PMC9649585/bin/13205_2022_3400_Figd_HTML.gif" /></th></tr></thead><tbody><tr><td align="left" rowspan="1" colspan="1">1</td><td align="left" rowspan="1" colspan="1">4-Trifluoromethylaniline</td><td align="left" rowspan="1" colspan="1">Dd1</td><td align="left" rowspan="1" colspan="1">De1</td><td align="left" rowspan="1" colspan="1">Df1</td></tr><tr><td align="left" rowspan="1" colspan="1">2</td><td align="left" rowspan="1" colspan="1"><em>N</em>,<em>N</em>-Dimethyl-p-phenylene diamine</td><td align="left" rowspan="1" colspan="1">Dd2</td><td align="left" rowspan="1" colspan="1">De2</td><td align="left" rowspan="1" colspan="1">Df2</td></tr><tr><td align="left" rowspan="1" colspan="1">3</td><td align="left" rowspan="1" colspan="1">Piperidine</td><td align="left" rowspan="1" colspan="1">Dd3</td><td align="left" rowspan="1" colspan="1">De3</td><td align="left" rowspan="1" colspan="1">Df3</td></tr><tr><td align="left" rowspan="1" colspan="1">4</td><td align="left" rowspan="1" colspan="1">1,3-Diaminopropane</td><td align="left" rowspan="1" colspan="1">Dd4</td><td align="left" rowspan="1" colspan="1">De4</td><td align="left" rowspan="1" colspan="1">Df4</td></tr><tr><td align="left" rowspan="1" colspan="1">5</td><td align="left" rowspan="1" colspan="1">3-Amino-1-propanol</td><td align="left" rowspan="1" colspan="1">Dd5</td><td align="left" rowspan="1" colspan="1">De5</td><td align="left" rowspan="1" colspan="1">Df5</td></tr><tr><td align="left" rowspan="1" colspan="1">6</td><td align="left" rowspan="1" colspan="1">4-Aminobenzonitrile</td><td align="left" rowspan="1" colspan="1">Dd6</td><td align="left" rowspan="1" colspan="1">De6</td><td align="left" rowspan="1" colspan="1">Df6</td></tr><tr><td align="left" rowspan="1" colspan="1">7</td><td align="left" rowspan="1" colspan="1">2-Piperazinoethanol</td><td align="left" rowspan="1" colspan="1">Dd7</td><td align="left" rowspan="1" colspan="1">De7</td><td align="left" rowspan="1" colspan="1">Df7</td></tr><tr><td align="left" rowspan="1" colspan="1">8</td><td align="left" rowspan="1" colspan="1">3,4-Dichloroaniline</td><td align="left" rowspan="1" colspan="1">Dd8</td><td align="left" rowspan="1" colspan="1">De8</td><td align="left" rowspan="1" colspan="1">Df8</td></tr><tr><td align="left" rowspan="1" colspan="1">9</td><td align="left" rowspan="1" colspan="1">3-Chloroaniline</td><td align="left" rowspan="1" colspan="1">Dd9</td><td align="left" rowspan="1" colspan="1">De9</td><td align="left" rowspan="1" colspan="1">Df9</td></tr><tr><td align="left" rowspan="1" colspan="1">10</td><td align="left" rowspan="1" colspan="1">o-Toluidine</td><td align="left" rowspan="1" colspan="1">Dd10</td><td align="left" rowspan="1" colspan="1">De10</td><td align="left" rowspan="1" colspan="1">Df10</td></tr><tr><td align="left" rowspan="1" colspan="1">11</td><td align="left" rowspan="1" colspan="1">p-Toluidine</td><td align="left" rowspan="1" colspan="1">Dd11</td><td align="left" rowspan="1" colspan="1">De11</td><td align="left" rowspan="1" colspan="1">Df11</td></tr><tr><td align="left" rowspan="1" colspan="1">12</td><td align="left" rowspan="1" colspan="1">m-Toluidine</td><td align="left" rowspan="1" colspan="1">Dd12</td><td align="left" rowspan="1" colspan="1">De12</td><td align="left" rowspan="1" colspan="1">Df12</td></tr><tr><td align="left" rowspan="1" colspan="1">13</td><td align="left" rowspan="1" colspan="1">3-Bromoaniline</td><td align="left" rowspan="1" colspan="1">Dd13</td><td align="left" rowspan="1" colspan="1">De13</td><td align="left" rowspan="1" colspan="1">Df13</td></tr><tr><td align="left" rowspan="1" colspan="1">14</td><td align="left" rowspan="1" colspan="1">2-Bromoaniline</td><td align="left" rowspan="1" colspan="1">Dd14</td><td align="left" rowspan="1" colspan="1">De14</td><td align="left" rowspan="1" colspan="1">Df14</td></tr><tr><td align="left" rowspan="1" colspan="1">15</td><td align="left" rowspan="1" colspan="1">4-Bromoaniline</td><td align="left" rowspan="1" colspan="1">Dd15</td><td align="left" rowspan="1" colspan="1">De15</td><td align="left" rowspan="1" colspan="1">Df15</td></tr><tr><td align="left" rowspan="1" colspan="1">16</td><td align="left" rowspan="1" colspan="1">m-Nitroaniline</td><td align="left" rowspan="1" colspan="1">Dd16</td><td align="left" rowspan="1" colspan="1">De16</td><td align="left" rowspan="1" colspan="1">Df16</td></tr><tr><td align="left" rowspan="1" colspan="1">17</td><td align="left" rowspan="1" colspan="1">p-Nitroaniline</td><td align="left" rowspan="1" colspan="1">Dd17</td><td align="left" rowspan="1" colspan="1">De17</td><td align="left" rowspan="1" colspan="1">Df17</td></tr><tr><td align="left" rowspan="1" colspan="1">18</td><td align="left" rowspan="1" colspan="1">2-Nitroaniline</td><td align="left" rowspan="1" colspan="1">Dd18</td><td align="left" rowspan="1" colspan="1">De18</td><td align="left" rowspan="1" colspan="1">Df18</td></tr><tr><td align="left" rowspan="1" colspan="1">19</td><td align="left" rowspan="1" colspan="1">4-Fluoroaniline</td><td align="left" rowspan="1" colspan="1">Dd19</td><td align="left" rowspan="1" colspan="1">De19</td><td align="left" rowspan="1" colspan="1">Df19</td></tr><tr><td align="left" rowspan="1" colspan="1">20</td><td align="left" rowspan="1" colspan="1">3-Fluoroaniline</td><td align="left" rowspan="1" colspan="1">Dd20</td><td align="left" rowspan="1" colspan="1">De20</td><td align="left" rowspan="1" colspan="1">Df20</td></tr><tr><td align="left" rowspan="1" colspan="1">21</td><td align="left" rowspan="1" colspan="1">2-Fluoroaniline</td><td align="left" rowspan="1" colspan="1">Dd21</td><td align="left" rowspan="1" colspan="1">De21</td><td align="left" rowspan="1" colspan="1">Df21</td></tr><tr><td align="left" rowspan="1" colspan="1">22</td><td align="left" rowspan="1" colspan="1">1-Methylpiperazine</td><td align="left" rowspan="1" colspan="1">Dd22</td><td align="left" rowspan="1" colspan="1">De22</td><td align="left" rowspan="1" colspan="1">Df22</td></tr><tr><td align="left" rowspan="1" colspan="1">23</td><td align="left" rowspan="1" colspan="1">1-Phenylpiperazine</td><td align="left" rowspan="1" colspan="1">Dd23</td><td align="left" rowspan="1" colspan="1">De23</td><td align="left" rowspan="1" colspan="1">Df23</td></tr><tr><td align="left" rowspan="1" colspan="1">24</td><td align="left" rowspan="1" colspan="1">N-Ethylpiperazine</td><td align="left" rowspan="1" colspan="1">Dd24</td><td align="left" rowspan="1" colspan="1">De24</td><td align="left" rowspan="1" colspan="1">Df24</td></tr><tr><td align="left" rowspan="1" colspan="1">25</td><td align="left" rowspan="1" colspan="1">Piperazine</td><td align="left" rowspan="1" colspan="1">Dd25</td><td align="left" rowspan="1" colspan="1">De25</td><td align="left" rowspan="1" colspan="1">Df25</td></tr><tr><td align="left" rowspan="1" colspan="1">26</td><td align="left" rowspan="1" colspan="1">m-Phenylenediamine</td><td align="left" rowspan="1" colspan="1">Dd26</td><td align="left" rowspan="1" colspan="1">De26</td><td align="left" rowspan="1" colspan="1">Df26</td></tr><tr><td align="left" rowspan="1" colspan="1">27</td><td align="left" rowspan="1" colspan="1">o-Phenylenediamine</td><td align="left" rowspan="1" colspan="1">Dd27</td><td align="left" rowspan="1" colspan="1">De27</td><td align="left" rowspan="1" colspan="1">Df27</td></tr><tr><td align="left" rowspan="1" colspan="1">28</td><td align="left" rowspan="1" colspan="1">Morpholine</td><td align="left" rowspan="1" colspan="1">Dd28</td><td align="left" rowspan="1" colspan="1">De28</td><td align="left" rowspan="1" colspan="1">Df28</td></tr><tr><td align="left" rowspan="1" colspan="1">29</td><td align="left" rowspan="1" colspan="1">Ethanolamine</td><td align="left" rowspan="1" colspan="1">Dd29</td><td align="left" rowspan="1" colspan="1">De29</td><td align="left" rowspan="1" colspan="1">Df29</td></tr><tr><td align="left" rowspan="1" colspan="1">30</td><td align="left" rowspan="1" colspan="1">Tert. Butylamine</td><td align="left" rowspan="1" colspan="1">Dd30</td><td align="left" rowspan="1" colspan="1">De30</td><td align="left" rowspan="1" colspan="1">Df30</td></tr><tr><td align="left" rowspan="1" colspan="1">31</td><td align="left" rowspan="1" colspan="1">Cyclohexylamine</td><td align="left" rowspan="1" colspan="1">Dd31</td><td align="left" rowspan="1" colspan="1">De31</td><td align="left" rowspan="1" colspan="1">Df31</td></tr><tr><td align="left" rowspan="1" colspan="1">32</td><td align="left" rowspan="1" colspan="1">Cyclopropylamin</td><td align="left" rowspan="1" colspan="1">Dd32</td><td align="left" rowspan="1" colspan="1">De32</td><td align="left" rowspan="1" colspan="1">Df32</td></tr><tr><td align="left" rowspan="1" colspan="1">33</td><td align="left" rowspan="1" colspan="1">Benzylamine</td><td align="left" rowspan="1" colspan="1">Dd33</td><td align="left" rowspan="1" colspan="1">De33</td><td align="left" rowspan="1" colspan="1">Df33</td></tr><tr><td align="left" rowspan="1" colspan="1">34</td><td align="left" rowspan="1" colspan="1">Ethylene diamine</td><td align="left" rowspan="1" colspan="1">Dd34</td><td align="left" rowspan="1" colspan="1">De34</td><td align="left" rowspan="1" colspan="1">Df34</td></tr><tr><td align="left" rowspan="1" colspan="1">35</td><td align="left" rowspan="1" colspan="1">Diphenylamine</td><td align="left" rowspan="1" colspan="1">Dd35</td><td align="left" rowspan="1" colspan="1">De35</td><td align="left" rowspan="1" colspan="1">Df35</td></tr><tr><td align="left" rowspan="1" colspan="1">36</td><td align="left" rowspan="1" colspan="1">N-Butylamine</td><td align="left" rowspan="1" colspan="1">Dd36</td><td align="left" rowspan="1" colspan="1">De36</td><td align="left" rowspan="1" colspan="1">Df36</td></tr><tr><td align="left" rowspan="1" colspan="1">37</td><td align="left" rowspan="1" colspan="1">Propylamine</td><td align="left" rowspan="1" colspan="1">Dd37</td><td align="left" rowspan="1" colspan="1">De37</td><td align="left" rowspan="1" colspan="1">Df37</td></tr><tr><td align="left" rowspan="1" colspan="1">38</td><td align="left" rowspan="1" colspan="1">Diethylamine</td><td align="left" rowspan="1" colspan="1">Dd38</td><td align="left" rowspan="1" colspan="1">De38</td><td align="left" rowspan="1" colspan="1">Df38</td></tr><tr><td align="left" rowspan="1" colspan="1">39</td><td align="left" rowspan="1" colspan="1">Ethylamine</td><td align="left" rowspan="1" colspan="1">Dd39</td><td align="left" rowspan="1" colspan="1">De39</td><td align="left" rowspan="1" colspan="1">Df39</td></tr><tr><td align="left" rowspan="1" colspan="1">40</td><td align="left" rowspan="1" colspan="1">Dimethylamine</td><td align="left" rowspan="1" colspan="1">Dd40</td><td align="left" rowspan="1" colspan="1">De40</td><td align="left" rowspan="1" colspan="1">Df40</td></tr></tbody></table></div><div class="largeobj-link align_right" id="largeobj_idm140311573372816"><a target="object" rel="noopener" href="/pmc/articles/PMC9649585/table/Tab1/?report=objectonly">Open in a separate window</a></div></div></div><div id="Sec5" class="sec"><p></p><h4 id="Sec5title" class="inline">Molecular property calculation </h4><p id="Par8" class="p p-first-last">It was observed that only 15 compounds out of 120 cleared the molecular properties window as per the Lipinski&#x02019;s parameters for possible bioavailability (shown in supplementary information in Table 1S). As a result, the toxicity risks of only above identified 15 compounds were assessed in further section.</p></div><div id="Sec6" class="sec"><p></p><h4 id="Sec6title" class="inline">Toxicity assessment </h4><p id="Par9" class="p p-first-last">According to the toxicity data presented in Table <a href="/pmc/articles/PMC9649585/table/Tab2/" target="table" class="fig-table-link figpopup" rid-figpopup="Tab2" rid-ob="ob-Tab2" co-legend-rid=""><span style="position: relative;text-decoration:none;">&#x200B;<span class="figpopup-sensitive-area" style="left: -2.5em;">Table2,</span></span><span>2</span></a>, it was found that the proposed compounds were non-mutagenic, non-carcinogenic, and non-irritant for skin with the exception of compounds Dd40, De3, De36, De39, De40.</p><!--table ft1--><!--table-wrap mode="anchored" t5--><div class="table-wrap anchored whole_rhythm" id="Tab2"><h3>Table 2</h3><!--caption a7--><div class="caption"><p>Assessed toxicity risks of the screened compounds using &#x02018;TOPKAT&#x02019; component</p></div><div class="xtable"><table frame="hsides" rules="groups" class="rendered small default_table"><thead><tr><th align="left" rowspan="1" colspan="1">Serial No.</th><th align="left" rowspan="1" colspan="1">Compound code</th><th align="left" rowspan="1" colspan="1">Ames mutagenicity</th><th align="left" rowspan="1" colspan="1">Mouse female carcinogenic prediction</th><th align="left" rowspan="1" colspan="1">Mouse male carcinogenic prediction</th><th align="left" rowspan="1" colspan="1">Skin irritancy</th></tr></thead><tbody><tr><td align="left" rowspan="1" colspan="1">1</td><td align="left" rowspan="1" colspan="1">Dd40</td><td align="left" rowspan="1" colspan="1">&#x02009;+&#x02009;</td><td align="left" rowspan="1" colspan="1">&#x02212;</td><td align="left" rowspan="1" colspan="1">&#x02212;</td><td align="left" rowspan="1" colspan="1">&#x02212;</td></tr><tr><td align="left" rowspan="1" colspan="1">2</td><td align="left" rowspan="1" colspan="1">De3</td><td align="left" rowspan="1" colspan="1">&#x02009;+&#x02009;</td><td align="left" rowspan="1" colspan="1">&#x02212;</td><td align="left" rowspan="1" colspan="1">&#x02212;</td><td align="left" rowspan="1" colspan="1">&#x02212;</td></tr><tr><td align="left" rowspan="1" colspan="1">3</td><td align="left" rowspan="1" colspan="1">De30</td><td align="left" rowspan="1" colspan="1">&#x02212;</td><td align="left" rowspan="1" colspan="1">&#x02212;</td><td align="left" rowspan="1" colspan="1">&#x02212;</td><td align="left" rowspan="1" colspan="1">&#x02212;</td></tr><tr><td align="left" rowspan="1" colspan="1">4</td><td align="left" rowspan="1" colspan="1">De32</td><td align="left" rowspan="1" colspan="1">&#x02212;</td><td align="left" rowspan="1" colspan="1">&#x02212;</td><td align="left" rowspan="1" colspan="1">&#x02212;</td><td align="left" rowspan="1" colspan="1">&#x02212;</td></tr><tr><td align="left" rowspan="1" colspan="1">5</td><td align="left" rowspan="1" colspan="1">De36</td><td align="left" rowspan="1" colspan="1">&#x02009;+&#x02009;</td><td align="left" rowspan="1" colspan="1">&#x02212;</td><td align="left" rowspan="1" colspan="1">&#x02212;</td><td align="left" rowspan="1" colspan="1">&#x02212;</td></tr><tr><td align="left" rowspan="1" colspan="1">6</td><td align="left" rowspan="1" colspan="1">De37</td><td align="left" rowspan="1" colspan="1">&#x02212;</td><td align="left" rowspan="1" colspan="1">&#x02212;</td><td align="left" rowspan="1" colspan="1">&#x02212;</td><td align="left" rowspan="1" colspan="1">&#x02212;</td></tr><tr><td align="left" rowspan="1" colspan="1">7</td><td align="left" rowspan="1" colspan="1">De38</td><td align="left" rowspan="1" colspan="1">&#x02212;</td><td align="left" rowspan="1" colspan="1">&#x02212;</td><td align="left" rowspan="1" colspan="1">&#x02212;</td><td align="left" rowspan="1" colspan="1">&#x02212;</td></tr><tr><td align="left" rowspan="1" colspan="1">8</td><td align="left" rowspan="1" colspan="1">De39</td><td align="left" rowspan="1" colspan="1">&#x02009;+&#x02009;</td><td align="left" rowspan="1" colspan="1">&#x02212;</td><td align="left" rowspan="1" colspan="1">&#x02212;</td><td align="left" rowspan="1" colspan="1">&#x02212;</td></tr><tr><td align="left" rowspan="1" colspan="1">9</td><td align="left" rowspan="1" colspan="1">De40</td><td align="left" rowspan="1" colspan="1">&#x02009;+&#x02009;</td><td align="left" rowspan="1" colspan="1">&#x02212;</td><td align="left" rowspan="1" colspan="1">&#x02212;</td><td align="left" rowspan="1" colspan="1">&#x02212;</td></tr><tr><td align="left" rowspan="1" colspan="1">10</td><td align="left" rowspan="1" colspan="1">Df3</td><td align="left" rowspan="1" colspan="1">&#x02212;</td><td align="left" rowspan="1" colspan="1">&#x02212;</td><td align="left" rowspan="1" colspan="1">&#x02212;</td><td align="left" rowspan="1" colspan="1">&#x02212;</td></tr><tr><td align="left" rowspan="1" colspan="1">11</td><td align="left" rowspan="1" colspan="1">Df22</td><td align="left" rowspan="1" colspan="1">&#x02212;</td><td align="left" rowspan="1" colspan="1">&#x02212;</td><td align="left" rowspan="1" colspan="1">&#x02212;</td><td align="left" rowspan="1" colspan="1">&#x02212;</td></tr><tr><td align="left" rowspan="1" colspan="1">12</td><td align="left" rowspan="1" colspan="1">Df24</td><td align="left" rowspan="1" colspan="1">&#x02212;</td><td align="left" rowspan="1" colspan="1">&#x02212;</td><td align="left" rowspan="1" colspan="1">&#x02212;</td><td align="left" rowspan="1" colspan="1">&#x02212;</td></tr><tr><td align="left" rowspan="1" colspan="1">13</td><td align="left" rowspan="1" colspan="1">Df28</td><td align="left" rowspan="1" colspan="1">&#x02212;</td><td align="left" rowspan="1" colspan="1">&#x02212;</td><td align="left" rowspan="1" colspan="1">&#x02212;</td><td align="left" rowspan="1" colspan="1">&#x02212;</td></tr><tr><td align="left" rowspan="1" colspan="1">14</td><td align="left" rowspan="1" colspan="1">Df38</td><td align="left" rowspan="1" colspan="1">&#x02212;</td><td align="left" rowspan="1" colspan="1">&#x02212;</td><td align="left" rowspan="1" colspan="1">&#x02212;</td><td align="left" rowspan="1" colspan="1">&#x02212;</td></tr><tr><td align="left" rowspan="1" colspan="1">15</td><td align="left" rowspan="1" colspan="1">Df40</td><td align="left" rowspan="1" colspan="1">&#x02212;</td><td align="left" rowspan="1" colspan="1">&#x02212;</td><td align="left" rowspan="1" colspan="1">&#x02212;</td><td align="left" rowspan="1" colspan="1">&#x02212;</td></tr></tbody></table></div><div class="largeobj-link align_right" id="largeobj_idm140311570751696"><a target="object" rel="noopener" href="/pmc/articles/PMC9649585/table/Tab2/?report=objectonly">Open in a separate window</a></div><div class="tblwrap-foot"><p>(&#x02009;+&#x02009;) indicates non-Ames mutagenic, non-female carcinogenic, non-male carcinogenic, non-irritant. (&#x02009;+) indicates Ames mutagenic</p><p><em>TOPKAT</em> Toxicity Prediction by Komputer Assisted Technology</p></div></div></div><div id="Sec7" class="sec"><p></p><h4 id="Sec7title" class="inline">Molecular docking </h4><p id="Par10" class="p p-first">The docking study of the selected molecules was performed against the wild-1J3I and quadruple mutant-1J3K <em>Pf</em>-DHFR-TS and results are presented as CDOCKER binding energies (Table <a href="/pmc/articles/PMC9649585/table/Tab3/" target="table" class="fig-table-link figpopup" rid-figpopup="Tab3" rid-ob="ob-Tab3" co-legend-rid=""><span style="position: relative;text-decoration:none;">&#x200B;<span class="figpopup-sensitive-area" style="left: -3em;">(Table3).</span></span><span>3</span></a>). The entire set of molecules showed diverse binding affinity and favorable docking interaction. These compounds showed formation of H-bonds with both the proteins, viz., 1J3I and 1J3K. This suggests that test compounds bind well to both target proteins with mutations and in a similar fashion with ligand WRA609.</p><!--table ft1--><!--table-wrap mode="anchored" t5--><div class="table-wrap anchored whole_rhythm" id="Tab3"><h3>Table 3</h3><!--caption a7--><div class="caption"><p>Binding energy of title compounds with wild <em>Pf</em>-DHFR-TS 1J3I and mutant <em>Pf</em>-DHFR-TS 1J3K</p></div><div class="xtable"><table frame="hsides" rules="groups" class="rendered small default_table"><thead><tr><th align="left" rowspan="2" colspan="1">Serial no.</th><th align="left" rowspan="2" colspan="1">Compound code</th><th align="left" rowspan="1" colspan="1">Wild <em>Pf</em>-DHFR-TS<br />(1J3I)</th><th align="left" rowspan="1" colspan="1">Mutant <em>Pf</em>-DHFR-TS<br />(1J3K)</th></tr><tr><th align="left" rowspan="1" colspan="1">Binding energy<br />(Kcal/mole)</th><th align="left" rowspan="1" colspan="1">Binding energy<br />(Kcal/mole)</th></tr></thead><tbody><tr><td align="left" rowspan="1" colspan="1">1</td><td align="left" rowspan="1" colspan="1">De30</td><td align="center" rowspan="1" colspan="1">&#x02212;&#x000a0;123.81</td><td align="left" rowspan="1" colspan="1">&#x02212;&#x000a0;82.55</td></tr><tr><td align="left" rowspan="1" colspan="1">2</td><td align="left" rowspan="1" colspan="1">De32</td><td align="center" rowspan="1" colspan="1">&#x02212;&#x000a0;83.96</td><td align="left" rowspan="1" colspan="1">&#x02212;&#x000a0;88.56</td></tr><tr><td align="left" rowspan="1" colspan="1">3</td><td align="left" rowspan="1" colspan="1">De37</td><td align="center" rowspan="1" colspan="1">&#x02212;&#x000a0;88.31</td><td align="left" rowspan="1" colspan="1">&#x02212;&#x000a0;89.48</td></tr><tr><td align="left" rowspan="1" colspan="1">4</td><td align="left" rowspan="1" colspan="1">De38</td><td align="center" rowspan="1" colspan="1">&#x02212;&#x000a0;77.76</td><td align="left" rowspan="1" colspan="1">&#x02212;&#x000a0;85.42</td></tr><tr><td align="left" rowspan="1" colspan="1">5</td><td align="left" rowspan="1" colspan="1">Df3</td><td align="center" rowspan="1" colspan="1">&#x02212;&#x000a0;54.08</td><td align="left" rowspan="1" colspan="1">&#x02212;&#x000a0;85.99</td></tr><tr><td align="left" rowspan="1" colspan="1">6</td><td align="left" rowspan="1" colspan="1">Df22</td><td align="center" rowspan="1" colspan="1">&#x02212;&#x000a0;74.78</td><td align="left" rowspan="1" colspan="1">&#x02212;&#x000a0;94.40</td></tr><tr><td align="left" rowspan="1" colspan="1">7</td><td align="left" rowspan="1" colspan="1">Df24</td><td align="center" rowspan="1" colspan="1">&#x02212;&#x000a0;48.96</td><td align="left" rowspan="1" colspan="1">&#x02212;&#x000a0;59.44</td></tr><tr><td align="left" rowspan="1" colspan="1">8</td><td align="left" rowspan="1" colspan="1">Df28</td><td align="center" rowspan="1" colspan="1">&#x02212;&#x000a0;102.46</td><td align="left" rowspan="1" colspan="1">&#x02212;&#x000a0;81.98</td></tr><tr><td align="left" rowspan="1" colspan="1">9</td><td align="left" rowspan="1" colspan="1">Df38</td><td align="center" rowspan="1" colspan="1">&#x02212;&#x000a0;32.76</td><td align="left" rowspan="1" colspan="1">&#x02212;&#x000a0;44.88</td></tr><tr><td align="left" rowspan="1" colspan="1">10</td><td align="left" rowspan="1" colspan="1">Df40</td><td align="center" rowspan="1" colspan="1">&#x02212;&#x000a0;96.03</td><td align="left" rowspan="1" colspan="1">&#x02212;&#x000a0;70.82</td></tr><tr><td align="left" rowspan="1" colspan="1">11</td><td align="left" rowspan="1" colspan="1">WRA609</td><td align="center" rowspan="1" colspan="1">&#x02212;&#x000a0;138.70</td><td align="left" rowspan="1" colspan="1">&#x02212;&#x000a0;98.45</td></tr></tbody></table></div><div class="largeobj-link align_right" id="largeobj_idm140311570101200"><a target="object" rel="noopener" href="/pmc/articles/PMC9649585/table/Tab3/?report=objectonly">Open in a separate window</a></div></div><p id="Par11" class="p">Docking study showed that compounds exhibited diverse range of binding energies with IJ3I, such as &#x02212;&#x000a0;32.76 to &#x02212;&#x000a0;123.81&#x000a0;kcal/mol, while with 1J3K, the compounds displayed binding energy ranges from &#x02212;&#x000a0;44.88 to &#x02212;&#x000a0;94.40&#x000a0;kcal/mol. According to Table <a href="/pmc/articles/PMC9649585/table/Tab3/" target="table" class="fig-table-link figpopup" rid-figpopup="Tab3" rid-ob="ob-Tab3" co-legend-rid=""><span style="position: relative;text-decoration:none;">&#x200B;<span class="figpopup-sensitive-area" style="left: -2.5em;">Table3,</span></span><span>3</span></a>, the compounds formed numerous H-bonds and hydrophobic interactions with the active sites of 1J3I and 1J3K by involving the <em>N</em>-(4-aminobenzoyl)-<span class="small-caps">l</span>-glutamic acid and 1,3,5-triazine moiety.</p><div id="Sec8" class="sec"><p></p><h5 id="Sec8title" class="inline">Docking interaction with the active site of wild-type <em>Pf</em>-DHFR-TS (1J3I) </h5><p id="Par12" class="p p-first-last">Molecular docking analysis against wild-type protein (1J3I) revealed that most of the title compounds created H-bonding by the involvement of amino acids like Arg122, Ser120 with <em>N</em>-(4-aminobenzoyl)-<span class="small-caps">l</span>-glutamic acid scaffold (Table <a href="/pmc/articles/PMC9649585/table/Tab4/" target="table" class="fig-table-link figpopup" rid-figpopup="Tab4" rid-ob="ob-Tab4" co-legend-rid=""><span style="position: relative;text-decoration:none;">&#x200B;<span class="figpopup-sensitive-area" style="left: -3em;">(Table4).</span></span><span>4</span></a>). Moreover, all the compounds had shown the formation of C-H bond<strong>,</strong> Pi-alkyl bonds with different amino acids of the active site. The compound Df3, Df28, and Df38 established Pi&#x02013;pi interaction with Phe58, which renders them as high-affinity molecules to the active site. On close inspection of docking interaction of compounds with 1J3I, it was observed that the test compounds showed increased interaction with the active site, as compared to co-crystallized ligand WRA609. Thus, it was corroborated that due to strong molecular interaction, these compounds possibly show strong inhibitory activity against <em>Pf</em>-DHFR strains.</p><!--table ft1--><!--table-wrap mode="anchored" t5--><div class="table-wrap anchored whole_rhythm" id="Tab4"><h3>Table 4</h3><!--caption a7--><div class="caption"><p>Docking interactions of title compounds</p></div><div class="xtable"><table frame="hsides" rules="groups" class="rendered small default_table"><thead><tr><th align="left" rowspan="1" colspan="1">Compound code</th><th align="left" rowspan="1" colspan="1">Wild type <em>Pf</em>-DHFR-TS (1J3I)</th><th align="left" rowspan="1" colspan="1">Mutant type <em>Pf</em>-DHFR-TS (1J3K)</th></tr></thead><tbody><tr><td align="left" rowspan="1" colspan="1">De30</td><td align="left" rowspan="1" colspan="1"><p>H bond: Arg122, Ser120, Ser111, Ile164</p><p>C-H bond: Leu40</p><p>Pi-alkyl, Alkyl: Leu46, Ile112, Met55</p></td><td align="left" rowspan="1" colspan="1"><p>H bond: Asp194, Gly44, Val45</p><p>C-H bond: Ser111, Thr107, Asn108, Gly166, Gly41, Phe58</p><p>Pi-alkyl, Alkyl: Leu46, Ile112, Phe116, Leu119, Met55</p></td></tr><tr><td align="left" rowspan="1" colspan="1">De32</td><td align="left" rowspan="1" colspan="1"><p>H bond: Arg122, Ser120, Met55</p><p>C-H bond: Tyr170, Ser108, Leu119, Phe116</p><p>Pi-alkyl, Alkyl: Leu46, Ile112, Ala16, Ile14, Phe58</p></td><td align="left" rowspan="1" colspan="1"><p>H bond: Ser111, Arg122</p><p>C-H bond: Leu164, Asn108</p><p>Pi-alkyl, Alkyl: Leu40, Val195, Leu46</p><p>Pi-sigma: Ile112</p></td></tr><tr><td align="left" rowspan="1" colspan="1">De37</td><td align="left" rowspan="1" colspan="1"><p>H bond: Arg122, Ser111, Tyr170</p><p>C-H bond: Ile164, Leu40, Phe116</p><p>Pi-alkyl, Alkyl: Phe58, Leu46, Ile112</p></td><td align="left" rowspan="1" colspan="1"><p>H bond: Arg122</p><p>C-H bond: Leu164, Tyr170, Asn108</p><p>Pi-alkyl, Alkyl: Leu40</p><p>Pi-sigma: Ile112</p></td></tr><tr><td align="left" rowspan="1" colspan="1">De38</td><td align="left" rowspan="1" colspan="1"><p>H bond: Arg122, Ser120, Ser111</p><p>C-H bond: Tyr170, Val45, Leu40, Thr107, Phe116</p><p>Pi-alkyl, Alkyl: Ile112, Leu46</p></td><td align="left" rowspan="1" colspan="1"><p>H bond: Arg122, Ser111</p><p>Pi-alkyl, Alkyl: Ala16, Leu40, Leu46</p><p>Pi-sigma: Ile112</p></td></tr><tr><td align="left" rowspan="1" colspan="1">Df3</td><td align="left" rowspan="1" colspan="1"><p>H bond: Ser108, Ser167, Thr107</p><p>C-H bond: Ser111, Phe116</p><p>Pi-alkyl, Alkyl: Leu46, Met55, Ile112, Leu119</p><p>Pi-pi: Phe58</p></td><td align="left" rowspan="1" colspan="1"><p>H bond: Arg122, Ser111</p><p>C-H bond: Val45, Leu164</p><p>Alkyl: Val195</p><p>Pi-sigma: Ile112</p></td></tr><tr><td align="left" rowspan="1" colspan="1">Df22</td><td align="left" rowspan="1" colspan="1"><p>H bond: Arg122, Ser120, Met55</p><p>C-H bond: Leu119, Ser108, Ile164, Leu40, Tyr170</p><p>Pi-alkyl, Alkyl: Ile112, Phe58, Ala16</p></td><td align="left" rowspan="1" colspan="1"><p>H bond: Arg122, Ser111, Met55</p><p>C-H bond: Leu164, Val45</p><p>Pi-sigma: Ile112</p></td></tr><tr><td align="left" rowspan="1" colspan="1">Df24</td><td align="left" rowspan="1" colspan="1"><p>H bond: Arg122, Phe116, Met55</p><p>C-H bond: Ser108, Leu40, Gly166, Tyr170, Ile164</p><p>Pi-alkyl, Alkyl: Ala16, Phe58, Leu46</p></td><td align="left" rowspan="1" colspan="1"><p>H bond: Arg59, Arg122</p><p>C-H bond: Leu40</p><p>Pi-alkyl, Alkyl: Phe58, Ala16, Val195, Leu46, Met55, Ile112</p></td></tr><tr><td align="left" rowspan="1" colspan="1">Df28</td><td align="left" rowspan="1" colspan="1"><p>H bond: Ser167, Val168, Val45, Ile164</p><p>C-H bond: Asp54, Gly41, Ser111, Ile112</p><p>Pi-alkyl, Alkyl: Ala16</p><p>Pi-pi: Phe58</p></td><td align="left" rowspan="1" colspan="1"><p>H bond: Arg122, Ser111</p><p>C-H bond: Leu164, Val45</p><p>Pi-alkyl: Leu46</p><p>Pi-sigma: Ile112</p></td></tr><tr><td align="left" rowspan="1" colspan="1">Df38</td><td align="left" rowspan="1" colspan="1"><p>H bond: Arg122, Ser120, Met55</p><p>C-H bond: Phe116, Ser108, Tyr170, Ile164, Asp54</p><p>Pi-alkyl, Alkyl: Ile112, Ala16</p><p>Pi-pi: Phe58</p></td><td align="left" rowspan="1" colspan="1"><p>H bond: Ser111</p><p>C-H bond: Gly166, Thr107</p><p>Pi-alkyl, Alkyl: Pro113, Phe116, Ile112</p><p>Pi-pi: Phe58</p></td></tr><tr><td align="left" rowspan="1" colspan="1">Df40</td><td align="left" rowspan="1" colspan="1"><p>H bond: Ser167, Val45, Leu40, Asp194, Gly44, Asn42</p><p>Pi-alkyl, Alkyl: Leu46, Met55, Phe116, Leu119, Ile112, Ile164, Met104</p></td><td align="left" rowspan="1" colspan="1"><p>H bond: Arg122, Ser120, Arg59, Met55, Asn108</p><p>C-H bond: Ile112, Leu46</p><p>Pi-pi: Phe58</p></td></tr><tr><td align="left" rowspan="1" colspan="1">WRA609</td><td align="left" rowspan="1" colspan="1"><p>H bond: Ile164, Ile14, Cys15, Asp54</p><p>Pi-alkyl, Alkyl: Val45, Pro113, Ile112, Leu46, Ala16, Met55</p></td><td align="left" rowspan="1" colspan="1"><p>H bond: Asp54, Cys15, Ile14, Leu164, Asn108</p><p>Pi-alkyl, Alkyl: Val195, Leu46, Met55, Ala16</p><p>Pi-sigma: Phe58</p></td></tr></tbody></table></div><div class="largeobj-link align_right" id="largeobj_idm140311573411120"><a target="object" rel="noopener" href="/pmc/articles/PMC9649585/table/Tab4/?report=objectonly">Open in a separate window</a></div></div></div><div id="Sec9" class="sec sec-last"><p></p><h5 id="Sec9title" class="inline">Docking interaction with the active site of mutant type <em>Pf</em>-DHFR-TS (1J3K) </h5><p id="Par13" class="p p-first-last">Molecular docking study against 1J3K revealed that all compounds formed H-bonds with numerous amino acids of the active site by involving of <em>N</em>-(4-aminobenzoyl)-<span class="small-caps">l</span>-glutamic acid scaffold. Moreover, the formation of C-H bond<strong>,</strong> Pi-alkyl bonds with different amino acids of the active site was also observed in some of the molecules. Compound De32, De37, De38, Df3, Df22, and Df28 showed formation of pi-sigma interaction with amino acid Ile112, which might be the reason for strong binding affinity with the mutant protein 1J3K (Fig. <a href="/pmc/articles/PMC9649585/figure/Fig1/" target="figure" class="fig-table-link figpopup" rid-figpopup="Fig1" rid-ob="ob-Fig1" co-legend-rid="lgnd_Fig1"><span style="position: relative;text-decoration:none;">&#x200B;<span class="figpopup-sensitive-area" style="left: -2.5em;">(Fig.1</span></span><span>1</span></a>).</p><!--fig ft0--><!--fig mode=article f1--><div class="fig iconblock whole_rhythm" id="Fig1" co-legend-rid="lgnd_Fig1"><a href="/pmc/articles/PMC9649585/figure/Fig1/" target="figure" rid-figpopup="Fig1" rid-ob="ob-Fig1"><!--fig/graphic|fig/alternatives/graphic mode="anchored" m1--><div class="figure" data-largeobj="" data-largeobj-link-rid="largeobj_idm140311567337376"><a class="inline_block ts_canvas" href="/core/lw/2.0/html/tileshop_pmc/tileshop_pmc_inline.html?title=Click%20on%20image%20to%20zoom&amp;p=PMC3&amp;id=9649585_13205_2022_3400_Fig1_HTML.jpg" target="tileshopwindow" rel="noopener"><div class="ts_bar small" title="Click on image to zoom"></div><img loading="lazy" alt="An external file that holds a picture, illustration, etc.&#10;Object name is 13205_2022_3400_Fig1_HTML.jpg" title="Click on image to zoom" class="tileshop" src="/pmc/articles/PMC9649585/bin/13205_2022_3400_Fig1_HTML.jpg" /></a></div><div class="largeobj-link align_right" id="largeobj_idm140311567337376"><a target="object" rel="noopener" href="/pmc/articles/PMC9649585/figure/Fig1/?report=objectonly">Open in a separate window</a></div></a><div class="icnblk_cntnt" id="lgnd_Fig1"><div><a class="figpopup" href="/pmc/articles/PMC9649585/figure/Fig1/" target="figure" rid-figpopup="Fig1" rid-ob="ob-Fig1">Fig. 1</a></div><!--caption a7--><div class="caption"><p>Best three docked poses with protein 1J3I and 1J3K</p></div></div></div></div></div><div id="Sec10" class="sec sec-last"><p></p><h4 id="Sec10title" class="inline">MD simulation </h4><p id="Par14" class="p p-first">Molecular dynamics simulation study was performed to understand the physical movements of atoms and molecules (Mahanta et al. <a href="#CR19" rid="CR19" class=" bibr popnode">2020</a>). As a part of the study, RMSD, RMSF, and ROG were calculated within the simulation period of 50&#x000a0;ns (50,000&#x000a0;ps) and compared with the control WRA609 to observe the stability of the complexes with both the protein 1J3I and 1J3K. The RMSD plots for the compound were analyzed and showed that 1J3I-WRA609 and 1J3I-Df3 had almost similar deviations within the simulation period. The fluctuations of the individual amino acid residues within the simulation period were plotted in RMSF. It was found that the residues for the 1J3I-WRA609 and 1J3I-Df3 had almost similar pattern with minimum deviations from each other. The ROG diagram indicated that the 1J3I-WRA609 and 1J3I-Df3 complexes were formed with almost equal compactness.</p><p id="Par15">For the protein&#x02013;ligand complex 1J3K-WRA609 and 1J3K-Df3,&#x000a0;some deviations were observed which suggests that the presence of ligand influenced the stability of the protein 1J3K and changed its dynamic behavior. From RMSF analysis, it was found that 1J3K-Df3 showed&#x000a0;minor fluctuations in interaction for some amino acid residue. These findings were also supported by calculated ROG for the 1J3K-Df3 and 1J3K-WRA609 complexes, but the differences between their deviations were found non-significant (Fig. <a href="/pmc/articles/PMC9649585/figure/Fig2/" target="figure" class="fig-table-link figpopup" rid-figpopup="Fig2" rid-ob="ob-Fig2" co-legend-rid="lgnd_Fig2"><span style="position: relative;text-decoration:none;">&#x200B;<span class="figpopup-sensitive-area" style="left: -2.5em;">(Fig.2</span></span><span>2</span></a>).</p><!--fig ft0--><!--fig mode=article f1--><div class="fig iconblock whole_rhythm" id="Fig2" co-legend-rid="lgnd_Fig2"><a href="/pmc/articles/PMC9649585/figure/Fig2/" target="figure" rid-figpopup="Fig2" rid-ob="ob-Fig2"><!--fig/graphic|fig/alternatives/graphic mode="anchored" m1--><div class="figure" data-largeobj="" data-largeobj-link-rid="largeobj_idm140311574935856"><a class="inline_block ts_canvas" href="/core/lw/2.0/html/tileshop_pmc/tileshop_pmc_inline.html?title=Click%20on%20image%20to%20zoom&amp;p=PMC3&amp;id=9649585_13205_2022_3400_Fig2_HTML.jpg" target="tileshopwindow" rel="noopener"><div class="ts_bar small" title="Click on image to zoom"></div><img loading="lazy" alt="An external file that holds a picture, illustration, etc.&#10;Object name is 13205_2022_3400_Fig2_HTML.jpg" title="Click on image to zoom" class="tileshop" src="/pmc/articles/PMC9649585/bin/13205_2022_3400_Fig2_HTML.jpg" /></a></div><div class="largeobj-link align_right" id="largeobj_idm140311574935856"><a target="object" rel="noopener" href="/pmc/articles/PMC9649585/figure/Fig2/?report=objectonly">Open in a separate window</a></div></a><div class="icnblk_cntnt" id="lgnd_Fig2"><div><a class="figpopup" href="/pmc/articles/PMC9649585/figure/Fig2/" target="figure" rid-figpopup="Fig2" rid-ob="ob-Fig2">Fig. 2</a></div><!--caption a7--><div class="caption"><p><strong>A</strong> RMSD value, <strong>B</strong> RMSF value, <strong>C</strong> ROG value analysis with 1J3I; <strong>D</strong> RMSD value, <strong>E</strong> RMSF value, <strong>F</strong> ROG value analysis with 1J3K. In (<strong>A</strong>, <strong>B</strong>, <strong>C</strong>) green lines indicates 1J3I-WRA609 and red line indicates 1J3I-Df3; In (<strong>D</strong>, <strong>E</strong>, <strong>F</strong>), blue lines indicates 1J3K-WRA609 and orange line indicates 1J3K-Df3</p></div></div></div><p id="Par16" class="p">The interactions of the average protein&#x02013;ligand complexes obtained after the MD simulation study showed that the compound Df3 formed six H-bonds with both the protein 1J3I and 1J3K, whereas the co-crystallized ligand WRA609 had only three H-bond with both the proteins (Fig.&#x000a0;<a href="/pmc/articles/PMC9649585/figure/Fig3/" target="figure" class="fig-table-link figpopup" rid-figpopup="Fig3" rid-ob="ob-Fig3" co-legend-rid="lgnd_Fig3"><span>3</span></a>).</p><!--fig ft0--><!--fig mode=article f1--><div class="fig iconblock whole_rhythm" id="Fig3" co-legend-rid="lgnd_Fig3"><a href="/pmc/articles/PMC9649585/figure/Fig3/" target="figure" rid-figpopup="Fig3" rid-ob="ob-Fig3"><!--fig/graphic|fig/alternatives/graphic mode="anchored" m1--><div class="figure" data-largeobj="" data-largeobj-link-rid="largeobj_idm140311567848544"><a class="inline_block ts_canvas" href="/core/lw/2.0/html/tileshop_pmc/tileshop_pmc_inline.html?title=Click%20on%20image%20to%20zoom&amp;p=PMC3&amp;id=9649585_13205_2022_3400_Fig3_HTML.jpg" target="tileshopwindow" rel="noopener"><div class="ts_bar small" title="Click on image to zoom"></div><img loading="lazy" alt="An external file that holds a picture, illustration, etc.&#10;Object name is 13205_2022_3400_Fig3_HTML.jpg" title="Click on image to zoom" class="tileshop" src="/pmc/articles/PMC9649585/bin/13205_2022_3400_Fig3_HTML.jpg" /></a></div><div class="largeobj-link align_right" id="largeobj_idm140311567848544"><a target="object" rel="noopener" href="/pmc/articles/PMC9649585/figure/Fig3/?report=objectonly">Open in a separate window</a></div></a><div class="icnblk_cntnt" id="lgnd_Fig3"><div><a class="figpopup" href="/pmc/articles/PMC9649585/figure/Fig3/" target="figure" rid-figpopup="Fig3" rid-ob="ob-Fig3">Fig. 3</a></div><!--caption a7--><div class="caption"><p>Distances of the hydrogen bonds within the simulation period for <strong>a</strong> 1J3I-Df3, <strong>b</strong> 1J3K-Df3 complexes</p></div></div></div><div id="Sec11" class="sec sec-last"><p></p><h5 id="Sec11title" class="inline">MMPBSA-based binding free energy </h5><p id="Par17" class="p p-first-last">After completing the MD simulation, the MM-PBSA based binding free energies were calculated for all the generated conformations, and the average binding free energy was then calculated for each protein&#x02013;ligand complex (Fig.&#x000a0;<a href="/pmc/articles/PMC9649585/figure/Fig4/" target="figure" class="fig-table-link figpopup" rid-figpopup="Fig4" rid-ob="ob-Fig4" co-legend-rid="lgnd_Fig4"><span>4</span></a>). The binding free energy of the test compound 1J3I-Df3 (&#x02212;&#x000a0;128.13&#x000a0;kcal/mol) was found considerably lower than that of the co-crystallized ligand 1J3I-WRA609 (&#x02212;&#x000a0;69.95&#x000a0;kcal/mol). This indicated that the test compound Df3 formed thermodynamically stable complex with the target protein 1J3I. Likewise, the binding free energy of the test compound 1J3K-Df3 (&#x02212;&#x000a0;124.97&#x000a0;kcal/mol) was found considerably lower than that of the co-crystallized ligand 1J3K-WRA609 (&#x02212;&#x000a0;74.09&#x000a0;kcal/mol) and hence the test compound Df3 formed thermodynamically stable complex with the target protein 1J3K.</p><!--fig ft0--><!--fig mode=article f1--><div class="fig iconblock whole_rhythm" id="Fig4" co-legend-rid="lgnd_Fig4"><a href="/pmc/articles/PMC9649585/figure/Fig4/" target="figure" rid-figpopup="Fig4" rid-ob="ob-Fig4"><!--fig/graphic|fig/alternatives/graphic mode="anchored" m1--><div class="figure" data-largeobj="" data-largeobj-link-rid="largeobj_idm140311567841600"><a class="inline_block ts_canvas" href="/core/lw/2.0/html/tileshop_pmc/tileshop_pmc_inline.html?title=Click%20on%20image%20to%20zoom&amp;p=PMC3&amp;id=9649585_13205_2022_3400_Fig4_HTML.jpg" target="tileshopwindow" rel="noopener"><div class="ts_bar small" title="Click on image to zoom"></div><img loading="lazy" alt="An external file that holds a picture, illustration, etc.&#10;Object name is 13205_2022_3400_Fig4_HTML.jpg" title="Click on image to zoom" class="tileshop" src="/pmc/articles/PMC9649585/bin/13205_2022_3400_Fig4_HTML.jpg" /></a></div><div class="largeobj-link align_right" id="largeobj_idm140311567841600"><a target="object" rel="noopener" href="/pmc/articles/PMC9649585/figure/Fig4/?report=objectonly">Open in a separate window</a></div></a><div class="icnblk_cntnt" id="lgnd_Fig4"><div><a class="figpopup" href="/pmc/articles/PMC9649585/figure/Fig4/" target="figure" rid-figpopup="Fig4" rid-ob="ob-Fig4">Fig. 4</a></div><!--caption a7--><div class="caption"><p>Fluctuation of binding free energies (&#x00394;G) of protein&#x02013;ligand complexes during the MD simulation period. <strong>a</strong> The green line represents the complex 1J3I-WRA609, red line represents 1J3I-Df3, <strong>b</strong> blue line represents 1J3K-WRA609 and orange line represents 1J3K-Df3 complexes</p></div></div></div></div></div></div><div id="Sec12" class="sec"><h3 id="Sec12title">Synthesis</h3><p id="Par18" class="p p-first">The complete synthetic scheme is reported in Scheme <a href="/pmc/articles/PMC9649585/figure/Sch1/" target="figure" class="fig-table-link figpopup" rid-figpopup="Sch1" rid-ob="ob-Sch1" co-legend-rid="lgnd_Sch1"><span style="position: relative;text-decoration:none;">&#x200B;<span class="figpopup-sensitive-area" style="left: -3em;">Scheme1.</span></span><span>1</span></a>. According to the scheme, mono-substitution <strong>(B)</strong> of 2,4,6-trichloro-1,3,5-triazine <strong>(A)</strong> with <strong>X</strong> was achieved at 0&#x02013;5&#x000a0;&#x000b0;C for 3&#x000a0;h. The 2-chloro-4,6-disubstituted 1,3,5-triazine derivatives <strong>(C)</strong> were synthesized by the reaction of <strong>(B)</strong> with different primary/secondary amines <strong>(Y)</strong> under microwave temperature of 27&#x02013;31&#x000a0;&#x000b0;C in 1,4-Dioxane. The tri-substituted 1,3,5-triazine derivatives <strong>(D)</strong> with <em>N</em>-(4-aminobenzoyl)-<span class="small-caps">l</span>-glutamic acid were achieved in 15&#x000a0;min under microwave temperature 90&#x000a0;&#x000b0;C. The obtained products were recrystallized with suitable solvents and dried properly.</p><!--fig ft0--><!--fig mode=article f1--><div class="fig iconblock whole_rhythm" id="Sch1" co-legend-rid="lgnd_Sch1"><a href="/pmc/articles/PMC9649585/figure/Sch1/" target="figure" rid-figpopup="Sch1" rid-ob="ob-Sch1"><!--fig/graphic|fig/alternatives/graphic mode="anchored" m1--><div class="figure" data-largeobj="" data-largeobj-link-rid="largeobj_idm140311576506144"><a class="inline_block ts_canvas" href="/core/lw/2.0/html/tileshop_pmc/tileshop_pmc_inline.html?title=Click%20on%20image%20to%20zoom&amp;p=PMC3&amp;id=9649585_13205_2022_3400_Sch1_HTML.jpg" target="tileshopwindow" rel="noopener"><div class="ts_bar small" title="Click on image to zoom"></div><img loading="lazy" alt="An external file that holds a picture, illustration, etc.&#10;Object name is 13205_2022_3400_Sch1_HTML.jpg" title="Click on image to zoom" class="tileshop" src="/pmc/articles/PMC9649585/bin/13205_2022_3400_Sch1_HTML.jpg" /></a></div><div class="largeobj-link align_right" id="largeobj_idm140311576506144"><a target="object" rel="noopener" href="/pmc/articles/PMC9649585/figure/Sch1/?report=objectonly">Open in a separate window</a></div></a><div class="icnblk_cntnt" id="lgnd_Sch1"><div><a class="figpopup" href="/pmc/articles/PMC9649585/figure/Sch1/" target="figure" rid-figpopup="Sch1" rid-ob="ob-Sch1">Scheme 1</a></div><!--caption a7--><div class="caption"><p>Synthesis of <em>N</em>-(4-aminobenzoyl)-<span class="small-caps">l</span>-glutamic acid conjugated 1,3,5-triazine derivatives. Reagents and Condition: <strong>(i)</strong> Acetone, 0&#x02013;5&#x02103;, 3&#x000a0;h, <strong>(ii)</strong> 1,4-Dioxane<sub>,</sub> Triethylamine, 27&#x02013;31&#x000a0;&#x02103;, 10&#x000a0;min, 1&#x000a0;bar, 20&#x000a0;W, <strong>(iii)</strong>
<em>N</em>-(4-aminobenzoyl)-<span class="small-caps">l</span>-glutamic acid, Dimethylformamide (DMF)<sub>,</sub> Triethylamine<sub>,</sub> 90&#x000a0;&#x02103;, 15&#x000a0;min, 5&#x000a0;bar, 50&#x000a0;W</p></div></div></div><p id="Par19" class="p p-last">The synthesized compounds were characterized by a variety of physical and chemical characteristics, such as solubility, physical state, color, melting point, and measurement of the R<sub>f</sub> value by TLC with a solvent system of Methanol, Ethylacetate, and Chloroform (1:1:2). Structural characterization was performed with different spectroscopic techniques. The <sup>1</sup>H NMR spectra analysis confirmed the presence of the characteristic acidic proton in between 12.43 and 9.56&#x000a0;ppm. The protons in the aromatic ring displayed a distinctive doublet signal in at approximately 8.50&#x02013;6&#x000a0;ppm, whereas the singlet in between 3 and 2&#x000a0;ppm corresponded mostly to the NH protons. Likewise, the <sup>13</sup>C NMR spectra analysis confirmed the presence of deshielded carbonyl carbon at about 174&#x02013;173&#x000a0;ppm. Indication of doublets (d) in between 8.50 and 6.56&#x000a0;ppm confirmed the presence of aromatic C&#x02013;H protons in <sup>1</sup>H NMR spectra. The remaining quantity and types of protons and carbons in the synthesized compounds displayed their signals in accordance with their typical multiplicities. The mass spectra (MS) measurements of the synthesized compounds identified that the molecular ion peaks and the estimated molecular mass were connected. For the N&#x02013;H substituted to 1,3,5-triazine moiety, some distinctive stretching vibrations were visible in the FT-IR spectra in between 3393 and 3238&#x000a0;cm<sup>&#x02212;1</sup>. At 3341&#x02013;2916&#x000a0;cm<sup>&#x02212;1</sup>, the OH stretching vibrations in COOH were observed. Stretching vibrations at 1887&#x02013;1625&#x000a0;cm<sup>&#x02212;1</sup> were associated with the C=O group present in the compounds. The range of 1599&#x02013;1503&#x000a0;cm<sup>&#x02212;1</sup> was responsible for the C&#x02013;C aromatic stretching, vibrations.</p></div><div id="Sec13" class="sec sec-last"><h3 id="Sec13title">In vitro antimalarial screening</h3><p id="Par20" class="p p-first">The antimalarial activity of all synthetic compounds against <em>P. falciparum</em> strains 3D7 (chloroquine-sensitive) and Dd2 (Chloroquine-resistant) is shown in Table <a href="/pmc/articles/PMC9649585/table/Tab5/" target="table" class="fig-table-link figpopup" rid-figpopup="Tab5" rid-ob="ob-Tab5" co-legend-rid=""><span style="position: relative;text-decoration:none;">&#x200B;<span class="figpopup-sensitive-area" style="left: -2.5em;">Table5.</span></span><span>5</span></a>. The IC<sub>50</sub> values for the compounds Df28, Df38, Df24, and Df22, ranged from 14.40 to 41.67 &#x003bc;g&#x000a0;mL<sup>&#x02212;1</sup> against 3D7 (chloroquine-sensitive) of strain of <em>P. falciparum</em> along with resistance index (RI) 0.27 to 3.69 and compounds Df3, Df22, De38, and Df40 showed IC<sub>50</sub> range from 9.54 to 23.24 &#x003bc;g&#x000a0;mL<sup>&#x02212;1</sup> against Dd2 (chloroquine-resistant) strain of <em>P. falciparum</em> with resistance index (RI) 0.16 to 0.51. Among the ten synthesized compounds, compound Df3 with heterocyclic such as piperidine substitution demonstrated superior efficacy against chloroquine resistant strain (Dd2) with IC<sub>50</sub> 9.54&#x000a0;&#x003bc;g&#x000a0;mL<sup>&#x02212;1</sup> and moderate antimalarial activity against 3D7 strains with IC<sub>50</sub> 57.85&#x000a0;&#x003bc;g&#x000a0;mL<sup>&#x02212;1</sup> along with resistance index (RI) 0.16 low as comparable to chloroquine 1.71. Replacement of heterocyclic amine analogue piperidine with other heterocyclic amine analogue, such as piperazine in compound Df22, showed good antimalarial activity in Dd2 strain and moderate in 3D7 strain with IC<sub>50</sub> 11.55 and 41.67&#x000a0;&#x003bc;g&#x000a0;mL<sup>&#x02212;1</sup>. On replacing heterocyclic amine analogue such as piperazine with aliphatic amine such as diethylamine in compound De38 showed insignificant antimalarial activity in 3D7 strain with IC<sub>50</sub> 93.88&#x000a0;&#x003bc;g&#x000a0;mL<sup>&#x02212;1</sup> but highest antimalarial activity in Dd2 strain with IC<sub>50</sub> 15.94&#x000a0;&#x003bc;g&#x000a0;mL<sup>&#x02212;1</sup> along with resistance index (RI) 0.16 low than standard drug chloroquine. On replacing aliphatic analogue such as diethylamine with heterocyclic analogous as ethylpiperazine in compound Df24 showed good antimalarial activity in 3D7 strain with IC<sub>50</sub> 22.96&#x000a0;&#x003bc;g&#x000a0;mL<sup>&#x02212;1</sup> but insignificant antimalarial activity in Dd2 strain with IC<sub>50</sub> 36.16&#x000a0;&#x003bc;g&#x000a0;mL<sup>&#x02212;1</sup> along with resistance index (RI) 1.57 low than standard drug chloroquine. Compounds contain heterocyclic amine analogue, such as morpholine substituted derivative Df28 showed promising antimalarial activity against 3D7 strain with IC<sub>50</sub> 14.40 and moderate antimalarial activity Dd2 strain with IC<sub>50</sub> 43.22&#x000a0;&#x003bc;g&#x000a0;mL<sup>&#x02212;1</sup>. Furthermore, diethylamine substituted derivatives Df38 showed mild antimalarial activity against 3D7 strain of <em>P. falciparum</em> with IC<sub>50</sub> 21.35&#x000a0;&#x003bc;g&#x000a0;mL<sup>&#x02212;1</sup> and negligible antimalarial activity against Dd2 strain with IC<sub>50</sub> 78.79&#x000a0;&#x003bc;g&#x000a0;mL<sup>&#x02212;1</sup>. Replacement of aliphatic diethylamine with dimethylamine in compounds Df40 showed negligible antimalarial activity against 3D7 strain of <em>P. falciparum</em> with IC<sub>50</sub> 44.82&#x000a0;&#x003bc;g&#x000a0;mL<sup>&#x02212;1</sup> and moderate antimalarial activity against Dd2 strain with IC<sub>50</sub> 23.24&#x000a0;&#x003bc;g&#x000a0;mL<sup>&#x02212;1</sup>.</p><!--table ft1--><!--table-wrap mode="anchored" t5--><div class="table-wrap anchored whole_rhythm" id="Tab5"><h3>Table 5</h3><!--caption a7--><div class="caption"><p>In vitro antimalarial activity of title compounds on <em>Plasmodium falciparum</em> chloroquine-sensitive (3D7) and chloroquine-resistant (Dd2) strains with Resistance index (RI)</p></div><div class="xtable"><table frame="hsides" rules="groups" class="rendered small default_table"><thead><tr><th align="left" rowspan="2" colspan="1">Serial no.</th><th align="left" rowspan="2" colspan="1">Compound code</th><th align="left" colspan="2" rowspan="1">IC<sub>50</sub><sup>*</sup></th><th align="left" rowspan="2" colspan="1">Resistance index (RI)<br />IC<sub>50</sub><sup>Dd2</sup>/IC<sub>50</sub><sup>3D7</sup></th></tr><tr><th align="left" rowspan="1" colspan="1">3D7<br />(&#x003bc;g mL<sup>&#x02212;1</sup>)</th><th align="left" rowspan="1" colspan="1">Dd2<br />(&#x003bc;g mL<sup>&#x02212;1</sup>)</th></tr></thead><tbody><tr><td align="left" rowspan="1" colspan="1">1</td><td align="left" rowspan="1" colspan="1">De30</td><td align="center" rowspan="1" colspan="1">86.29&#x02009;&#x000b1;&#x02009;0.64</td><td align="center" rowspan="1" colspan="1">91.12&#x02009;&#x000b1;&#x02009;0.52</td><td align="center" rowspan="1" colspan="1">1.05</td></tr><tr><td align="left" rowspan="1" colspan="1">2</td><td align="left" rowspan="1" colspan="1">De32</td><td align="center" rowspan="1" colspan="1">92.85&#x02009;&#x000b1;&#x02009;0.98</td><td align="center" rowspan="1" colspan="1">27.07&#x02009;&#x000b1;&#x02009;0.44</td><td align="center" rowspan="1" colspan="1">0.29</td></tr><tr><td align="left" rowspan="1" colspan="1">3</td><td align="left" rowspan="1" colspan="1">De37</td><td align="center" rowspan="1" colspan="1">73.13&#x02009;&#x000b1;&#x02009;0.79</td><td align="center" rowspan="1" colspan="1">54.38&#x02009;&#x000b1;&#x02009;0.51</td><td align="center" rowspan="1" colspan="1">0.74</td></tr><tr><td align="left" rowspan="1" colspan="1">4</td><td align="left" rowspan="1" colspan="1">De38</td><td align="center" rowspan="1" colspan="1">93.88&#x02009;&#x000b1;&#x02009;0.84</td><td align="center" rowspan="1" colspan="1">15.94&#x02009;&#x000b1;&#x02009;0.22</td><td align="center" rowspan="1" colspan="1">0.16</td></tr><tr><td align="left" rowspan="1" colspan="1">5</td><td align="left" rowspan="1" colspan="1">Df3</td><td align="center" rowspan="1" colspan="1">57.85&#x02009;&#x000b1;&#x02009;0.20</td><td align="center" rowspan="1" colspan="1">9.54&#x02009;&#x000b1;&#x02009;0.01</td><td align="center" rowspan="1" colspan="1">0.16</td></tr><tr><td align="left" rowspan="1" colspan="1">6</td><td align="left" rowspan="1" colspan="1">Df22</td><td align="center" rowspan="1" colspan="1">41.67&#x02009;&#x000b1;&#x02009;0.82</td><td align="center" rowspan="1" colspan="1">11.55&#x02009;&#x000b1;&#x02009;0.09</td><td align="center" rowspan="1" colspan="1">0.27</td></tr><tr><td align="left" rowspan="1" colspan="1">7</td><td align="left" rowspan="1" colspan="1">Df24</td><td align="center" rowspan="1" colspan="1">22.96&#x02009;&#x000b1;&#x02009;0.34</td><td align="center" rowspan="1" colspan="1">36.16&#x02009;&#x000b1;&#x02009;0.0.74</td><td align="center" rowspan="1" colspan="1">1.57</td></tr><tr><td align="left" rowspan="1" colspan="1">8</td><td align="left" rowspan="1" colspan="1">Df28</td><td align="center" rowspan="1" colspan="1">14.40&#x02009;&#x000b1;&#x02009;0.20</td><td align="center" rowspan="1" colspan="1">43.22&#x02009;&#x000b1;&#x02009;0.81</td><td align="center" rowspan="1" colspan="1">3.00</td></tr><tr><td align="left" rowspan="1" colspan="1">9</td><td align="left" rowspan="1" colspan="1">Df38</td><td align="center" rowspan="1" colspan="1">21.35&#x02009;&#x000b1;&#x02009;0.29</td><td align="center" rowspan="1" colspan="1">78.79&#x02009;&#x000b1;&#x02009;0.81</td><td align="center" rowspan="1" colspan="1">3.69</td></tr><tr><td align="left" rowspan="1" colspan="1">10</td><td align="left" rowspan="1" colspan="1">Df40</td><td align="center" rowspan="1" colspan="1">44.82&#x02009;&#x000b1;&#x02009;0.88</td><td align="center" rowspan="1" colspan="1">23.24&#x02009;&#x000b1;&#x02009;0.33</td><td align="center" rowspan="1" colspan="1">0.51</td></tr><tr><td align="left" rowspan="1" colspan="1">11</td><td align="left" rowspan="1" colspan="1">Chloroquine</td><td align="center" rowspan="1" colspan="1">0.70&#x02009;&#x000b1;&#x02009;0.004</td><td align="center" rowspan="1" colspan="1">1.20&#x02009;&#x000b1;&#x02009;0.006</td><td align="center" rowspan="1" colspan="1">1.71</td></tr></tbody></table></div><div class="largeobj-link align_right" id="largeobj_idm140311571175632"><a target="object" rel="noopener" href="/pmc/articles/PMC9649585/table/Tab5/?report=objectonly">Open in a separate window</a></div><div class="tblwrap-foot"><p>*IC<sub>50</sub> values are the means&#x02009;&#x000b1;&#x02009;SD of <em>n</em>&#x02009;=&#x02009;3</p></div></div><div id="Sec14" class="sec sec-last"><p></p><h4 id="Sec14title" class="inline">Structure&#x02013;activity relationship study </h4><p id="Par21" class="p p-first-last">The antimalarial activity result was used to generate a structure&#x02013;activity relationship (SAR), as shown in Fig.&#x000a0;<a href="/pmc/articles/PMC9649585/figure/Fig5/" target="figure" class="fig-table-link figpopup" rid-figpopup="Fig5" rid-ob="ob-Fig5" co-legend-rid="lgnd_Fig5"><span>5</span></a>. Compounds Df3 and Df28 with <em>N</em>-containing hetero alicyclic substitution such as morpholine and piperidine showed the highest antimalarial activity in chloroquine resistant Dd2 and chloroquine sensitive (3D7) strains of <em>P. falciparum.</em> Antimalarial activity is increased by substituting <em>N</em>-containing aliphatic groups, which is supported by previous research published by our group and other researchers (Bhat et al. <a href="#CR4" rid="CR4" class=" bibr popnode">2013a</a>, <a href="#CR5" rid="CR5" class=" bibr popnode">b</a>). Compounds Df22 and Df24 containing a hetero alicyclic linkage with a 1,3,5-triazine ring, such as piperazine and ethylpiperazine, demonstrated good antimalarial activity against the Dd2 strain of <em>P. falciparum</em> and moderate antimalarial activity against the (3D7) strain of <em>P. falciparum</em>. Furthermore, substituting chain aliphatic group for a hetero alicyclic analogue in compounds Df38, Df40, De30, and De37 such as diethylamine, dimethylamine, tert-butylamine, and propylamine showed reduced antimalarial activity against both the strains. Furthermore, increasing the chain length of the substitution linkage with the 1,3,5-triazine ring reduces activity against both 3D7 and Dd2 strains due to steric hindrance of aliphatic chain analogous that may interfere with the active site of the receptor with ligand (Alven and Aderibigbe <a href="#CR2" rid="CR2" class=" bibr popnode">2019</a>).</p><!--fig ft0--><!--fig mode=article f1--><div class="fig iconblock whole_rhythm" id="Fig5" co-legend-rid="lgnd_Fig5"><a href="/pmc/articles/PMC9649585/figure/Fig5/" target="figure" rid-figpopup="Fig5" rid-ob="ob-Fig5"><!--fig/graphic|fig/alternatives/graphic mode="anchored" m1--><div class="figure" data-largeobj="" data-largeobj-link-rid="largeobj_idm140311569202576"><a class="inline_block ts_canvas" href="/core/lw/2.0/html/tileshop_pmc/tileshop_pmc_inline.html?title=Click%20on%20image%20to%20zoom&amp;p=PMC3&amp;id=9649585_13205_2022_3400_Fig5_HTML.jpg" target="tileshopwindow" rel="noopener"><div class="ts_bar small" title="Click on image to zoom"></div><img loading="lazy" alt="An external file that holds a picture, illustration, etc.&#10;Object name is 13205_2022_3400_Fig5_HTML.jpg" title="Click on image to zoom" class="tileshop" src="/pmc/articles/PMC9649585/bin/13205_2022_3400_Fig5_HTML.jpg" /></a></div><div class="largeobj-link align_right" id="largeobj_idm140311569202576"><a target="object" rel="noopener" href="/pmc/articles/PMC9649585/figure/Fig5/?report=objectonly">Open in a separate window</a></div></a><div class="icnblk_cntnt" id="lgnd_Fig5"><div><a class="figpopup" href="/pmc/articles/PMC9649585/figure/Fig5/" target="figure" rid-figpopup="Fig5" rid-ob="ob-Fig5">Fig. 5</a></div><!--caption a7--><div class="caption"><p>SAR study</p></div></div></div></div></div></div><div id="Sec15" class="tsec sec"><h2 class="head no_bottom_margin" id="Sec15title">Experimental section</h2><div id="Sec16" class="sec sec-first"><h3 id="Sec16title">Designed chemical library</h3><p id="Par22" class="p p-first-last">A 1,3,5-triazine scaffold was employed in this study as the fundamental structural foundation for creating novel 1,3,5-triazine derivatives via molecular modification. Their antimalarial effectiveness may be significantly influenced by the presence <em>N</em>-(4-aminobenzoyl)-<span class="small-caps">l</span>-glutamic acid scaffold. The primary/ secondary amines with aliphatic chains or aromatic rings that make up the functional groups were set for the chemical library. A total of three series were created from all of the designed 120 compounds: (Dd1 to Dd40, De1 to De40 and Df1 to Df40). The substitutions in 1,3,5-triazine conjugated with <em>N</em>-(4-aminobenzoyl)-<span class="small-caps">l</span>-glutamic acid scaffold are tabulated in Table <a href="/pmc/articles/PMC9649585/table/Tab1/" target="table" class="fig-table-link figpopup" rid-figpopup="Tab1" rid-ob="ob-Tab1" co-legend-rid=""><span style="position: relative;text-decoration:none;">&#x200B;<span class="figpopup-sensitive-area" style="left: -2.5em;">Table1</span></span><span>1</span></a>.</p></div><div id="Sec17" class="sec"><h3 id="Sec17title">Computational screening</h3><p id="Par23" class="p p-first">In order to conduct computational screening and molecular modelling studies, Molinspiration Cheminformatics, and Biovia Discovery Studio (DS) 2020 was adopted. The Biovia Discovery Studio (DS) 2020 was from Dassault Syst&#x000e8;mes BIOVIA, San Diego, USA on a Dell Precision workstation T3400 with an Intel Core 2 Duo processor, 4&#x000a0;GB of RAM, a 250&#x000a0;GB hard drive, and NVidia Quodro FX 4500 graphics card.</p><div id="Sec18" class="sec"><p></p><h4 id="Sec18title" class="inline">Molecular property </h4><p id="Par24" class="p p-first-last">Molecular properties of the designed compounds such as partition co-efficient, total polar surface area, number of atoms, molecular weight, numbers of hydrogen bond acceptors and donors, and numbers of rotatable bonds were calculated with the help of Molinspiration cheminformatics software. Molinspiration Cheminformatics states that molecules that violate more than one of these rules may have bioavailability problems (<a href="http://www.molinspiration.com" data-ga-action="click_feat_suppl" ref="reftype=extlink&amp;article-id=9649585&amp;issue-id=419667&amp;journal-id=1811&amp;FROM=Article%7CBody&amp;TO=External%7CLink%7CURI" target="_blank">http://www.molinspiration.com</a>). The molecular weight, partition coefficient/MiLogP, and total polar surface area suggest good intestinal absorption, membrane permeability, and oral bioavailability, respectively. The remaining parameters, number of atoms, numbers of hydrogen bond acceptors and donors, and numbers of rotatable bonds, help to generate well-defined drug&#x02013;receptor interactions for the best possible pharmacological action (Dahlgren and Lennern&#x000e4;s <a href="#CR7" rid="CR7" class=" bibr popnode">2019</a>).</p></div><div id="Sec19" class="sec"><p></p><h4 id="Sec19title" class="inline">Toxicity assessment </h4><p id="Par25" class="p p-first-last">The TOPKAT component of the DS 2020 program was used to predict in silico toxicity on rodent models. To examine that, the following toxicity parameters were checked: Ames mutagenicity, mouse female carcinogenicity, mouse male carcinogenicity, and skin irritancy.</p></div><div id="Sec20" class="sec"><p></p><h4 id="Sec20title" class="inline">Molecular docking </h4><p id="Par26" class="p p-first">According to the DS software&#x02019;s standard approach, ligands and proteins were prepared before docking. Utilizing a smart minimizer built on the CHARMm (Chemistry at Harvard Macromolecular Mechanics) platform, three-dimensional structures of compounds (ligands) were produced and their energy was minimized.</p><p id="Par27">From RCSB Protein Data Bank (<a href="http://www.rcsb.org/" data-ga-action="click_feat_suppl" ref="reftype=extlink&amp;article-id=9649585&amp;issue-id=419667&amp;journal-id=1811&amp;FROM=Article%7CBody&amp;TO=External%7CLink%7CURI" target="_blank">http://www.rcsb.org/</a>), the protein&#x02019;s X-ray crystal structures (PDB ID: 1J3I and 1J3K) were obtained. The method made use of Chain A of both the proteins 1J3I and 1J3K. The standard process was followed to clean the protein molecules as needed, removed water molecules, and minimized energy. The CHARMm-based smart minimizer method with a maximum step size of 200 and an RMSD gradient of 0.1&#x000a0;kcal/mol was used to minimize the energy (Jain <a href="#CR13" rid="CR13" class=" bibr popnode">2008</a>).</p><p id="Par28">By identifying the important amino acid residues, a receptor grid was created around the binding cavity (active sites) of the energy-minimized protein molecule. The amino acid residues were defined for the purpose of predicting the binding locations using the co-crystal ligand (active inhibitor) of the relevant protein molecule. The binding site sphere of the receptor grid box was created with a radius of 8.96 and <em>x</em>, <em>y</em>, and <em>z</em> dimensions of 28.741985, 5.926629, and 60.148934 for 1J3I. Again, the same was created with a radius of 8.98 and <em>x</em>, <em>y</em>, and <em>z</em> dimensions of 29.567696, 6.016929, and 60.120070 for 1J3K.</p><p id="Par29" class="p p-last">A simulation-based docking protocol, namely CDOCKER of DS 2020, was used for the docking. The CDOCKER is used to dock substances into the receptor molecule&#x02019;s active site(s) with better accuracy. The estimated dock poses were ranked. By examining interactions between receptor&#x02013;ligand complexes, the binding energies of docked ligands were predicted. The 2D diagram of receptor&#x02013;ligand complexes was also used to examine various nonbonding interactions (hydrogen bonding, hydrophobic, etc.). To assess the binding mode of the test compounds, the co-crystal ligand&#x02019;s docking energy was employed as reference ligand in each case.</p></div><div id="Sec21" class="sec sec-last"><p></p><h4 id="Sec21title" class="inline">Molecular dynamics simulation study </h4><p id="Par30" class="p p-first">For the Molecular dynamics <strong>(</strong>MD) simulation investigation utilizing DS 2020, the compound Df3 with promising in vitro antimalarial activity against chloroquine-resistant (Dd2) strain was taken into consideration. The original X-ray crystal structure of the target proteins (1J3I and 1J3K) complexed with the co-crystal inhibitors was submitted to the MD simulation study together with the protein&#x02013;ligand complexes produced by the flexible docking analysis. The macromolecule tool of DS 2020 was initially used to clean and prepare the protein&#x02013;ligand complexes (Lin et al. <a href="#CR17" rid="CR17" class=" bibr popnode">2011</a>). In a water-filled cubic box, the complexes were solvated at a distance of 5&#x000a0;&#x000c5; from the boundary. In the solvation procedure, the system was neutralized by the addition of 0.15&#x000a0;M NaCl. The solvated systems underwent energy minimization (5000 steps conjugate gradient with energy RMSD gradient 0.01&#x000a0;kcal/mol and 5000 steps steepest descent), heating (20&#x000a0;ps), and equilibration (500&#x000a0;ps) using the &#x0201c;Standard Dynamic Cascade&#x0201d; procedure of DS 2020. Analyses were replicated for 30&#x000a0;ns at 300&#x000a0;K in order to evaluate the convergence of the results following an MD simulation. The particle mesh ewald (PME) approach was employed for the electrostatics calculations. The SHAKE algorithm was applied with a 2-fs time step to limit hydrogen-containing bonds. To assess receptor&#x02013;ligand conformation changes and their stability, root-mean-square deviation (RMSD), root mean square fluctuation (RMSF), and radius of gyration (ROG) were computed using the starting structure as a reference for the complete protein&#x02013;ligand complex. The &#x0201c;Analyze Trajectory&#x0201d; protocol was used to calculate the RMSD, RMSF, and ROG values. The distance of the various hydrogen bonds that formed during the simulation was also examined. Finally, the average interaction of the receptor-ligand complexes was determined (Noha et al. <a href="#CR21" rid="CR21" class=" bibr popnode">2017</a>; Lai et al. <a href="#CR16" rid="CR16" class=" bibr popnode">2011</a>).</p><div id="Sec22" class="sec sec-last"><p></p><h5 id="Sec22title" class="inline">MM-PBSA based binding free energy calculation </h5><p id="Par31" class="p p-first-last">One of the crucial parameters to calculate the binding affinity of a molecule to a target is the binding free energy (&#x02206;G), which was calculated using the MM-PBSA method (Genheden and Ryde <a href="#CR11" rid="CR11" class=" bibr popnode">2015</a>). Additionally, it offers quick and precise prediction of absolute binding affinity of a molecule within the active binding region of the target protein. This is crucial for the particular potency in terms of activation or inhibition, as well as its thermodynamic stability (Rastelli et al. <a href="#CR24" rid="CR24" class=" bibr popnode">2010</a>). The &#x02018;Binding Free Energy-Single Trajectory&#x02019; protocol of DS v 2020 along with the MM-PBSA method was used in this investigation to compute the binding free energies for each protein&#x02013;ligand combination. Finally, the average binding free energy (&#x02206;G) for each protein&#x02013;ligand complex was calculated from the binding free energies of all the produced conformations.</p></div></div></div><div id="Sec23" class="sec"><h3 id="Sec23title">Synthesis</h3><div id="Sec24" class="sec sec-first"><p></p><h4 id="Sec24title" class="inline">General requirements </h4><p id="Par32" class="p p-first-last">The synthesis used no extra purification of the commercial precursors and solvents that were purchased from Sigma Aldrich (Merck KGaA), TCI chemicals (India) Pvt. Ltd., and Spectrochem Pvt. Ltd. Thin-layer chromatography was used to keep the track of the reaction progress. For that, pre-coated aluminum TLC plates (TLC silica gel 60 F254, Merck KGaA, Germany) were used and visualized in iodine chamber. Melting point instrument M-560: Buchi (Switzerland) was used to record melting points. Utilizing the CEM microwave synthesizer (CEM, Discover System Model No. 908010), microwave assisted synthesis was carried out.</p></div><div id="Sec25" class="sec"><p></p><h4 id="Sec25title" class="inline">Spectroscopic measurements </h4><p id="Par33" class="p p-first-last">On Bruker Avance Neo 500&#x000a0;MHz NMR, the <sup>1</sup>H and <sup>13</sup>C spectra were recorded. At the respective operating frequencies of 125&#x000a0;MHz and 500&#x000a0;MHz, <sup>13</sup>C NMR and <sup>1</sup>H NMR spectrum observations in DMSO-d6 were carried out using TMS as internal standard. The signals in <sup>1</sup>H NMR were denoted by the letters s-singlet, d-doublet, t-triplet, q-quartet, quint-quintet, and m-multiplet, expressed alongwith <em>J</em> value/coupling constant wherever required. The mid-infrared FT-IR spectra were captured using a Bruker FTIR spectrophotometer (Bruker ALPHA ECO-ATR, Germany). With a UV/Visible Spectrophotometer (Lab India analytical: UV 3200), the maximum wavelength (<em>&#x003bb;</em><sub>max</sub>) for compounds was recorded. The LC&#x02013;MS study was carried out using a Waters Q-TOF Micromass spectrometer (ESI&#x02013;MS). The spectra have been displayed in the supplementary materials.</p></div><div id="Sec26" class="sec"><p></p><h4 id="Sec26title" class="inline">The general synthesis for monosubstituted 1,3,5-triazine derivatives </h4><p id="Par34" class="p p-first">Utilizing the nucleophilic substitution mechanism shown in Scheme <a href="/pmc/articles/PMC9649585/figure/Sch1/" target="figure" class="fig-table-link figpopup" rid-figpopup="Sch1" rid-ob="ob-Sch1" co-legend-rid="lgnd_Sch1"><span style="position: relative;text-decoration:none;">&#x200B;<span class="figpopup-sensitive-area" style="left: -3em;">Scheme1,</span></span><span>1</span></a>, the intermediates and the final compounds were synthesized.</p><p id="Par35" class="p p-last">2,4,6-trichloro-1,3,5-triazine (0.02&#x000a0;mol) was stirred for 0.5&#x000a0;h in acetone (40&#x000a0;mL). Respective amine (0.02&#x000a0;mol) was gradually added to that stirred solution using a dropping funnel at a constant ice bath temperature of 0&#x02013;5&#x000a0;&#x000b0;C. Reaction was carried out for 3&#x000a0;h. After completion of the reaction, the resulting mixture was filtered, dried, and recrystallized with suitable solvent.</p></div><div id="Sec27" class="sec"><p></p><h4 id="Sec27title" class="inline">Synthesis for disubstituted 1,3,5-triazine derivatives </h4><p id="Par36" class="p p-first-last">A solution of first intermediate (0.002&#x000a0;mol), 5&#x000a0;mL 1,4-dioxane, 0.5&#x000a0;mL triethylamine and the appropriate amine (0.004&#x000a0;mol) was agitated together for 10&#x000a0;min at 27 to 31&#x000a0;&#x000b0;C under microwave irradiation at a pressure of 1&#x000a0;bar and power of 20&#x000a0;W. In a petridish, the reaction mixture was poured and allowed to dry. The residue was washed with distilled water before being recrystallized with the appropriate solvents to produce intermediates. TLC was used to monitor the reactions, with Methanol, Ethylacetate, and Chloroform (1:1:2) serving as the mobile phase.</p></div><div id="Sec28" class="sec"><p></p><h4 id="Sec28title" class="inline">Synthesis for title compounds </h4><p id="Par37" class="p p-first-last"><em>N</em>-(4-aminobenzoyl)-<span class="small-caps">l</span>-glutamic acid (0.001&#x000a0;mol) was added to the solution of corresponding disubstituted 1,3,5-triazine derivatives intermediate, in 5&#x000a0;mL&#x000a0;<em>N</em>,<em>N</em>-Dimethylformamide. In the presence of 0.5&#x000a0;mL triethylamine, the reaction mixture was agitated at 90&#x000a0;&#x000b0;C for 15&#x000a0;min in microwave-irradiated closed vessel at a pressure 5&#x000a0;bar and power 50&#x000a0;W. The reaction mixture was then dried in a hot air oven and recrystallized. TLC was used to monitor the reactions, using Methanol, Ethylacetate, and Chloroform as the mobile phase (1:1:2). The melting points of compounds&#x000a0;were recorded.</p></div><div id="Sec29" class="sec sec-last"><p></p><h4 id="Sec29title" class="inline">Characterization and spectral data of </h4><p id="Par38" class="p p-first"><strong>2-[(4-{[4-(Tert-butylamino)-6-(diethylamino)-1,3,5-triazin-2-yl]amino}phenyl)formamido]pentanedioic acid (De30):</strong> Off-white; semi-solid; yield 47%; solubility: DMSO; R<sub>f</sub> 0.53; FTIR(cm<sup>&#x02212;1</sup>):&#x000a0;3284 (NH stretching), 2973 (OH stretching, COOH), 1711 (C=O stretching, COOH), 1625 (C=O stretching, NHCO), 1589 1534 (C&#x02013;C stretching, aromatic), 1497,1443,1404,1358,1310 (CH bending), 1182 (C&#x02013;N stretching); <em>&#x003bb;</em><sub>max</sub> 273&#x000a0;nm; MS For C<sub>23</sub>H<sub>33</sub>N<sub>7</sub>O<sub>5</sub> (M&#x02009;+&#x02009;H)<sup>+</sup>: 488.26; <sup>1</sup>H NMR (500&#x000a0;MHz, DMSO-<em>d</em><sub><em>6</em>,</sub> TMS) &#x003b4;: 11.20 (s, 2H,COOH&#x02009;&#x000d7;&#x02009;2,COOH), 8.49(d, <em>J</em>&#x02009;=&#x02009;10&#x000a0;Hz,2H,CH&#x02009;&#x000d7;&#x02009;2,Ar&#x02013;CH), 7.85(d, <em>J</em>&#x02009;=&#x02009;10&#x000a0;Hz,2H,CH&#x02009;&#x000d7;&#x02009;2,Ar&#x02013;CH), 3.63(q, 6H,CH<sub>2</sub>&#x02009;&#x000d7;&#x02009;3,Aliphatic-CH<sub>2</sub>), 2.89(s, 1H,NH), 2.74(s, 1H,NH), 2.51(s, 1H,NH), 2.37(t, <em>J</em>&#x02009;=&#x02009;10&#x000a0;Hz, 3H,Aliphatic-CH and Aliphatic-CH<sub>2</sub>), 1.42(s, 9H,CH<sub>3</sub>&#x02009;&#x000d7;&#x02009;3,CH<sub>3</sub>), 1.24&#x02013;1.07(m, 6H,CH<sub>3</sub>&#x02009;&#x000d7;&#x02009;2,CH<sub>3</sub>); <sup>13</sup>C NMR (125&#x000a0;MHz, DMSO-<em>d</em><sub><em>6</em></sub>) &#x003b4;: 174.01,173.80, 166.03, 163.55, 163.28, 162.26, 149.84, 128.22, 128.10, 127.99, 119.54, 51.81, 45.42, 30.35, 28.68, 28.42, 28.36, 27.02, 25.87, 13.10, 12.85, 12.78,12.57.</p><p id="Par39"><strong>2-[(4-{[4-(Cyclopropylamino)-6-(diethylamino)-1,3,5-triazin-2-yl]amino}phenyl)formamido]pentanedioic acid (De32):</strong> Off-white; semi-solid; yield 44%; solubility: DMSO; R<sub>f</sub> 0.51; FTIR(cm<sup>&#x02212;1</sup>): 3391 (NH stretching), 2916 (OH stretching, COOH), 2819,2771,2717,2454 (CH stretching), 1775 (C=O stretching, COOH), 1708(C=O stretching, NHCO), 1564 (C&#x02013;C stretching, aromatic), 1438,1399,1360,1303 (CH bending), 1185 (C&#x02013;N stretching); <em>&#x003bb;</em><sub>max</sub> 277&#x000a0;nm; MS For C<sub>22</sub>H<sub>29</sub>N<sub>7</sub>O<sub>5</sub> (M&#x02009;+&#x02009;H)<sup>+</sup>: 472.23; <sup>1</sup>H NMR (500&#x000a0;MHz, DMSO-<em>d</em><sub><em>6</em>,</sub> TMS) &#x003b4;: 10.21(s, 2H, COOH&#x02009;&#x000d7;&#x02009;2,COOH), 8.39(d, <em>J</em>&#x02009;=&#x02009;5&#x000a0;Hz,1H,Ar&#x02013;CH), 7.80(d, <em>J</em>&#x02009;=&#x02009;10&#x000a0;Hz,1H,Ar&#x02013;CH), 7.62(d, <em>J</em>&#x02009;=&#x02009;5&#x000a0;Hz,1H,Ar&#x02013;CH), 6.57(d, <em>J</em>&#x02009;=&#x02009;10&#x000a0;Hz,1H,Ar&#x02013;CH), 4.42&#x02013;4.33(m, 6H,CH<sub>2</sub>&#x02009;&#x000d7;&#x02009;3,Aliphatic-CH<sub>2</sub>), 3.09(q, 4H,CH<sub>2</sub>&#x02009;&#x000d7;&#x02009;2,Cyclopropyl-CH<sub>2</sub>), 2.89(s, 1H,NH), 2.73(s, 1H,NH), 2.51(s, 1H,NH), 2.38(q,2H,Aliphatic-CH<sub>2</sub>), 2.10(t, <em>J</em>&#x02009;=&#x02009;10&#x000a0;Hz,1H,Aliphatic-CH), 1.96(t, <em>J</em>&#x02009;=&#x02009;5&#x000a0;Hz,6H,CH<sub>3</sub>&#x02009;&#x000d7;&#x02009;2,CH<sub>3</sub>), 1.20(quint, 1H,Cyclopropyl-CH); <sup>13</sup>C NMR (125&#x000a0;MHz, DMSO-<em>d</em><sub><em>6</em></sub>) &#x003b4;: 173.93, 166.54, 163.88, 162.34, 151.78, 149.89, 143.89, 128.98, 127.91, 125.83, 120.48, 117.98, 112.45, 51.81, 45.56, 35.76, 30.39, 25.97, 23.39, 13.05,8.48,6.21.</p><p id="Par40"><strong>2-[(4-{[4-(Diethylamino)-6-(propylamino)-1,3,5-triazin-2-yl]amino}phenyl)formamido]pentanedioic acid (De37):</strong> Brown; solid; yield 51%; solubility: methanol; R<sub>f</sub> 0.46; Mp. 271&#x002da;C; FTIR(cm<sup>&#x02212;1</sup>):&#x000a0;3367,3287 (NH stretching), 2928 (OH stretching, COOH), 2859 (CH stretching), 1705 (C=O stretching, COOH), 1671 (C=O stretching, NHCO), 1541 (C&#x02013;C stretching, aromatic), 1444,1394,1344 (CH bending), 1150 (C&#x02013;N stretching); <em>&#x003bb;</em><sub>max</sub> 274&#x000a0;nm; MS For C<sub>22</sub>H<sub>31</sub>N<sub>7</sub>O<sub>5</sub> (M&#x02009;+&#x02009;H)<sup>+</sup>: 474.24; <sup>1</sup>H NMR (500&#x000a0;MHz, DMSO-<em>d</em><sub><em>6</em>,</sub> TMS) &#x003b4;: 12.30 (s, 2H,COOH&#x02009;&#x000d7;&#x02009;2,COOH), 8.50 (d, <em>J</em>&#x02009;=&#x02009;5&#x000a0;Hz,2H,CH&#x02009;&#x000d7;&#x02009;2,Ar&#x02013;CH), 7.84 (d, <em>J</em>&#x02009;=&#x02009;5&#x000a0;Hz,2H,CH&#x02009;&#x000d7;&#x02009;2,Ar&#x02013;CH), 3.32(q, 4H, CH<sub>2</sub>&#x02009;&#x000d7;&#x02009;2,Aliphatic-CH<sub>2</sub>), 3.21 (q, 2H, CH<sub>2</sub>,Aliphatic-CH<sub>2</sub>), 3.06(t, <em>J</em>&#x02009;=&#x02009;5&#x000a0;Hz,2H,Aliphatic-CH<sub>2</sub> ), 2.89 (s, 1H, NH), 2.72 (s, 1H, NH), 2.52 (s, 1H,NH), 2.38 (t, <em>J</em>&#x02009;=&#x02009;10&#x000a0;Hz,1H, Aliphatic-CH), 1.57 (t, <em>J</em>&#x02009;=&#x02009;5&#x000a0;Hz,2H,CH<sub>2</sub>, Aliphatic-CH<sub>2</sub>), 1.22&#x02013;1.07(m, 2H,Aliphatic-CH<sub>2</sub>), 0.91 (t, <em>J</em>&#x02009;=&#x02009;15&#x000a0;Hz,9H,CH<sub>3</sub>&#x02009;&#x000d7;&#x02009;3,CH<sub>3</sub>); <sup>13</sup>C NMR (125&#x000a0;MHz, DMSO-<em>d</em><sub><em>6</em></sub>) &#x003b4;: 173.83, 173.47, 167.86, 166.03, 165.01, 163.57, 162.95, 162.29, 128.25, 118.81, 117.95, 112.75, 51.86, 51.86, 45.40, 35.74, 25.90, 22.18, 13.08, 13.01, 12.56, 11.32.</p><p id="Par41"><strong>2-[(4-{[4,6-Bis(diethylamino)-1,3,5-triazin-2-yl]amino}phenyl)formamido]pentanedioic acid (De38):</strong> Brown; semi-solid; yield 53%; solubility: methanol; R<sub>f</sub> 0.58; FTIR(cm<sup>&#x02212;1</sup>):&#x000a0;3319 (NH stretching), 2976 (OH stretching, COOH), 2934 (CH stretching), 1711 (C=O stretching), 1537,1503 (C&#x02013;C stretching, aromatic), 1435,1377,1361,1344,1321 (CH bending), 1182 (C&#x02013;N stretching); <em>&#x003bb;</em><sub>max</sub> 277&#x000a0;nm; MS For C<sub>23</sub>H<sub>33</sub>N<sub>7</sub>O<sub>5</sub> (M&#x02009;+&#x02009;H)<sup>+</sup>: 488.26; <sup>1</sup>H NMR (500&#x000a0;MHz, DMSO-<em>d</em><sub><em>6</em>,</sub> TMS) &#x003b4;: 11.18 (s, 1H, COOH), 9.56 (s, 1H,COOH), 8.48 (d, <em>J</em>&#x02009;=&#x02009;10&#x000a0;Hz,&#x000a0;2H, CH&#x02009;&#x000d7;&#x02009;2,Ar&#x02013;CH), 7.80 (d, <em>J</em>&#x02009;=&#x02009;5&#x000a0;Hz,2H,CH&#x02009;&#x000d7;&#x02009;2,Ar&#x02013;CH), 2.89 (s, 1H,NH), 2.74 (s,1H, NH), 2.51 (t, <em>J</em>&#x02009;=&#x02009;5&#x000a0;Hz,1H, Aliphatic-CH), 2.38 (t, <em>J</em>&#x02009;=&#x02009;10&#x000a0;Hz,2H,Aliphatic-CH<sub>2</sub>), 2.13 (q, 2H,Aliphatic-CH<sub>2</sub>), 1.22 (q, 8H,CH<sub>2</sub>&#x02009;&#x000d7;&#x02009;4,Aliphatic-CH<sub>2</sub>), 1.10(t, <em>J</em>&#x02009;=&#x02009;5&#x000a0;Hz,12H,CH<sub>3</sub>&#x02009;&#x000d7;&#x02009;4,CH<sub>3</sub>); <sup>13</sup>C NMR (125&#x000a0;MHz, DMSO-<em>d</em><sub><em>6</em></sub>) &#x003b4;: 173.87, 173.54,173.47,168.28,166.15, 165.99,163.33, 163.24, 162.31, 149.88, 143.07, 128.44, 128.06, 126.67, 118.49, 118.49, 51.86,45.48, 35.76, 30.40, 25.92, 13.14, 10.93, 8.45.</p><p id="Par42"><strong>2-[(4-{[4-(Methylamino)-6-(piperidin-1-yl)-1,3,5-triazin-2-yl]amino}phenyl)formamido]pentanedioic acid (Df3):</strong> Off-white; semi-solid; yield 64%; solubility: DMSO; R<sub>f</sub> 0.76; Mp. 190&#x000a0;&#x000b0;C; FTIR(cm<sup>&#x02212;1</sup>):&#x000a0;3375,3238 (NH stretching), 2958 (OH stretching, COOH), 3103,2875 (CH stretching), 1717 (C=O stretching), 1586,1534 (C&#x02013;C stretching, aromatic), 1482,1397,1348,1311 (CH bending), 1173 (C&#x02013;N stretching); <em>&#x003bb;</em><sub>max</sub> 279&#x000a0;nm; MS For C<sub>21</sub>H<sub>27</sub>N<sub>7</sub>O<sub>5</sub> (M&#x02009;+&#x02009;H)<sup>+</sup>: 458.25; <sup>1</sup>H NMR (500&#x000a0;MHz, DMSO-<em>d</em><sub><em>6</em>,</sub> TMS) &#x003b4;: 12.43(s, 2H,COOH&#x02009;&#x000d7;&#x02009;2,COOH), 8.47(d, <em>J</em>&#x02009;=&#x02009;5&#x000a0;Hz,2H,CH&#x02009;&#x000d7;&#x02009;2,Ar&#x02013;CH), 7.97(d, <em>J</em>&#x02009;=&#x02009;5&#x000a0;Hz,2H,CH&#x02009;&#x000d7;&#x02009;2,Ar&#x02013;CH), 7.85(s, 1H,NH), 2.98(q, 2H,Aliphatic-CH<sub>2</sub>), 2.73(s, 1H,NH), 2.51(s, 3H,CH<sub>3</sub>), 2.38(t, <em>J</em>&#x02009;=&#x02009;5&#x000a0;Hz,1H,Aliphatic-CH), 2.03&#x02013;1.94(m, 6H,CH<sub>2</sub>&#x02009;&#x000d7;&#x02009;3,Piperidine-CH<sub>2</sub>), 1.52(s, 1H,NH), 1.19(t, <em>J</em>&#x02009;=&#x02009;10&#x000a0;Hz,6H,CH<sub>2</sub>&#x02009;&#x000d7;&#x02009;3,Piperdine-CH<sub>2</sub> and Aliphatic-CH<sub>2</sub>); <sup>13</sup>C NMR (125&#x000a0;MHz, DMSO-<em>d</em><sub><em>6</em></sub>) &#x003b4;: 173.85, 173.83, 173.49, 166.14, 166.08, 163.48, 143.22, 128.03, 126.68, 126.45, 118.49, 51.81, 45.42, 43.94, 34.12, 30.36, 27.30,27, 25.88, 25.26, 24.12.</p><p id="Par43"><strong>2-[(4-{[4-(Methylamino)-6-(4-methylpiperazin-1-yl)-1,3,5-triazin-2-yl]amino}phenyl)formamido]pentanedioic acid (Df22):</strong> Brown; semi-solid; yield 64%; solubility: DMSO; R<sub>f</sub> 0.70; FTIR(cm<sup>&#x02212;1</sup>):&#x000a0;3341 (OH stretching, COOH), 2787 (CH stretching), 1714 (C=O stretching), 1598,1547 (C&#x02013;C stretching, aromatic), 1495,1392 (CH bending), 1185 (C&#x02013;N stretching); <em>&#x003bb;</em><sub>max</sub> 270&#x000a0;nm; MS For C<sub>21</sub>H<sub>28</sub>N<sub>8</sub>O<sub>5</sub> (M&#x02009;+&#x02009;H)<sup>+</sup>: 473.28; <sup>1</sup>H NMR (500&#x000a0;MHz, DMSO-<em>d</em><sub><em>6</em></sub>, TMS) &#x003b4;: 10.39 (s, 2H,COOH&#x02009;&#x000d7;&#x02009;2,COOH), 7.82(s,1H,NH), 7.62(d, <em>J</em>&#x02009;=&#x02009;10&#x000a0;Hz,2H,CH&#x02009;&#x000d7;&#x02009;2,Ar&#x02013;CH), 6.56(d, <em>J</em>&#x02009;=&#x02009;10&#x000a0;Hz,2H,CH&#x02009;&#x000d7;&#x02009;2,Ar&#x02013;CH), 2.76(s,2H,NH&#x02009;&#x000d7;&#x02009;2,NH), 2.60(s, 3H,CH<sub>3</sub>), 2.53(s,3H,CH<sub>3</sub>), 1.20(t, <em>J</em>&#x02009;=&#x02009;10&#x000a0;Hz,10H,CH<sub>2</sub>&#x02009;&#x000d7;&#x02009;5,Aliphatic-CH<sub>2</sub> and Piperazine-CH<sub>2</sub>), 3.07(q, 2H,Aliphatic-CH<sub>2</sub>); <sup>13</sup>C NMR (125&#x000a0;MHz, DMSO-<em>d</em><sub><em>6</em></sub>) &#x003b4;: 173.87, 173.84, 173.77, 166.44, 156.70, 151.76, 149.84, 129.58, 128.93, 120.43, 112.38, 112.38, 45.20, 40.22, 40.01, 39.92, 39.84, 30.41, 8.86, 8.35, 7.84.</p><p id="Par44"><strong>2-[(4-{[4-(4-Ethylpiperazin-1-yl)-6-(methylamino)-1,3,5-triazin-2-yl]amino}phenyl)formamido]pentanedioic acid (Df24):</strong> Off-white; semi-solid; yield 66%; solubility: DMSO; R<sub>f</sub> 0.69; FTIR(cm<sup>&#x02212;1</sup>): 3349 (NH stretching), 2949 (OH stretching, COOH), 2681,2607 (CH stretching), 1638 (C=O stretching), 1596,1528 (C&#x02013;C stretching, aromatic), 1490,1396 (CH bending), 1192 (C&#x02013;N stretching); <em>&#x003bb;</em><sub>max</sub> 279&#x000a0;nm; MS For C<sub>22</sub>H<sub>30</sub>N<sub>8</sub>O<sub>5</sub> (M&#x02009;+&#x02009;H)<sup>+</sup>: 487.26; <sup>1</sup>H NMR (500&#x000a0;MHz, DMSO-<em>d</em><sub><em>6</em></sub>, TMS) &#x003b4;: 11.37 (s, 1H,COOH), 11.17 (s, 1H,COOH), 8.44(s, 1H,NH), 8.12(d, <em>J</em>&#x02009;=&#x02009;5&#x000a0;Hz,1H,Ar&#x02013;CH), 7.84(d, <em>J</em>&#x02009;=&#x02009;10&#x000a0;Hz,1H,Ar&#x02013;CH), 7.63(d, <em>J</em>&#x02009;=&#x02009;10&#x000a0;Hz,1H,Ar&#x02013;CH), 6.58 (d, <em>J</em>&#x02009;=&#x02009;5&#x000a0;Hz,1H,Ar&#x02013;CH), 3.11(t, <em>J</em>&#x02009;=&#x02009;10&#x000a0;Hz,1H,Aliphatic-CH), 3.06 (q, 2H,Aliphatic-CH<sub>2</sub>), 2.89(s, 2H,NH&#x02009;&#x000d7;&#x02009;2,NH), 2.81(t, <em>J</em>&#x02009;=&#x02009;10&#x000a0;Hz,8H,CH<sub>2</sub>&#x02009;&#x000d7;&#x02009;4,Aliphatic-CH<sub>2</sub>), 2.71(s, 3H,CH<sub>3</sub>), 2.51(t, <em>J</em>&#x02009;=&#x02009;10&#x000a0;Hz,2H, Aliphatic-CH<sub>2</sub>), 1.30(q, 2H,Aliphatic-CH<sub>2</sub>), 1.20(t, <em>J</em>&#x02009;=&#x02009;5&#x000a0;Hz,3H,CH<sub>3</sub>); <sup>13</sup>C NMR (125&#x000a0;MHz, DMSO-<em>d</em><sub><em>6</em></sub>) &#x003b4;: 173.84, 173.72, 173.47, 168.98, 168.10, 166.45, 164.08, 151.47, 129.59, 128.94, 120.63, 113.22, 112.57, 51.81, 51.67, 50.58, 45.24, 30.39, 27.24, 25.86, 8.63, 8.32.</p><p id="Par45"><strong>2&#x02010;[(4&#x02010;{[4&#x02010;(Methylamino)&#x02010;6&#x02010;(morpholin&#x02010;4&#x02010;yl)&#x02010;1,3,5&#x02010;triazin&#x02010;2&#x02010;yl]amino}phenyl)formamido]pentanedioic acid (Df28):</strong> Brown; semi-solid; yield 67%; solubility: DMSO; R<sub>f</sub> 0.66; FTIR(cm<sup>&#x02212;1</sup>): 3304 (NH stretching), 2928 (OH stretching, COOH), 1714 (C=O stretching), 1599,1533 (C&#x02013;C stretching, aromatic), 1446,1412,1344,1300 (CH bending), 1182(C&#x02013;N stretching); <em>&#x003bb;</em><sub>max</sub> 281&#x000a0;nm; MS For C<sub>20</sub>H<sub>25</sub>N<sub>7</sub>O<sub>6</sub> (M&#x02009;+&#x02009;H)<sup>+</sup>: 460.24; <sup>1</sup>H NMR (500&#x000a0;MHz, DMSO-<em>d</em><sub><em>6</em></sub>, TMS) &#x003b4;: 12.27 (s, 2H,COOH&#x02009;&#x000d7;&#x02009;2,COOH), 8.13(d, <em>J</em>&#x02009;=&#x02009;10&#x000a0;Hz,1H,Ar&#x02013;CH), 7.95(s, 1H,NH), 7.64(d, <em>J</em>&#x02009;=&#x02009;5&#x000a0;Hz,2H,CH&#x02009;&#x000d7;&#x02009;2,Ar&#x02013;CH), 6.60(d, <em>J</em>&#x02009;=&#x02009;5&#x000a0;Hz,1H,Ar&#x02013;CH), 3.53(t, <em>J</em>&#x02009;=&#x02009;10&#x000a0;Hz,4H,CH<sub>2</sub>&#x02009;&#x000d7;&#x02009;2,Morpholin-CH<sub>2</sub>), 3.05(t, <em>J</em>&#x02009;=&#x02009;5&#x000a0;Hz,1H,Aliphatic-CH), 2.89(s, 1H,NH), 2.75(s, 1H,NH), 2.53(s, 3H,CH<sub>3</sub>), 2.37(t, <em>J</em>&#x02009;=&#x02009;5&#x000a0;Hz,4H,CH<sub>2</sub>&#x02009;&#x000d7;&#x02009;2,Morpholin-CH<sub>2</sub>), 2.11(q, 2H,Aliphatic-CH<sub>2</sub>), 1.20(t, <em>J</em>&#x02009;=&#x02009;10&#x000a0;Hz,2H,Aliphatic-CH<sub>2</sub>); <sup>13</sup>C NMR (125&#x000a0;MHz, DMSO-<em>d</em><sub><em>6</em></sub>) &#x003b4;: 173.90, 173.51, 167.99, 166.48, 163.64, 151.20, 128.97, 128.06, 120.91, 118.50, 112.79, 65.89, 63.15, 51.71, 45.37, 43.39, 30.41, 27.07, 25.96, 8.39.</p><p id="Par46"><strong>2-[(4-{[4-(Diethylamino)-6-(methylamino)-1,3,5-triazin-2-yl]amino}phenyl)formamido]pentanedioic acid (Df38):</strong> Brown; solid; yield 65%; solubility: DMSO; R<sub>f</sub> 0.72; Mp. 170&#x000a0;&#x000b0;C; FTIR(cm<sup>&#x02212;1</sup>):&#x000a0;3481,3375 (NH stretching), 2934 (OH stretching, COOH), 1887 (C=O stretching), 1585,1539 (C&#x02013;C stretching, aromatic), 1497,1387,1313 (CH bending), 1177 (C&#x02013;N stretching); <em>&#x003bb;</em><sub>max</sub> 274&#x000a0;nm; MS For C<sub>20</sub>H<sub>27</sub>N<sub>7</sub>O<sub>5</sub> (M&#x02009;+&#x02009;H)<sup>+</sup>: 446.24; <sup>1</sup>H NMR (500&#x000a0;MHz, DMSO-<em>d</em><sub><em>6</em>,</sub> TMS) &#x003b4;: 12.24(s, 1H,COOH), 10.50(s, 1H,COOH), 8.47(d, <em>J</em>&#x02009;=&#x02009;5&#x000a0;Hz,1H,Ar&#x02013;CH), 7.96(d, <em>J</em>&#x02009;=&#x02009;15&#x000a0;Hz,1H,Ar&#x02013;CH), 7.87(s,1H,NH), 7.64(d, <em>J</em>&#x02009;=&#x02009;5&#x000a0;Hz,1H,Ar&#x02013;CH), 7.57(d, <em>J</em>&#x02009;=&#x02009;5&#x000a0;Hz,1H,Ar&#x02013;CH), 3.58(q, 4H,CH<sub>2</sub>&#x02009;&#x000d7;&#x02009;2,Aliphatic-CH<sub>2</sub>), 3.49(t, <em>J</em>&#x02009;=&#x02009;5&#x000a0;Hz,1H,Aliphatic-CH), 2.90(s, 2H,NH&#x02009;&#x000d7;&#x02009;2,NH), 2.52(s, 3H,CH<sub>3</sub>), 2.40(q, 2H,Aliphatic-CH<sub>2</sub>), 1.11(t, <em>J</em>&#x02009;=&#x02009;5&#x000a0;Hz,2H,Aliphatic-CH<sub>2</sub>), 1.08(t, <em>J</em>&#x02009;=&#x02009;5&#x000a0;Hz,6H,CH<sub>3</sub>&#x02009;&#x000d7;&#x02009;2,CH<sub>3</sub>); <sup>13</sup>C NMR (125&#x000a0;MHz, DMSO-<em>d</em><sub><em>6</em></sub>) &#x003b4;: 173.89, 173.86, 168.56, 167.79, 165.42, 163.62, 163.25, 143.26, 128.03, 51.87, 45.50, 41.15, 30.39, 27.18, 25.91, 13.11, 13.03, 12.63, 12.54, 8.45.</p><p id="Par47" class="p p-last"><strong>2-[(4-{[4-(Dimethylamino)-6-(methylamino)-1,3,5-triazin-2-yl]amino}phenyl)formamido]pentanedioic acid (Df40):</strong> Brown; semi-solid; yield 64%; solubility: DMSO; R<sub>f</sub> 0.72; FTIR(cm<sup>&#x02212;1</sup>):&#x000a0;3393 (NH stretching), 2931 (OH stretching, COOH), 2869 (CH stretching), 1690 (C=O stretching), 1550 (C&#x02013;C stretching, aromatic), 1457,1391,1338 (CH bending), 1189,1150 (C&#x02013;N stretching); <em>&#x003bb;</em><sub>max</sub> 281&#x000a0;nm; MS For C<sub>18</sub>H<sub>23</sub>N<sub>7</sub>O<sub>5</sub> (M&#x02009;+&#x02009;H)<sup>+</sup>: 418.22; <sup>1</sup>H NMR (500&#x000a0;MHz, DMSO-<em>d</em><sub><em>6</em>,</sub> TMS) &#x003b4;: 11.18(s, 2H,COOH&#x02009;&#x000d7;&#x02009;2,COOH), 8.12(d, <em>J</em>&#x02009;=&#x02009;5&#x000a0;Hz,1H,Ar&#x02013;CH), 7.64(d, <em>J</em>&#x02009;=&#x02009;10&#x000a0;Hz,1H,Ar&#x02013;CH), 6.58(d, <em>J</em>&#x02009;=&#x02009;5&#x000a0;Hz,2H,CH&#x02009;&#x000d7;&#x02009;2,Ar&#x02013;CH), 3.04(t, <em>J</em>&#x02009;=&#x02009;10&#x000a0;Hz,1H,Aliphatic-CH), 3.09(s, 3H,NH&#x02009;&#x000d7;&#x02009;3,NH), 2.51(s, 9H,CH<sub>3</sub>&#x02009;&#x000d7;&#x02009;3,CH<sub>3</sub>), 2.37(q, 2H,Aliphatic-CH<sub>2</sub>), 1.20(t, <em>J</em>&#x02009;=&#x02009;5&#x000a0;Hz,2H,Aliphatic-CH<sub>2</sub>); <sup>13</sup>C NMR (125&#x000a0;MHz, DMSO-<em>d</em><sub><em>6</em></sub>) &#x003b4;: 173.90, 166.51, 165.32, 164.62, 151.63, 149.88, 128.98, 128.02, 120.58, 112.53, 51.86, 45.32, 35.78, 34.03, 30.42, 27.04, 25.90, 8.36.</p></div></div><div id="Sec30" class="sec sec-last"><h3 id="Sec30title">In vitro antimalarial activity</h3><p id="Par48" class="p p-first">Giemsa-stained slide technique was used to conduct in vitro antimalarial screening of the synthesized compounds against 3D7 (chloroquine-sensitive) and Dd2 (chloroquine-resistant) P. falciparum strains, respectively.</p><div id="Sec31" class="sec"><p></p><h4 id="Sec31title" class="inline">Preparation of parasite </h4><p id="Par49" class="p p-first-last">The cryopreserved parasite strains of P. falciparum were brought from liquid nitrogen or (&#x02212;&#x000a0;80&#x000a0;&#x000b0;C) to room temperature in order to thaw the 3D7 and Dd2 strains. 1.6% and 12% NaCl solutions were added progressively in 1-ml increments, and the mixture was centrifuged at 2000&#x000a0;rpm for 5&#x000a0;min. After discarding the supernatant, required fresh medium was added to wash the lysed parasitized RBCs away two to three times. The strains were then routinely maintained as continuous cultures in the malariology division of the ICMR-RMRC-North East Region, Dibrugarh, using a slightly modified version of Trager and Jensen's technique (Trager and Jensen <a href="#CR32" rid="CR32" class=" bibr popnode">1978</a>; Trager and Jensen <a href="#CR31" rid="CR31" class=" bibr popnode">1997</a>). The parasites were kept in RPMI-1640 medium with 25&#x000a0;mM HEPES, 0.2% d-glucose, 0.1% gentamycin sulfate, 0.1% amphotericin B, 0.5% Albumax-II, 0.01% hypoxanthine, and 1.77&#x000a0;mM NaHCO3 at a pH of 7.2 to maintain a hematocrit of 5%. The culture flask was incubated at 37&#x000a0;&#x000b0;C and 5% CO<sub>2</sub> level in a CO<sub>2</sub> incubator with regular parasitemia evaluation and medium change. The red blood cells used were O&#x02009;+&#x02009;. An incomplete medium preparation of the culture medium (without sodium bicarbonate) was made weekly and kept at 4&#x000a0;&#x000b0;C. Before using in a culture, sodium bicarbonate was freshly added after being warmed to 37&#x000a0;&#x000b0;C (Radfar et al. <a href="#CR23" rid="CR23" class=" bibr popnode">2009</a>).</p></div><div id="Sec32" class="sec"><p></p><h4 id="Sec32title" class="inline">In vitro antimalarial efficacy test </h4><p id="Par50" class="p p-first-last">The synthetic compounds were subjected to screening against the 3D7 and Dd2 strains of P. falciparum, with modified micro assay procedures of (Rieckmann et al. <a href="#CR26" rid="CR26" class=" bibr popnode">1978</a>). A stock solution of 5000&#x000a0;&#x000b5;g/mL of each of the test samples was prepared in DMSO (1:200). By further dilution of the stock with incomplete media, two different doses of 5 and 50&#x000a0;&#x000b5;g/mL were utilized for preliminary screening (without NaHCO3). A total volume of 200 &#x000b5;L of medium RPMI-1640 is evenly maintained in a 96-well microtiter plate to conduct the experiment, with an initial ring-stage parasitemia of 1% at 3% hematocrit. Negative control wells were created by adding just complete medium and 0.5% DMSO. In duplicate wells, the test compound was introduced in 20 &#x000b5;L volume at the necessary concentrations (5 and 50&#x000a0;&#x000b5;g/mL). As a positive control, the reference chloroquine was used concurrently at a dosage that corresponded to its predefined IC<sub>50</sub> (Basco et al. <a href="#CR3" rid="CR3" class=" bibr popnode">1994</a>; Bhat et al. <a href="#CR4" rid="CR4" class=" bibr popnode">2013a</a>, <a href="#CR5" rid="CR5" class=" bibr popnode">b</a>). After that, the test plate was incubated in 5% CO<sub>2</sub> and 37&#x000a0;&#x000b0;C. The blood smears from each well were prepared after 36&#x02013;40&#x000a0;h of incubation, fixed with methanol, and stained with 10% Giemsa stain for microscopic observation. A total of 100 asexual parasites were counted, and the percentage of dead rings, trophozoites, and schizonts was determined based on the morphology of the parasites (Fig.&#x000a0;<a href="/pmc/articles/PMC9649585/figure/Fig6/" target="figure" class="fig-table-link figpopup" rid-figpopup="Fig6" rid-ob="ob-Fig6" co-legend-rid="lgnd_Fig6"><span>6</span></a>). GraphPad Prism software was used to calculate IC<sub>50</sub> values at different lower dosages.</p><!--fig ft0--><!--fig mode=article f1--><div class="fig iconblock whole_rhythm" id="Fig6" co-legend-rid="lgnd_Fig6"><a href="/pmc/articles/PMC9649585/figure/Fig6/" target="figure" rid-figpopup="Fig6" rid-ob="ob-Fig6"><!--fig/graphic|fig/alternatives/graphic mode="anchored" m1--><div class="figure" data-largeobj="" data-largeobj-link-rid="largeobj_idm140311569127024"><a class="inline_block ts_canvas" href="/core/lw/2.0/html/tileshop_pmc/tileshop_pmc_inline.html?title=Click%20on%20image%20to%20zoom&amp;p=PMC3&amp;id=9649585_13205_2022_3400_Fig6_HTML.jpg" target="tileshopwindow" rel="noopener"><div class="ts_bar small" title="Click on image to zoom"></div><img loading="lazy" alt="An external file that holds a picture, illustration, etc.&#10;Object name is 13205_2022_3400_Fig6_HTML.jpg" title="Click on image to zoom" class="tileshop" src="/pmc/articles/PMC9649585/bin/13205_2022_3400_Fig6_HTML.jpg" /></a></div><div class="largeobj-link align_right" id="largeobj_idm140311569127024"><a target="object" rel="noopener" href="/pmc/articles/PMC9649585/figure/Fig6/?report=objectonly">Open in a separate window</a></div></a><div class="icnblk_cntnt" id="lgnd_Fig6"><div><a class="figpopup" href="/pmc/articles/PMC9649585/figure/Fig6/" target="figure" rid-figpopup="Fig6" rid-ob="ob-Fig6">Fig. 6</a></div><!--caption a7--><div class="caption"><p>Parasite images <strong>a</strong> Control/untreated, <strong>b</strong> Dead parasites</p></div></div></div></div><div id="Sec33" class="sec sec-last"><p></p><h4 id="Sec33title" class="inline">Resistance index (RI) </h4><p id="Par51" class="p p-first-last">The level of resistance was assessed by comparing the activity of synthesized title derivatives on chloroquine-sensitive and chloroquine-resistant <em>P. falciparum</em> strains using the formula (Sinha et&#x000a0;al. <a href="#CR30" rid="CR30" class=" bibr popnode">2019</a>):</p><div class="disp-formula" id="Equa"><div class="f"><math xmlns:mml="http://www.w3.org/1998/Math/MathML" id="M2" display="block"><mrow><mtable><mtr><mtd><mrow><mrow><mtext>RI</mtext><mspace width="0.333333em"></mspace></mrow><mo>=</mo><msub><mrow><mspace width="0.333333em"></mspace><mtext>IC</mtext></mrow><mrow><mn>50</mn></mrow></msub><mtext>Chloroquine</mtext><mo>-</mo><mrow><mtext>resistant strain</mtext></mrow></mrow></mtd></mtr><mtr><mtd><mrow><mrow></mrow><mspace width="1em"></mspace><mspace width="0.277778em"></mspace><mspace width="0.277778em"></mspace><mspace width="0.277778em"></mspace><mspace width="0.277778em"></mspace><mspace width="0.277778em"></mspace><mspace width="0.277778em"></mspace><mo stretchy="false">/</mo><msub><mtext>IC</mtext><mrow><mn>50</mn></mrow></msub><mtext>Chloroquine</mtext><mo>-</mo><mrow><mtext>sensitive strain</mtext></mrow></mrow></mtd></mtr><mtr><mtd><mrow></mrow></mtd></mtr></mtable></mrow></math></div></div><p></p></div></div></div><div id="Sec34" class="tsec sec"><h2 class="head no_bottom_margin" id="Sec34title">Conclusion</h2><p id="Par52" class="p p-first">In conclusion, the hybrid title <em>N</em>-(4-aminobenzoyl)-<span class="small-caps">l</span>-glutamic acid substituted 1,3,5-triazine derivatives were synthesized in good yield by facile and microwave synthesizer. Docking results indicated that compound Df3 revealed higher binding interaction with amino acids Ser108, Ser167, Thr107 (1J3I), and Arg122 (1J3K) and MD simulation study suggested that these compounds bound to the target proteins with comparatively better binding affinity than the co-crystallized ligand WRA609.</p><p id="Par53" class="p p-last">Furthermore, the antimalarial activity results revealed that compound Df3 had the highest activity against Dd2 (chloroquine-resistant) strain of <em>P. falciparum</em>. These compounds could lead to the discovery of a new class of <em>Pf</em>-DHFR inhibitors for antimalarial drug development.</p></div><div id="sec-a.v.e" class="tsec sec"><a id="supplementary-material-sec"></a><h2 class="head no_bottom_margin" id="sec-a.v.etitle">Supplementary Information</h2><!--/article/body/sec/--><div id="Sec35" class="sec sec-first-last"><p class="p p-first-last">Below is the link to the electronic supplementary material.</p><div class="sec suppmat" id="MOESM1"><div class="sup-box half_rhythm" id="media-a.v.e.b.a.a.a"><a href="/pmc/articles/PMC9649585/bin/13205_2022_3400_MOESM1_ESM.docx" data-ga-action="click_feat_suppl">Supplementary file1 (DOCX 2394 KB)</a><sup>(2.3M, docx)</sup></div></div><p></p></div></div><div id="ack-a.w.a" class="tsec sec"><h2 class="head no_bottom_margin" id="ack-a.w.atitle">Acknowledgements</h2><div class="sec"><p>The financial support from the Ministry of Science and Technology, Department of Science and Technology (DST), Government of India, New Delhi, India is gratefully acknowledged (INSPIRE Scheme, No. DST/INSPIRE Fellowship/2018/IF180193). Authors are also thankful to SAIF, Panjab University, Chandigarh, India for providing NMR, MS spectroscopic data.</p></div></div><div id="notes-a.w.b" class="tsec sec"><h2 class="head no_bottom_margin" id="notes-a.w.btitle">Author contributions</h2><p>SKG and HRB designed the research study; NA synthesized compounds and performed the spectral analysis; AAKC and SJP performed antimalarial activity; AS and UPS performed the in silico study. SKG and HRB wrote the paper. UPS critically revised the manuscript. All authors approved the final version of the manuscript.</p></div><div id="notes-a.w.c" class="tsec sec"><h2 class="head no_bottom_margin" id="notes-a.w.ctitle">Funding</h2><p>Department of Science and Technology (DST), Government of India, New Delhi, (Grant no. DST/INSPIRE Fellowship/2018/IF180193).</p></div><div id="notes-a.w.d" class="tsec sec"><h2 class="head no_bottom_margin" id="notes-a.w.dtitle">Declarations</h2><div>Conflict of interest<p id="Par54">The authors declare no competing interests.</p></div></div><div id="Bib1" class="tsec sec"><h2 class="head no_bottom_margin" id="Bib1title">References</h2><div class="ref-list-sec sec" id="reference-list"><ul class="first-line-outdent"><li id="CR1"><span class="element-citation">Adhikari N, Kashyap A, Shakya A, et al. Microwave assisted synthesis, docking and antimalarial evaluation of hybrid PABA-substituted 1,3,5-triazine derivatives. <span><span class="ref-journal">J Heterocyclic Chem. </span>2020 doi: 10.1002/jhet.3955.</span> [<a href="//doi.org/10.1002%2Fjhet.3955" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=9649585&amp;issue-id=419667&amp;journal-id=1811&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CCrosslink%7CDOI">CrossRef</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=J+Heterocyclic+Chem&amp;title=Microwave+assisted+synthesis,+docking+and+antimalarial+evaluation+of+hybrid+PABA-substituted+1,3,5-triazine+derivatives&amp;author=N+Adhikari&amp;author=A+Kashyap&amp;author=A+Shakya&amp;publication_year=2020&amp;doi=10.1002/jhet.3955&amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=9649585&amp;issue-id=419667&amp;journal-id=1811&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></li><li id="CR2"><span class="element-citation">Alven S, Aderibigbe B. Combination therapy strategies for the treatment of malaria. <span><span class="ref-journal">Molecules. </span>2019;<span class="ref-vol">24</span>(19):3601. doi: 10.3390/molecules24193601.</span> <span class="nowrap">[<a class="int-reflink" href="/pmc/articles/PMC6804225/">PMC free article</a>]</span> [<a href="https://pubmed.ncbi.nlm.nih.gov/31591293" ref="reftype=pubmed&amp;article-id=9649585&amp;issue-id=419667&amp;journal-id=1811&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] [<a href="//doi.org/10.3390%2Fmolecules24193601" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=9649585&amp;issue-id=419667&amp;journal-id=1811&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CCrosslink%7CDOI">CrossRef</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Molecules&amp;title=Combination+therapy+strategies+for+the+treatment+of+malaria&amp;author=S+Alven&amp;author=B+Aderibigbe&amp;volume=24&amp;issue=19&amp;publication_year=2019&amp;pages=3601&amp;pmid=31591293&amp;doi=10.3390/molecules24193601&amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=9649585&amp;issue-id=419667&amp;journal-id=1811&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></li><li id="CR3"><span class="element-citation">Basco LK, Ramiliarisoa O, Le Bras J. In vitro activity of pyrimethamine, cycloguanil, and other antimalarial drugs against African isolates and clones of <em>Plasmodium falciparum</em>. <span><span class="ref-journal">Am J Trop Med Hyg. </span>1994;<span class="ref-vol">50</span>:193–199. doi: 10.4269/ajtmh.1994.50.193.</span> [<a href="https://pubmed.ncbi.nlm.nih.gov/8116812" ref="reftype=pubmed&amp;article-id=9649585&amp;issue-id=419667&amp;journal-id=1811&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] [<a href="//doi.org/10.4269%2Fajtmh.1994.50.193" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=9649585&amp;issue-id=419667&amp;journal-id=1811&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CCrosslink%7CDOI">CrossRef</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Am+J+Trop+Med+Hyg&amp;title=In+vitro+activity+of+pyrimethamine,+cycloguanil,+and+other+antimalarial+drugs+against+African+isolates+and+clones+of+Plasmodium+falciparum&amp;author=LK+Basco&amp;author=O+Ramiliarisoa&amp;author=J+Le+Bras&amp;volume=50&amp;publication_year=1994&amp;pages=193-199&amp;pmid=8116812&amp;doi=10.4269/ajtmh.1994.50.193&amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=9649585&amp;issue-id=419667&amp;journal-id=1811&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></li><li id="CR4"><span class="element-citation">Bhat HR, Pandey PK, Ghosh SK, et al. Development of 4-aminoquinoline-1,3,5-triazine conjugates as potent antibacterial agent through facile synthetic route. <span><span class="ref-journal">Med Chem Res. </span>2013;<span class="ref-vol">22</span>:5056–5065. doi: 10.1007/s00044-013-0521-8.</span> [<a href="//doi.org/10.1007%2Fs00044-013-0521-8" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=9649585&amp;issue-id=419667&amp;journal-id=1811&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CCrosslink%7CDOI">CrossRef</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Med+Chem+Res&amp;title=Development+of+4-aminoquinoline-1,3,5-triazine+conjugates+as+potent+antibacterial+agent+through+facile+synthetic+route&amp;author=HR+Bhat&amp;author=PK+Pandey&amp;author=SK+Ghosh&amp;volume=22&amp;publication_year=2013&amp;pages=5056-5065&amp;doi=10.1007/s00044-013-0521-8&amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=9649585&amp;issue-id=419667&amp;journal-id=1811&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></li><li id="CR5"><span class="element-citation">Bhat HR, Singh UP, Gahtori P, et al. 4-Aminoquinoline-1,3,5-triazine: design, synthesis, in vitro antimalarial activity and docking studies. <span><span class="ref-journal">N J Chem. </span>2013;<span class="ref-vol">37</span>:2654–2662. doi: 10.1039/c3nj00317e.</span> [<a href="//doi.org/10.1039%2Fc3nj00317e" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=9649585&amp;issue-id=419667&amp;journal-id=1811&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CCrosslink%7CDOI">CrossRef</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=N+J+Chem&amp;title=4-Aminoquinoline-1,3,5-triazine:+design,+synthesis,+in+vitro+antimalarial+activity+and+docking+studies&amp;author=HR+Bhat&amp;author=UP+Singh&amp;author=P+Gahtori&amp;volume=37&amp;publication_year=2013&amp;pages=2654-2662&amp;doi=10.1039/c3nj00317e&amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=9649585&amp;issue-id=419667&amp;journal-id=1811&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></li><li id="CR6"><span class="element-citation">Choudhury AAK, Vinayagam S, Adhikari N, et al. Microwave synthesis and antimalarial screening of novel 4-amino benzoic acid (PABA)-substituted pyrimidine derivatives as&#x000a0;<em>Plasmodium falciparum</em>&#x000a0;dihydrofolate reductase inhibitors. <span><span class="ref-journal">3 Biotech. </span>2022;<span class="ref-vol">12</span>:170. doi: 10.1007/s13205-022-03236-w.</span> <span class="nowrap">[<a class="int-reflink" href="/pmc/articles/PMC9279537/">PMC free article</a>]</span> [<a href="https://pubmed.ncbi.nlm.nih.gov/35845109" ref="reftype=pubmed&amp;article-id=9649585&amp;issue-id=419667&amp;journal-id=1811&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] [<a href="//doi.org/10.1007%2Fs13205-022-03236-w" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=9649585&amp;issue-id=419667&amp;journal-id=1811&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CCrosslink%7CDOI">CrossRef</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=3+Biotech&amp;title=Microwave+synthesis+and+antimalarial+screening+of+novel+4-amino+benzoic+acid+(PABA)-substituted+pyrimidine+derivatives+as&#x000a0;Plasmodium+falciparum&#x000a0;dihydrofolate+reductase+inhibitors&amp;author=AAK+Choudhury&amp;author=S+Vinayagam&amp;author=N+Adhikari&amp;volume=12&amp;publication_year=2022&amp;pages=170&amp;pmid=35845109&amp;doi=10.1007/s13205-022-03236-w&amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=9649585&amp;issue-id=419667&amp;journal-id=1811&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></li><li id="CR7"><span class="element-citation">Dahlgren D, Lennern&#x000e4;s H. Intestinal permeability and drug absorption: predictive experimental, computational and in vivo approaches. <span><span class="ref-journal">Pharmaceutics. </span>2019;<span class="ref-vol">11</span>(8):411. doi: 10.3390/pharmaceutics11080411.</span> <span class="nowrap">[<a class="int-reflink" href="/pmc/articles/PMC6723276/">PMC free article</a>]</span> [<a href="https://pubmed.ncbi.nlm.nih.gov/31412551" ref="reftype=pubmed&amp;article-id=9649585&amp;issue-id=419667&amp;journal-id=1811&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] [<a href="//doi.org/10.3390%2Fpharmaceutics11080411" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=9649585&amp;issue-id=419667&amp;journal-id=1811&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CCrosslink%7CDOI">CrossRef</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Pharmaceutics&amp;title=Intestinal+permeability+and+drug+absorption:+predictive+experimental,+computational+and+in+vivo+approaches&amp;author=D+Dahlgren&amp;author=H+Lennern&#x000e4;s&amp;volume=11&amp;issue=8&amp;publication_year=2019&amp;pages=411&amp;pmid=31412551&amp;doi=10.3390/pharmaceutics11080411&amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=9649585&amp;issue-id=419667&amp;journal-id=1811&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></li><li id="CR8"><span class="element-citation">Dansena H, Dhongade HJ, Chandrakar K. Pharmacological potentials of pyrimidine derivative: a review. <span><span class="ref-journal">Asian J Pharm Clin Res. </span>2015;<span class="ref-vol">8</span>:171–177.</span> <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Asian+J+Pharm+Clin+Res&amp;title=Pharmacological+potentials+of+pyrimidine+derivative:+a+review&amp;author=H+Dansena&amp;author=HJ+Dhongade&amp;author=K+Chandrakar&amp;volume=8&amp;publication_year=2015&amp;pages=171-177&amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=9649585&amp;issue-id=419667&amp;journal-id=1811&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></li><li id="CR9"><span class="element-citation">Dubey V, Pathak M, Bhat HR, Singh UP. Design, facile synthesis, and antibacterial asseactivity of hybrid 1,3,4-thiadiazole-1,3,5-triazine derivatives tethered via -S- bridge. <span><span class="ref-journal">Chem Biol Drug Des. </span>2012;<span class="ref-vol">80</span>(4):598–604. doi: 10.1111/j.1747-0285.2012.01433.x.</span> [<a href="https://pubmed.ncbi.nlm.nih.gov/22716235" ref="reftype=pubmed&amp;article-id=9649585&amp;issue-id=419667&amp;journal-id=1811&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] [<a href="//doi.org/10.1111%2Fj.1747-0285.2012.01433.x" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=9649585&amp;issue-id=419667&amp;journal-id=1811&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CCrosslink%7CDOI">CrossRef</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Chem+Biol+Drug+Des&amp;title=Design,+facile+synthesis,+and+antibacterial+asseactivity+of+hybrid+1,3,4-thiadiazole-1,3,5-triazine+derivatives+tethered+via+-S-+bridge&amp;author=V+Dubey&amp;author=M+Pathak&amp;author=HR+Bhat&amp;author=UP+Singh&amp;volume=80&amp;issue=4&amp;publication_year=2012&amp;pages=598-604&amp;pmid=22716235&amp;doi=10.1111/j.1747-0285.2012.01433.x&amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=9649585&amp;issue-id=419667&amp;journal-id=1811&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></li><li id="CR10"><span class="element-citation">Gahtori P, Ghosh SK, Parida P, et al. Antimalarial evaluation and docking studies of hybrid phenylthiazolyl-1,3,5-triazine derivatives: a novel and potential antifolate lead for Pf-DHFR-TS inhibition. <span><span class="ref-journal">Exp Parasitol. </span>2012;<span class="ref-vol">130</span>(3):292–299. doi: 10.1016/j.exppara.2011.12.014.</span> [<a href="https://pubmed.ncbi.nlm.nih.gov/22233734" ref="reftype=pubmed&amp;article-id=9649585&amp;issue-id=419667&amp;journal-id=1811&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] [<a href="//doi.org/10.1016%2Fj.exppara.2011.12.014" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=9649585&amp;issue-id=419667&amp;journal-id=1811&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CCrosslink%7CDOI">CrossRef</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Exp+Parasitol&amp;title=Antimalarial+evaluation+and+docking+studies+of+hybrid+phenylthiazolyl-1,3,5-triazine+derivatives:+a+novel+and+potential+antifolate+lead+for+Pf-DHFR-TS+inhibition&amp;author=P+Gahtori&amp;author=SK+Ghosh&amp;author=P+Parida&amp;volume=130&amp;issue=3&amp;publication_year=2012&amp;pages=292-299&amp;pmid=22233734&amp;doi=10.1016/j.exppara.2011.12.014&amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=9649585&amp;issue-id=419667&amp;journal-id=1811&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></li><li id="CR11"><span class="element-citation">Genheden S, Ryde U. The MM/PBSA and MM/GBSA methods to estimate ligand-binding affinities. <span><span class="ref-journal">Expert Opin Drug Discov. </span>2015;<span class="ref-vol">10</span>:449–461. doi: 10.1517/17460441.2015.1032936.</span> <span class="nowrap">[<a class="int-reflink" href="/pmc/articles/PMC4487606/">PMC free article</a>]</span> [<a href="https://pubmed.ncbi.nlm.nih.gov/25835573" ref="reftype=pubmed&amp;article-id=9649585&amp;issue-id=419667&amp;journal-id=1811&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] [<a href="//doi.org/10.1517%2F17460441.2015.1032936" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=9649585&amp;issue-id=419667&amp;journal-id=1811&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CCrosslink%7CDOI">CrossRef</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Expert+Opin+Drug+Discov&amp;title=The+MM/PBSA+and+MM/GBSA+methods+to+estimate+ligand-binding+affinities&amp;author=S+Genheden&amp;author=U+Ryde&amp;volume=10&amp;publication_year=2015&amp;pages=449-461&amp;pmid=25835573&amp;doi=10.1517/17460441.2015.1032936&amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=9649585&amp;issue-id=419667&amp;journal-id=1811&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></li><li id="CR12"><span class="element-citation">Gogoi P, Shakya A, Ghosh SK, Gogoi N, Gahtori P, Singh N, Bhattacharyya DR, Singh UP, Bhat HR. In silico study, synthesis, and evaluation of the antimalarial activity of hybrid dimethoxy pyrazole 1,3,5-triazine derivatives. <span><span class="ref-journal">J Biochem Mol Toxicol. </span>2021;<span class="ref-vol">35</span>(3):e22682. doi: 10.1002/jbt.22682.</span> [<a href="https://pubmed.ncbi.nlm.nih.gov/33332673" ref="reftype=pubmed&amp;article-id=9649585&amp;issue-id=419667&amp;journal-id=1811&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] [<a href="//doi.org/10.1002%2Fjbt.22682" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=9649585&amp;issue-id=419667&amp;journal-id=1811&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CCrosslink%7CDOI">CrossRef</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=J+Biochem+Mol+Toxicol&amp;title=In+silico+study,+synthesis,+and+evaluation+of+the+antimalarial+activity+of+hybrid+dimethoxy+pyrazole+1,3,5-triazine+derivatives&amp;author=P+Gogoi&amp;author=A+Shakya&amp;author=SK+Ghosh&amp;author=N+Gogoi&amp;author=P+Gahtori&amp;volume=35&amp;issue=3&amp;publication_year=2021&amp;pages=e22682&amp;pmid=33332673&amp;doi=10.1002/jbt.22682&amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=9649585&amp;issue-id=419667&amp;journal-id=1811&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></li><li id="CR13"><span class="element-citation">Jain ANB. Bias, reporting and sharing: computational evaluations of docking methods. <span><span class="ref-journal">J Comput Aided Mol Des. </span>2008;<span class="ref-vol">22</span>(3&#x02013;4):201–212. doi: 10.1007/s10822-007-9151-x.</span> [<a href="https://pubmed.ncbi.nlm.nih.gov/18075713" ref="reftype=pubmed&amp;article-id=9649585&amp;issue-id=419667&amp;journal-id=1811&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] [<a href="//doi.org/10.1007%2Fs10822-007-9151-x" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=9649585&amp;issue-id=419667&amp;journal-id=1811&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CCrosslink%7CDOI">CrossRef</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=J+Comput+Aided+Mol+Des&amp;title=Bias,+reporting+and+sharing:+computational+evaluations+of+docking+methods&amp;author=ANB+Jain&amp;volume=22&amp;issue=3&#x02013;4&amp;publication_year=2008&amp;pages=201-212&amp;pmid=18075713&amp;doi=10.1007/s10822-007-9151-x&amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=9649585&amp;issue-id=419667&amp;journal-id=1811&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></li><li id="CR14"><span class="element-citation">Kashyap A, Adhikari N, Das A, Shakya A, Ghosh SK, Singh UP, Bhat HR. Review on synthetic chemistry and antibacterial importance of thiazole derivatives. <span><span class="ref-journal">Curr Drug Discov Technol. </span>2018;<span class="ref-vol">15</span>(3):214–228. doi: 10.2174/1570163814666170911144036.</span> [<a href="https://pubmed.ncbi.nlm.nih.gov/28901248" ref="reftype=pubmed&amp;article-id=9649585&amp;issue-id=419667&amp;journal-id=1811&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] [<a href="//doi.org/10.2174%2F1570163814666170911144036" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=9649585&amp;issue-id=419667&amp;journal-id=1811&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CCrosslink%7CDOI">CrossRef</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Curr+Drug+Discov+Technol&amp;title=Review+on+synthetic+chemistry+and+antibacterial+importance+of+thiazole+derivatives&amp;author=A+Kashyap&amp;author=N+Adhikari&amp;author=A+Das&amp;author=A+Shakya&amp;author=SK+Ghosh&amp;volume=15&amp;issue=3&amp;publication_year=2018&amp;pages=214-228&amp;pmid=28901248&amp;doi=10.2174/1570163814666170911144036&amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=9649585&amp;issue-id=419667&amp;journal-id=1811&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></li><li id="CR15"><span class="element-citation">Kr&#x000e1;tk&#x000fd; M, Kone&#x0010d;n&#x000e1; K, Janou&#x00161;ek J, et al. 4-Aminobenzoic acid derivatives: converting folate precursor to antimicrobial and cytotoxic agents. <span><span class="ref-journal">Biomolecules. </span>2019;<span class="ref-vol">10</span>:E9. doi: 10.3390/biom10010009.</span> <span class="nowrap">[<a class="int-reflink" href="/pmc/articles/PMC7023430/">PMC free article</a>]</span> [<a href="https://pubmed.ncbi.nlm.nih.gov/31861596" ref="reftype=pubmed&amp;article-id=9649585&amp;issue-id=419667&amp;journal-id=1811&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] [<a href="//doi.org/10.3390%2Fbiom10010009" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=9649585&amp;issue-id=419667&amp;journal-id=1811&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CCrosslink%7CDOI">CrossRef</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Biomolecules&amp;title=4-Aminobenzoic+acid+derivatives:+converting+folate+precursor+to+antimicrobial+and+cytotoxic+agents&amp;author=M+Kr&#x000e1;tk&#x000fd;&amp;author=K+Kone&#x0010d;n&#x000e1;&amp;author=J+Janou&#x00161;ek&amp;volume=10&amp;publication_year=2019&amp;pages=E9&amp;doi=10.3390/biom10010009&amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=9649585&amp;issue-id=419667&amp;journal-id=1811&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></li><li id="CR16"><span class="element-citation">Lai CY, Chang TT, Sun MF, Chen HY, Tsai FJ, Lin JG, Chen CY. Molecular dynamics analysis of potent inhibitors of M2 proton channel against H1N1 swine influenza virus. <span><span class="ref-journal">Mol Simul. </span>2011;<span class="ref-vol">37</span>:250–256. doi: 10.1080/08927022.2010.543972.</span> [<a href="//doi.org/10.1080%2F08927022.2010.543972" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=9649585&amp;issue-id=419667&amp;journal-id=1811&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CCrosslink%7CDOI">CrossRef</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Mol+Simul&amp;title=Molecular+dynamics+analysis+of+potent+inhibitors+of+M2+proton+channel+against+H1N1+swine+influenza+virus&amp;author=CY+Lai&amp;author=TT+Chang&amp;author=MF+Sun&amp;author=HY+Chen&amp;author=FJ+Tsai&amp;volume=37&amp;publication_year=2011&amp;pages=250-256&amp;doi=10.1080/08927022.2010.543972&amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=9649585&amp;issue-id=419667&amp;journal-id=1811&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></li><li id="CR17"><span class="element-citation">Lin CH, Chang TT, Sun MF, Chen HY, Tsai FJ, Chang KL, Fisher M, Chen CY. Potent inhibitor design against h1n1 swine influenza: structure-based and molecular dynamics analysis for m2 inhibitors from traditional chinese medicine database. <span><span class="ref-journal">J Biomol Struct Dyn. </span>2011;<span class="ref-vol">28</span>:471–482. doi: 10.1080/07391102.2011.10508589.</span> [<a href="https://pubmed.ncbi.nlm.nih.gov/21142218" ref="reftype=pubmed&amp;article-id=9649585&amp;issue-id=419667&amp;journal-id=1811&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] [<a href="//doi.org/10.1080%2F07391102.2011.10508589" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=9649585&amp;issue-id=419667&amp;journal-id=1811&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CCrosslink%7CDOI">CrossRef</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=J+Biomol+Struct+Dyn&amp;title=Potent+inhibitor+design+against+h1n1+swine+influenza:+structure-based+and+molecular+dynamics+analysis+for+m2+inhibitors+from+traditional+chinese+medicine+database&amp;author=CH+Lin&amp;author=TT+Chang&amp;author=MF+Sun&amp;author=HY+Chen&amp;author=FJ+Tsai&amp;volume=28&amp;publication_year=2011&amp;pages=471-482&amp;pmid=21142218&amp;doi=10.1080/07391102.2011.10508589&amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=9649585&amp;issue-id=419667&amp;journal-id=1811&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></li><li id="CR18"><span class="element-citation">L&#x000f6;dige M, Hiersch L. Design and synthesis of novel hybrid molecules against malaria. <span><span class="ref-journal">Int J Med Chem. </span>2015;<span class="ref-vol">2015</span>:e458319.</span> <span class="nowrap">[<a class="int-reflink" href="/pmc/articles/PMC4334980/">PMC free article</a>]</span> [<a href="https://pubmed.ncbi.nlm.nih.gov/25734014" ref="reftype=pubmed&amp;article-id=9649585&amp;issue-id=419667&amp;journal-id=1811&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Int+J+Med+Chem&amp;title=Design+and+synthesis+of+novel+hybrid+molecules+against+malaria&amp;author=M+L&#x000f6;dige&amp;author=L+Hiersch&amp;volume=2015&amp;publication_year=2015&amp;pages=e458319&amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=9649585&amp;issue-id=419667&amp;journal-id=1811&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></li><li id="CR19"><span class="element-citation">Mahanta S, Chowdhury P, Gogoi N, et al. Potential antiviral activity of approved repurposed drug against main protease of SARS-CoV-2: an in silico-based approach. <span><span class="ref-journal">J Biomol Struct Dyn. </span>2020;<span class="ref-vol">39</span>(10):3802–3811. doi: 10.1080/07391102.2020.1768902.</span> [<a href="https://pubmed.ncbi.nlm.nih.gov/32406317" ref="reftype=pubmed&amp;article-id=9649585&amp;issue-id=419667&amp;journal-id=1811&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] [<a href="//doi.org/10.1080%2F07391102.2020.1768902" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=9649585&amp;issue-id=419667&amp;journal-id=1811&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CCrosslink%7CDOI">CrossRef</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=J+Biomol+Struct+Dyn&amp;title=Potential+antiviral+activity+of+approved+repurposed+drug+against+main+protease+of+SARS-CoV-2:+an+in+silico-based+approach&amp;author=S+Mahanta&amp;author=P+Chowdhury&amp;author=N+Gogoi&amp;volume=39&amp;issue=10&amp;publication_year=2020&amp;pages=3802-3811&amp;pmid=32406317&amp;doi=10.1080/07391102.2020.1768902&amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=9649585&amp;issue-id=419667&amp;journal-id=1811&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></li><li id="CR21"><span class="element-citation">Noha SM, Schmidhammer H, Spetea M. Molecular docking, molecular dynamics, and structure-activity relationship explorations of 14-oxygenated N-methylmorphinan-6-ones as potent &#x003bc;-opioid receptor agonists. <span><span class="ref-journal">ACS Chem Neurosci. </span>2017;<span class="ref-vol">8</span>:1327–1337. doi: 10.1021/acschemneuro.6b00460.</span> <span class="nowrap">[<a class="int-reflink" href="/pmc/articles/PMC5481819/">PMC free article</a>]</span> [<a href="https://pubmed.ncbi.nlm.nih.gov/28125215" ref="reftype=pubmed&amp;article-id=9649585&amp;issue-id=419667&amp;journal-id=1811&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] [<a href="//doi.org/10.1021%2Facschemneuro.6b00460" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=9649585&amp;issue-id=419667&amp;journal-id=1811&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CCrosslink%7CDOI">CrossRef</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=ACS+Chem+Neurosci&amp;title=Molecular+docking,+molecular+dynamics,+and+structure-activity+relationship+explorations+of+14-oxygenated+N-methylmorphinan-6-ones+as+potent+&#x003bc;-opioid+receptor+agonists&amp;author=SM+Noha&amp;author=H+Schmidhammer&amp;author=M+Spetea&amp;volume=8&amp;publication_year=2017&amp;pages=1327-1337&amp;pmid=28125215&amp;doi=10.1021/acschemneuro.6b00460&amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=9649585&amp;issue-id=419667&amp;journal-id=1811&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></li><li id="CR22"><span class="element-citation">Nzila A, Ward SA, Marsh K, et al. Comparative folate metabolism in humans and malaria parasites (part I): pointers for malaria treatment from cancer chemotherapy. <span><span class="ref-journal">Trends Parasitol. </span>2005;<span class="ref-vol">21</span>:292–298. doi: 10.1016/j.pt.2005.04.002.</span> <span class="nowrap">[<a class="int-reflink" href="/pmc/articles/PMC2720520/">PMC free article</a>]</span> [<a href="https://pubmed.ncbi.nlm.nih.gov/15922251" ref="reftype=pubmed&amp;article-id=9649585&amp;issue-id=419667&amp;journal-id=1811&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] [<a href="//doi.org/10.1016%2Fj.pt.2005.04.002" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=9649585&amp;issue-id=419667&amp;journal-id=1811&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CCrosslink%7CDOI">CrossRef</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Trends+Parasitol&amp;title=Comparative+folate+metabolism+in+humans+and+malaria+parasites+(part+I):+pointers+for+malaria+treatment+from+cancer+chemotherapy&amp;author=A+Nzila&amp;author=SA+Ward&amp;author=K+Marsh&amp;volume=21&amp;publication_year=2005&amp;pages=292-298&amp;pmid=15922251&amp;doi=10.1016/j.pt.2005.04.002&amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=9649585&amp;issue-id=419667&amp;journal-id=1811&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></li><li id="CR23"><span class="element-citation">Radfar A, M&#x000e9;ndez D, Moneriz C, et al. Synchronous culture of <em>Plasmodium falciparum</em> at high parasitemia levels. <span><span class="ref-journal">Nat Protoc. </span>2009;<span class="ref-vol">4</span>:1899. doi: 10.1038/nprot.2009.198.</span> [<a href="https://pubmed.ncbi.nlm.nih.gov/20010926" ref="reftype=pubmed&amp;article-id=9649585&amp;issue-id=419667&amp;journal-id=1811&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] [<a href="//doi.org/10.1038%2Fnprot.2009.198" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=9649585&amp;issue-id=419667&amp;journal-id=1811&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CCrosslink%7CDOI">CrossRef</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Nat+Protoc&amp;title=Synchronous+culture+of+Plasmodium+falciparum+at+high+parasitemia+levels&amp;author=A+Radfar&amp;author=D+M&#x000e9;ndez&amp;author=C+Moneriz&amp;volume=4&amp;publication_year=2009&amp;pages=1899&amp;pmid=20010926&amp;doi=10.1038/nprot.2009.198&amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=9649585&amp;issue-id=419667&amp;journal-id=1811&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></li><li id="CR24"><span class="element-citation">Rastelli G, Del Rio A, Gianluca Degliesposti MS. Fast and accurate predictions of binding free energies using MM-PBSA and MM-GBSA. <span><span class="ref-journal">J Comput Chem. </span>2010;<span class="ref-vol">31</span>:797–810.</span> [<a href="https://pubmed.ncbi.nlm.nih.gov/19569205" ref="reftype=pubmed&amp;article-id=9649585&amp;issue-id=419667&amp;journal-id=1811&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=J+Comput+Chem&amp;title=Fast+and+accurate+predictions+of+binding+free+energies+using+MM-PBSA+and+MM-GBSA&amp;author=G+Rastelli&amp;author=A+Del+Rio&amp;author=MS+Gianluca+Degliesposti&amp;volume=31&amp;publication_year=2010&amp;pages=797-810&amp;pmid=19569205&amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=9649585&amp;issue-id=419667&amp;journal-id=1811&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></li><li id="CR26"><span class="element-citation">Rieckmann KH, Campbell GH, Sax LJ, Mrema JE. Drug sensitivity of <em>Plasmodium falciparum</em>. An in vitro microtechnique. <span><span class="ref-journal">Lancet Lond Engl. </span>1978;<span class="ref-vol">1</span>:22–23. doi: 10.1016/S0140-6736(78)90365-3.</span> [<a href="https://pubmed.ncbi.nlm.nih.gov/74500" ref="reftype=pubmed&amp;article-id=9649585&amp;issue-id=419667&amp;journal-id=1811&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] [<a href="//doi.org/10.1016%2FS0140-6736(78)90365-3" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=9649585&amp;issue-id=419667&amp;journal-id=1811&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CCrosslink%7CDOI">CrossRef</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Lancet+Lond+Engl&amp;title=Drug+sensitivity+of+Plasmodium+falciparum.+An+in+vitro+microtechnique&amp;author=KH+Rieckmann&amp;author=GH+Campbell&amp;author=LJ+Sax&amp;author=JE+Mrema&amp;volume=1&amp;publication_year=1978&amp;pages=22-23&amp;doi=10.1016/S0140-6736(78)90365-3&amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=9649585&amp;issue-id=419667&amp;journal-id=1811&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></li><li id="CR27"><span class="element-citation">Sakakibara N, Balboni G, Congiu C, Onnis V, Demizu Y, Misawa T, Kurihara M, Kato Y, Maruyama T, Toyama M, Okamoto M, Baba M. Design, synthesis, and anti-HIV-1 activity of 1-substituted 3-(3,5-dimethylbenzyl)triazine derivatives. <span><span class="ref-journal">Antivir Chem Chemother. </span>2015;<span class="ref-vol">24</span>(2):62–71. doi: 10.1177/2040206615612208.</span> <span class="nowrap">[<a class="int-reflink" href="/pmc/articles/PMC5890519/">PMC free article</a>]</span> [<a href="https://pubmed.ncbi.nlm.nih.gov/26514833" ref="reftype=pubmed&amp;article-id=9649585&amp;issue-id=419667&amp;journal-id=1811&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] [<a href="//doi.org/10.1177%2F2040206615612208" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=9649585&amp;issue-id=419667&amp;journal-id=1811&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CCrosslink%7CDOI">CrossRef</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Antivir+Chem+Chemother&amp;title=Design,+synthesis,+and+anti-HIV-1+activity+of+1-substituted+3-(3,5-dimethylbenzyl)triazine+derivatives&amp;author=N+Sakakibara&amp;author=G+Balboni&amp;author=C+Congiu&amp;author=V+Onnis&amp;author=Y+Demizu&amp;volume=24&amp;issue=2&amp;publication_year=2015&amp;pages=62-71&amp;pmid=26514833&amp;doi=10.1177/2040206615612208&amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=9649585&amp;issue-id=419667&amp;journal-id=1811&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></li><li id="CR28"><span class="element-citation">Singh UP, Bhat HR, Gahtori P. Antifungal activity, SAR and physicochemical correlation of some thiazole-1,3,5-triazine derivatives. <span><span class="ref-journal">J Mycol Med. </span>2012;<span class="ref-vol">22</span>(2):134–141. doi: 10.1016/j.mycmed.2011.12.073.</span> [<a href="https://pubmed.ncbi.nlm.nih.gov/23518015" ref="reftype=pubmed&amp;article-id=9649585&amp;issue-id=419667&amp;journal-id=1811&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] [<a href="//doi.org/10.1016%2Fj.mycmed.2011.12.073" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=9649585&amp;issue-id=419667&amp;journal-id=1811&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CCrosslink%7CDOI">CrossRef</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=J+Mycol+Med&amp;title=Antifungal+activity,+SAR+and+physicochemical+correlation+of+some+thiazole-1,3,5-triazine+derivatives&amp;author=UP+Singh&amp;author=HR+Bhat&amp;author=P+Gahtori&amp;volume=22&amp;issue=2&amp;publication_year=2012&amp;pages=134-141&amp;pmid=23518015&amp;doi=10.1016/j.mycmed.2011.12.073&amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=9649585&amp;issue-id=419667&amp;journal-id=1811&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></li><li id="CR29"><span class="element-citation">Singh UP, Bhat HR, Gahtori P, Singh RK. Hybrid phenylthiazole and 1,3,5-triazine target cytosolic leucyl-tRNA synthetase for antifungal action as revealed by molecular docking studies. <span><span class="ref-journal">In Silico Pharmacol. </span>2013;<span class="ref-vol">1</span>:3. doi: 10.1186/2193-9616-1-3.</span> <span class="nowrap">[<a class="int-reflink" href="/pmc/articles/PMC4230311/">PMC free article</a>]</span> [<a href="https://pubmed.ncbi.nlm.nih.gov/25505648" ref="reftype=pubmed&amp;article-id=9649585&amp;issue-id=419667&amp;journal-id=1811&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] [<a href="//doi.org/10.1186%2F2193-9616-1-3" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=9649585&amp;issue-id=419667&amp;journal-id=1811&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CCrosslink%7CDOI">CrossRef</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=In+Silico+Pharmacol&amp;title=Hybrid+phenylthiazole+and+1,3,5-triazine+target+cytosolic+leucyl-tRNA+synthetase+for+antifungal+action+as+revealed+by+molecular+docking+studies&amp;author=UP+Singh&amp;author=HR+Bhat&amp;author=P+Gahtori&amp;author=RK+Singh&amp;volume=1&amp;publication_year=2013&amp;pages=3&amp;pmid=25505648&amp;doi=10.1186/2193-9616-1-3&amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=9649585&amp;issue-id=419667&amp;journal-id=1811&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></li><li id="CR30"><span class="element-citation">Sinha S, Batovska DI, Medhi B, et al. In vitro anti-malarial efficacy of chalcones: cytotoxicity profile, mechanism of action and their effect on erythrocytes. <span><span class="ref-journal">Malar J. </span>2019;<span class="ref-vol">18</span>:1–11. doi: 10.1186/s12936-019-3060-z.</span> <span class="nowrap">[<a class="int-reflink" href="/pmc/articles/PMC6916019/">PMC free article</a>]</span> [<a href="https://pubmed.ncbi.nlm.nih.gov/31842914" ref="reftype=pubmed&amp;article-id=9649585&amp;issue-id=419667&amp;journal-id=1811&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] [<a href="//doi.org/10.1186%2Fs12936-019-3060-z" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=9649585&amp;issue-id=419667&amp;journal-id=1811&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CCrosslink%7CDOI">CrossRef</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Malar+J&amp;title=In+vitro+anti-malarial+efficacy+of+chalcones:+cytotoxicity+profile,+mechanism+of+action+and+their+effect+on+erythrocytes&amp;author=S+Sinha&amp;author=DI+Batovska&amp;author=B+Medhi&amp;volume=18&amp;publication_year=2019&amp;pages=1-11&amp;pmid=30602373&amp;doi=10.1186/s12936-019-3060-z&amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=9649585&amp;issue-id=419667&amp;journal-id=1811&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></li><li id="CR31"><span class="element-citation">Trager W, Jensen JB. Continuous culture of <em>Plasmodium falciparum</em>: its impact on malaria research. <span><span class="ref-journal">Int J Parasitol. </span>1997;<span class="ref-vol">27</span>:989–1006. doi: 10.1016/S0020-7519(97)00080-5.</span> [<a href="https://pubmed.ncbi.nlm.nih.gov/9363481" ref="reftype=pubmed&amp;article-id=9649585&amp;issue-id=419667&amp;journal-id=1811&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] [<a href="//doi.org/10.1016%2FS0020-7519(97)00080-5" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=9649585&amp;issue-id=419667&amp;journal-id=1811&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CCrosslink%7CDOI">CrossRef</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Int+J+Parasitol&amp;title=Continuous+culture+of+Plasmodium+falciparum:+its+impact+on+malaria+research&amp;author=W+Trager&amp;author=JB+Jensen&amp;volume=27&amp;publication_year=1997&amp;pages=989-1006&amp;pmid=9363481&amp;doi=10.1016/S0020-7519(97)00080-5&amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=9649585&amp;issue-id=419667&amp;journal-id=1811&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></li><li id="CR32"><span class="element-citation">Trager W, Jenson JB. Cultivation of malarial parasites. <span><span class="ref-journal">Nature. </span>1978;<span class="ref-vol">273</span>:621–622. doi: 10.1038/273621a0.</span> [<a href="https://pubmed.ncbi.nlm.nih.gov/351412" ref="reftype=pubmed&amp;article-id=9649585&amp;issue-id=419667&amp;journal-id=1811&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] [<a href="//doi.org/10.1038%2F273621a0" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=9649585&amp;issue-id=419667&amp;journal-id=1811&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CCrosslink%7CDOI">CrossRef</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Nature&amp;title=Cultivation+of+malarial+parasites&amp;author=W+Trager&amp;author=JB+Jenson&amp;volume=273&amp;publication_year=1978&amp;pages=621-622&amp;pmid=351412&amp;doi=10.1038/273621a0&amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=9649585&amp;issue-id=419667&amp;journal-id=1811&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></li><li id="CR33"><span class="mixed-citation">World Malaria Report 2020. <a href="https://www.who.int/publications/i/item/9789240015791" data-ga-action="click_feat_suppl" ref="reftype=extlink&amp;article-id=9649585&amp;issue-id=419667&amp;journal-id=1811&amp;FROM=Article%7CCitationRef&amp;TO=External%7CLink%7CURI" target="_blank">https://www.who.int/publications/i/item/9789240015791</a>. Accessed 1 June 2022</span></li><li id="CR34"><span class="mixed-citation">World Malaria Report 2021. <a href="https://www.who.int/publications-detail-redirect/9789240040496" data-ga-action="click_feat_suppl" ref="reftype=extlink&amp;article-id=9649585&amp;issue-id=419667&amp;journal-id=1811&amp;FROM=Article%7CCitationRef&amp;TO=External%7CLink%7CURI" target="_blank">https://www.who.int/publications-detail-redirect/9789240040496</a>. Accessed 1 June 2022</span></li><li id="CR35"><span class="element-citation">Yuthavong Y, Tarnchompoo B, Vilaivan T, et al. Malarial dihydrofolate reductase as a paradigm for drug development against a resistance-compromised target. <span><span class="ref-journal">Proc Natl Acad Sci. </span>2012;<span class="ref-vol">109</span>:16823–16828. doi: 10.1073/pnas.1204556109.</span> <span class="nowrap">[<a class="int-reflink" href="/pmc/articles/PMC3479511/">PMC free article</a>]</span> [<a href="https://pubmed.ncbi.nlm.nih.gov/23035243" ref="reftype=pubmed&amp;article-id=9649585&amp;issue-id=419667&amp;journal-id=1811&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] [<a href="//doi.org/10.1073%2Fpnas.1204556109" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=9649585&amp;issue-id=419667&amp;journal-id=1811&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CCrosslink%7CDOI">CrossRef</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Proc+Natl+Acad+Sci&amp;title=Malarial+dihydrofolate+reductase+as+a+paradigm+for+drug+development+against+a+resistance-compromised+target&amp;author=Y+Yuthavong&amp;author=B+Tarnchompoo&amp;author=T+Vilaivan&amp;volume=109&amp;publication_year=2012&amp;pages=16823-16828&amp;pmid=23035243&amp;doi=10.1073/pnas.1204556109&amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=9649585&amp;issue-id=419667&amp;journal-id=1811&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></li></ul></div></div></div><!--post-content--><div class="courtesy-note whole_rhythm small"><hr /><div class="half_rhythm">Articles from <span class="acknowledgment-journal-title">3 Biotech</span> are provided here courtesy of <strong>Springer</strong></div><hr /></div><div id="body-link-poppers"><span></span></div></div>
            
        </section>
    </article>
    <aside class="usa-width-one-fourth usa-layout-docs-sidenav pmc-sidebar">
         
  

<div class="scroller">

    
        <section>
                <h6>Other Formats</h6>
                <ul class="pmc-sidebar__formats">
                  <li class="pdf-link other_item"><a href="/pmc/articles/PMC9649585/pdf/13205_2022_Article_3400.pdf" class="int-view">PDF (3.4M)</a></li>
                </ul>
        </section>
    
    <section>
        <h6>Actions</h6>
        <ul class="pmc-sidebar__actions">
            <li>
                <button role="button" class="citation-button citation-dialog-trigger ctxp"
                        aria-label="Open dialog with citation text in different styles" data-ga-category="save_share" data-ga-action="cite" data-ga-label="open"
                        data-all-citations-url="/pmc/resources/citations/9649585/"
                        data-citation-style="nlm"
                        data-download-format-link="/pmc/resources/citations/9649585/export/"
                >
                    <span class="button-label">Cite</span>
                </button>
            </li>
            <li>
                
                    

<link type="text/css" href="ncbi-overlay-block/src/overlay-block.css">
<div class="collections-button-container" data-article-id="9649585" data-article-db="pmc">
  <button class="collections-button collections-dialog-trigger"
          aria-label="Save article in MyNCBI collections."
          data-ga-category="collections_button"
          data-ga-action="click"
          data-ga-label="collections_button"
          data-collections-open-dialog-enabled="false"
          data-collections-open-dialog-url="https://www.ncbi.nlm.nih.gov/account?back_url=https%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC9649585%2F%23open-collections-dialog"
          data-in-collections="false">
      <span class="button-label">Collections</span>
  </button>
  <div class="overlay" role="dialog">
  <div id="collections-action-dialog"
       class="dialog collections-dialog"
       aria-hidden="true">
    <div class="title">Add to Collections</div>
    <div class="collections-action-panel action-panel">
      


<form id="collections-action-dialog-form"
      class="collections-action-panel-form action-panel-content action-form action-panel-smaller-selectors"
      data-existing-collections-url="/pmc/list-existing-collections/"
      data-add-to-existing-collection-url="/pmc/add-to-existing-collection/"
      data-create-and-add-to-new-collection-url="/pmc/create-and-add-to-new-collection/"
      data-myncbi-max-collection-name-length="100"
      data-collections-root-url="https://www.ncbi.nlm.nih.gov/myncbi/collections/">

  <input type="hidden" name="csrfmiddlewaretoken" value="yfGWKaQo2ErPSez4RQOlX7UeoTWiqI6eSV84UtRTYujMPYoGGcqIZWYpRnOIdIZL">

  

  <div class="choice-group" role="radiogroup">
    <ul class="radio-group-items">
      <li>
        <input type="radio"
               id="collections-action-dialog-new-aside "
               class="collections-new"
               name="collections"
               value="new"
               data-ga-category="collections_button"
               data-ga-action="click"
               data-ga-label="collections_radio_new">
        <label for="collections-action-dialog-new-aside ">Create a new collection</label>
      </li>
      <li>
        <input type="radio"
               id="collections-action-dialog-existing-aside "
               class="collections-existing"
               name="collections"
               value="existing"
               checked="true"
               data-ga-category="collections_button"
               data-ga-action="click"
               data-ga-label="collections_radio_existing">
        <label for="collections-action-dialog-existing-aside ">Add to an existing collection</label>
      </li>
    </ul>
  </div>

  <div class="controls-wrapper">
    <div class="action-panel-control-wrap new-collections-controls">
      <label for="collections-action-dialog-add-to-new" class="action-panel-label required-field-asterisk">
        Name your collection:
      </label>
      <input
        type="text"
        name="add-to-new-collection"
        id="collections-action-dialog-add-to-new"
        class="collections-action-add-to-new"
        pattern="[^&quot;&amp;=&lt;&gt;/]*" title="The following characters are not allowed in the Name field: &quot;&amp;=&lt;&gt;/"
        maxlength=""
        data-ga-category="collections_button"
        data-ga-action="create_collection"
        data-ga-label="non_favorties_collection">
      <div class="collections-new-name-too-long usa-input-error-message selection-validation-message">
        Name must be less than  characters
      </div>
    </div>
    <div class="action-panel-control-wrap existing-collections-controls">
      <label for="collections-action-dialog-add-to-existing" class="action-panel-label">
        Choose a collection:
      </label>
      <select id="collections-action-dialog-add-to-existing"
              class="action-panel-selector collections-action-add-to-existing"
              data-ga-category="collections_button"
              data-ga-action="select_collection"
              data-ga-label="($('.collections-action-add-to-existing').val() === 'Favorites') ? 'Favorites' : 'non_favorites_collection'">
      </select>
      <div class="collections-retry-load-on-error usa-input-error-message selection-validation-message">
        Unable to load your collection due to an error<br>
        <a href="#">Please try again</a>
      </div>
    </div>
  </div>

  <div class="action-panel-actions">
    <button class="action-panel-submit"
            type="submit"
            data-loading-label="Adding..."
            data-pinger-ignore
            data-ga-category="collections_button"
            data-ga-action="click"
            data-ga-label="add">
      Add
    </button>
    <button class="action-panel-cancel"
            aria-label="Close 'Add to Collections' panel"
            ref="linksrc=close_collections_panel"
            aria-controls="collections-action-panel"
            aria-expanded="false"
            data-ga-category="collections_button"
            data-ga-action="click"
            data-ga-label="cancel">
      Cancel
    </button>
  </div>
</form>
    </div>
  </div>
</div>
</div>
                
            </li>

        </ul>
    </section>
    
        <section class="social-sharing">
            <h6>Share</h6>
            <ul class="pmc-sidebar__share">
                <li><a class="fa-stack fa-lg" target="_blank" rel="noopener noreferrer" role="button" href="https://twitter.com/intent/tweet?url=https%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC9649585%2F&amp;text=Molecular%20docking%20and%20antimalarial%20evaluation%20of%20novel%20N-(4-aminobenzoyl)-l-glutamic%20acid%20conjugated%201%2C3%2C5-triazine%20..." alt="Share on Twitter"><i class="fa fa-twitter fa-stack-1x">&#160;</i></a></li> 
<li><a class="fa-stack fa-lg" target="_blank" rel="noopener noreferrer" role="button" href="https://www.facebook.com/sharer/sharer.php?u=https%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC9649585%2F" alt="Share on Facebook"><i class="fa fa-facebook fa-stack-1x">&#160;</i></a></li>
                <li>
                    <div class="share-permalink">
                        <button class="trigger"  alt="Show article permalink" aria-expanded="false" aria-haspopup="true">
                            <i class="fa-stack fa-lg" >
                                <i class="fa fa-link fa-stack-1x">&nbsp;</i>
                            </i>
                        </button>
                        <div class="dropdown dropdown-container" hidden>
                              <div class="title">
                                Permalink
                              </div>
                              <div class="content">
                                  <input type="text" class="permalink-text" value="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9649585/" aria-label="Article permalink"><button class="permalink-copy-button usa-button-primary" title="Copy article permalink" data-ga-category="save_share" data-ga-action="link" data-ga-label="copy_link">
                                      <span class="button-title">Copy</span>
                                  </button>
                              </div>
                        </div>
                    </div>
                </li>
            </ul>
        </section>
    
    <section>
        <h6>RESOURCES</h6>
        <ul class="pmc-sidebar__resources">
        
            <li>
                <div class="usa-accordion">
                    <button
                            data-ga-category="resources_accordion"
                            data-ga-action="open_similar_articles"
                            data-ga-label="/pmc/articles/PMC9649585/"
                            class="usa-accordion-button"
                            aria-controls="similar-articles-accordion-aside"
                            aria-expanded="false"
                            data-action-open="open_similar_articles"
                            data-action-close="close_similar_articles"
                    >
                        Similar articles
                    </button>
                    <div
                            
                                data-source-url="/pmc/resources/similar-article-links/36386564/"
                            

                         class="usa-accordion-content pmc-sidebar__resources--citations" id="similar-articles-accordion-aside" aria-hidden="true">
                        
                    </div>
                </div>
            </li>
            <li>
                <div class="usa-accordion">
                    <button
                            data-ga-category="resources_accordion"
                            data-ga-action="open_cited_by"
                            data-ga-label="/pmc/articles/PMC9649585/"
                            class="usa-accordion-button"
                            aria-controls="cited-by-accordion-aside"
                            aria-expanded="false"
                            data-action-open="open_cited_by"
                            data-action-close="close_cited_by"
                    >
                        Cited by other articles
                    </button>
                    <div
                            
                                data-source-url="/pmc/resources/cited-by-links/36386564/"
                            
                            class="usa-accordion-content pmc-sidebar__resources--citations"
                            id="cited-by-accordion-aside"
                            aria-hidden="true"
                    >
                        
                    </div>
                </div>
            </li>
            <li>
                <div class="usa-accordion">
                    <button
                            data-ga-category="resources_accordion"
                            data-ga-action="open_NCBI_links"
                            data-ga-label="/pmc/articles/PMC9649585/"
                            class="usa-accordion-button"
                            aria-controls="links-accordion-aside"
                            aria-expanded="false"
                            data-action-open="open_NCBI_links"
                            data-action-close="close_NCBI_link"
                    >
                        Links to NCBI Databases
                    </button>
                    <div data-source-url="/pmc/resources/db-links/9649585/" class="usa-accordion-content" id="links-accordion-aside" aria-hidden="true"></div>
                </div>
            </li>

            
        
        </ul>
    </section>

 </div>

    </aside>
</main>

    <div class="overlay" role="dialog" aria-label="Citation Dialog">
  <div class="dialog citation-dialog">
    <button class="close-overlay" tabindex="1">[x]</button>
    <div class="title">Cite</div>
    <div class="citation-text-block">
  <div class="citation-text"></div>
  <div class="citation-actions">
    <button
      class="copy-button dialog-focus"
      data-ga-category="save_share"
      data-ga-action="cite"
      data-ga-label="copy"
      tabindex="2">
      Copy
    </button>

      <a href="#"
              class="export-button"
              data-ga-category="save_share"
              data-ga-action="cite"
              data-ga-label="download"
              title="Download a file for external citation management software"
              tabindex="3">
          <span class="title">Download .nbib</span>
          <span class="title-mobile">.nbib</span>
      </a>


    

<div class="citation-style-selector-wrapper">
  <label class="selector-label">Format:</label>
  <select aria-label="Format" class="citation-style-selector" tabindex="4" >
    
      <option data-style-url-name="ama"
              value="AMA"
              >
        AMA
      </option>
    
      <option data-style-url-name="apa"
              value="APA"
              >
        APA
      </option>
    
      <option data-style-url-name="mla"
              value="MLA"
              >
        MLA
      </option>
    
      <option data-style-url-name="nlm"
              value="NLM"
              selected="selected">
        NLM
      </option>
    
  </select>
</div>
  </div>
</div>
  </div>
</div>

     <!-- ========== BEGIN FOOTER ========== -->
 <footer>
      <section class="icon-section">
        <div id="icon-section-header" class="icon-section_header">Follow NCBI</div>
        <div class="grid-container container">
          <div class="icon-section_container">
            <a class="footer-icon" id="footer_twitter" href="https://twitter.com/ncbi" aria-label="Twitter"><svg
                data-name="Layer 1" xmlns="http://www.w3.org/2000/svg" viewBox="0 0 300 300">
                <defs>
                  <style>
                    .cls-11 {
                      fill: #737373;
                    }
                  </style>
                </defs>
                <title>Twitter</title>
                <path class="cls-11"
                  d="M250.11,105.48c-7,3.14-13,3.25-19.27.14,8.12-4.86,8.49-8.27,11.43-17.46a78.8,78.8,0,0,1-25,9.55,39.35,39.35,0,0,0-67,35.85,111.6,111.6,0,0,1-81-41.08A39.37,39.37,0,0,0,81.47,145a39.08,39.08,0,0,1-17.8-4.92c0,.17,0,.33,0,.5a39.32,39.32,0,0,0,31.53,38.54,39.26,39.26,0,0,1-17.75.68,39.37,39.37,0,0,0,36.72,27.3A79.07,79.07,0,0,1,56,223.34,111.31,111.31,0,0,0,116.22,241c72.3,0,111.83-59.9,111.83-111.84,0-1.71,0-3.4-.1-5.09C235.62,118.54,244.84,113.37,250.11,105.48Z">
                </path>
              </svg></a>
            <a class="footer-icon" id="footer_facebook" href="https://www.facebook.com/ncbi.nlm" aria-label="Facebook"><svg
                data-name="Layer 1" xmlns="http://www.w3.org/2000/svg" viewBox="0 0 300 300">
                <title>Facebook</title>
                <path class="cls-11"
                  d="M210.5,115.12H171.74V97.82c0-8.14,5.39-10,9.19-10h27.14V52l-39.32-.12c-35.66,0-42.42,26.68-42.42,43.77v19.48H99.09v36.32h27.24v109h45.41v-109h35Z">
                </path>
              </svg></a>
            <a class="footer-icon" id="footer_linkedin"
              href="https://www.linkedin.com/company/ncbinlm"
              aria-label="LinkedIn"><svg data-name="Layer 1" xmlns="http://www.w3.org/2000/svg" viewBox="0 0 300 300">
                <title>LinkedIn</title>
                <path class="cls-11"
                  d="M101.64,243.37H57.79v-114h43.85Zm-22-131.54h-.26c-13.25,0-21.82-10.36-21.82-21.76,0-11.65,8.84-21.15,22.33-21.15S101.7,78.72,102,90.38C102,101.77,93.4,111.83,79.63,111.83Zm100.93,52.61A17.54,17.54,0,0,0,163,182v61.39H119.18s.51-105.23,0-114H163v13a54.33,54.33,0,0,1,34.54-12.66c26,0,44.39,18.8,44.39,55.29v58.35H198.1V182A17.54,17.54,0,0,0,180.56,164.44Z">
                </path>
              </svg></a>
            <a class="footer-icon" id="footer_github" href="https://github.com/ncbi" aria-label="GitHub"><svg
                data-name="Layer 1" xmlns="http://www.w3.org/2000/svg" viewBox="0 0 300 300">
                <defs>
                  <style>
                    .cls-11,
                    .cls-12 {
                      fill: #737373;
                    }

                    .cls-11 {
                      fill-rule: evenodd;
                    }
                  </style>
                </defs>
                <title>GitHub</title>
                <path class="cls-11"
                  d="M151.36,47.28a105.76,105.76,0,0,0-33.43,206.1c5.28,1,7.22-2.3,7.22-5.09,0-2.52-.09-10.85-.14-19.69-29.42,6.4-35.63-12.48-35.63-12.48-4.81-12.22-11.74-15.47-11.74-15.47-9.59-6.56.73-6.43.73-6.43,10.61.75,16.21,10.9,16.21,10.9,9.43,16.17,24.73,11.49,30.77,8.79,1-6.83,3.69-11.5,6.71-14.14C108.57,197.1,83.88,188,83.88,147.51a40.92,40.92,0,0,1,10.9-28.39c-1.1-2.66-4.72-13.42,1-28,0,0,8.88-2.84,29.09,10.84a100.26,100.26,0,0,1,53,0C198,88.3,206.9,91.14,206.9,91.14c5.76,14.56,2.14,25.32,1,28a40.87,40.87,0,0,1,10.89,28.39c0,40.62-24.74,49.56-48.29,52.18,3.79,3.28,7.17,9.71,7.17,19.58,0,14.15-.12,25.54-.12,29,0,2.82,1.9,6.11,7.26,5.07A105.76,105.76,0,0,0,151.36,47.28Z">
                </path>
                <path class="cls-12"
                  d="M85.66,199.12c-.23.52-1.06.68-1.81.32s-1.2-1.06-.95-1.59,1.06-.69,1.82-.33,1.21,1.07.94,1.6Zm-1.3-1">
                </path>
                <path class="cls-12"
                  d="M90,203.89c-.51.47-1.49.25-2.16-.49a1.61,1.61,0,0,1-.31-2.19c.52-.47,1.47-.25,2.17.49s.82,1.72.3,2.19Zm-1-1.08">
                </path>
                <path class="cls-12"
                  d="M94.12,210c-.65.46-1.71,0-2.37-.91s-.64-2.07,0-2.52,1.7,0,2.36.89.65,2.08,0,2.54Zm0,0"></path>
                <path class="cls-12"
                  d="M99.83,215.87c-.58.64-1.82.47-2.72-.41s-1.18-2.06-.6-2.7,1.83-.46,2.74.41,1.2,2.07.58,2.7Zm0,0">
                </path>
                <path class="cls-12"
                  d="M107.71,219.29c-.26.82-1.45,1.2-2.64.85s-2-1.34-1.74-2.17,1.44-1.23,2.65-.85,2,1.32,1.73,2.17Zm0,0">
                </path>
                <path class="cls-12"
                  d="M116.36,219.92c0,.87-1,1.59-2.24,1.61s-2.29-.68-2.3-1.54,1-1.59,2.26-1.61,2.28.67,2.28,1.54Zm0,0">
                </path>
                <path class="cls-12"
                  d="M124.42,218.55c.15.85-.73,1.72-2,1.95s-2.37-.3-2.52-1.14.73-1.75,2-2,2.37.29,2.53,1.16Zm0,0"></path>
              </svg></a>
            <a class="footer-icon" id="footer_blog" href="https://ncbiinsights.ncbi.nlm.nih.gov/" aria-label="Blog">
              <svg id="Layer_1" data-name="Layer 1" xmlns="http://www.w3.org/2000/svg" viewBox="0 0 40 40"><defs><style>.cls-1{fill:#737373;}</style></defs><path class="cls-1" d="M14,30a4,4,0,1,1-4-4,4,4,0,0,1,4,4Zm11,3A19,19,0,0,0,7.05,15a1,1,0,0,0-1,1v3a1,1,0,0,0,.93,1A14,14,0,0,1,20,33.07,1,1,0,0,0,21,34h3a1,1,0,0,0,1-1Zm9,0A28,28,0,0,0,7,6,1,1,0,0,0,6,7v3a1,1,0,0,0,1,1A23,23,0,0,1,29,33a1,1,0,0,0,1,1h3A1,1,0,0,0,34,33Z"/></svg>
            </a>
          </div>
        </div>
      </section>

      <section class="container-fluid bg-primary">
        <div class="container pt-5">
          <div class="row mt-3">
            <div class="col-lg-3 col-12">
              <p><a class="text-white" href="https://www.nlm.nih.gov/socialmedia/index.html">Connect with NLM</a></p>
              <ul class="list-inline social_media">
                <li class="list-inline-item"><a href="https://twitter.com/NLM_NIH" aria-label="Twitter"
                    target="_blank" rel="noopener noreferrer"><svg version="1.1" xmlns="http://www.w3.org/2000/svg"
                      xmlns:xlink="http://www.w3.org/1999/xlink" x="0px" y="0px" viewBox="0 0 249 249"
                      style="enable-background:new 0 0 249 249;" xml:space="preserve">
                      <style type="text/css">
                        .st20 {
                          fill: #FFFFFF;
                        }

                        .st30 {
                          fill: none;
                          stroke: #FFFFFF;
                          stroke-width: 8;
                          stroke-miterlimit: 10;
                        }
                      </style>
                      <title>SM-Twitter</title>
                      <g>
                        <g>
                          <g>
                            <path class="st20" d="M192.9,88.1c-5,2.2-9.2,2.3-13.6,0.1c5.7-3.4,6-5.8,8.1-12.3c-5.4,3.2-11.4,5.5-17.6,6.7
                                                c-10.5-11.2-28.1-11.7-39.2-1.2c-7.2,6.8-10.2,16.9-8,26.5c-22.3-1.1-43.1-11.7-57.2-29C58,91.6,61.8,107.9,74,116
                                                c-4.4-0.1-8.7-1.3-12.6-3.4c0,0.1,0,0.2,0,0.4c0,13.2,9.3,24.6,22.3,27.2c-4.1,1.1-8.4,1.3-12.5,0.5c3.6,11.3,14,19,25.9,19.3
                                                c-11.6,9.1-26.4,13.2-41.1,11.5c12.7,8.1,27.4,12.5,42.5,12.5c51,0,78.9-42.2,78.9-78.9c0-1.2,0-2.4-0.1-3.6
                                                C182.7,97.4,189.2,93.7,192.9,88.1z"></path>
                          </g>
                        </g>
                        <circle class="st30" cx="124.4" cy="128.8" r="108.2"></circle>
                      </g>
                    </svg></a></li>
                <li class="list-inline-item"><a href="https://www.facebook.com/nationallibraryofmedicine"
                    aria-label="Facebook" rel="noopener noreferrer" target="_blank">
                    <svg version="1.1" xmlns="http://www.w3.org/2000/svg" xmlns:xlink="http://www.w3.org/1999/xlink" x="0px"
                      y="0px" viewBox="0 0 249 249" style="enable-background:new 0 0 249 249;" xml:space="preserve">
                      <style type="text/css">
                        .st10 {
                          fill: #FFFFFF;
                        }

                        .st110 {
                          fill: none;
                          stroke: #FFFFFF;
                          stroke-width: 8;
                          stroke-miterlimit: 10;
                        }
                      </style>
                      <title>SM-Facebook</title>
                      <g>
                        <g>
                          <path class="st10" d="M159,99.1h-24V88.4c0-5,3.3-6.2,5.7-6.2h16.8V60l-24.4-0.1c-22.1,0-26.2,16.5-26.2,27.1v12.1H90v22.5h16.9
                                                      v67.5H135v-67.5h21.7L159,99.1z"></path>
                        </g>
                      </g>
                      <circle class="st110" cx="123.6" cy="123.2" r="108.2"></circle>
                    </svg>
                  </a></li>
                <li class="list-inline-item"><a href="https://www.youtube.com/user/NLMNIH" aria-label="Youtube"
                    target="_blank" rel="noopener noreferrer"><svg version="1.1" xmlns="http://www.w3.org/2000/svg"
                      xmlns:xlink="http://www.w3.org/1999/xlink" x="0px" y="0px" viewBox="0 0 249 249"
                      style="enable-background:new 0 0 249 249;" xml:space="preserve">
                      <title>SM-Youtube</title>
                      <style type="text/css">
                        .st4 {
                          fill: none;
                          stroke: #FFFFFF;
                          stroke-width: 8;
                          stroke-miterlimit: 10;
                        }

                        .st5 {
                          fill: #FFFFFF;
                        }
                      </style>
                      <circle class="st4" cx="124.2" cy="123.4" r="108.2"></circle>
                      <g transform="translate(0,-952.36218)">
                        <path class="st5"
                          d="M88.4,1037.4c-10.4,0-18.7,8.3-18.7,18.7v40.1c0,10.4,8.3,18.7,18.7,18.7h72.1c10.4,0,18.7-8.3,18.7-18.7
                                            v-40.1c0-10.4-8.3-18.7-18.7-18.7H88.4z M115.2,1058.8l29.4,17.4l-29.4,17.4V1058.8z"></path>
                      </g>
                    </svg></a></li>
              </ul>
            </div>
            <div class="col-lg-3 col-12">
              <p class="address_footer text-white">National Library of Medicine<br>
                <a href="https://www.google.com/maps/place/8600+Rockville+Pike,+Bethesda,+MD+20894/@38.9959508,-77.101021,17z/data=!3m1!4b1!4m5!3m4!1s0x89b7c95e25765ddb:0x19156f88b27635b8!8m2!3d38.9959508!4d-77.0988323"
                  class="text-white" target="_blank" rel="noopener noreferrer">8600 Rockville Pike<br>
                  Bethesda, MD 20894</a></p>
            </div>
            <div class="col-lg-3 col-12 centered-lg">
              <p><a href="https://www.nlm.nih.gov/web_policies.html" class="text-white">Web Policies</a><br>
                <a href="https://www.nih.gov/institutes-nih/nih-office-director/office-communications-public-liaison/freedom-information-act-office"
                  class="text-white">FOIA</a><br>
                <a href="https://www.hhs.gov/vulnerability-disclosure-policy/index.html" class="text-white" id="vdp">HHS Vulnerability Disclosure</a></p>
            </div>
            <div class="col-lg-3 col-12 centered-lg">
              <p><a class="supportLink text-white" href="https://support.nlm.nih.gov/">Help</a><br>
                <a href="https://www.nlm.nih.gov/accessibility.html" class="text-white">Accessibility</a><br>
                <a href="https://www.nlm.nih.gov/careers/careers.html" class="text-white">Careers</a></p>
            </div>
          </div>
          <div class="row">
            <div class="col-lg-12 centered-lg">
              <nav class="bottom-links">
                <ul class="mt-3">
                  <li>
                    <a class="text-white" href="//www.nlm.nih.gov/">NLM</a>
                  </li>
                  <li>
                    <a class="text-white"
                  href="https://www.nih.gov/">NIH</a>
                  </li>
                  <li>
                    <a class="text-white" href="https://www.hhs.gov/">HHS</a>
                  </li>
                  <li>
                    <a
                  class="text-white" href="https://www.usa.gov/">USA.gov</a>
                  </li>
                </ul>
              </nav>
            </div>
          </div>
        </div>
      </section>
    </footer>
 <!-- ========== END FOOTER ========== -->
  <!-- javascript to inject NWDS meta tags. Note: value of nwds_version is updated by "npm version" command -->
 
  <script type="text/javascript">
    var nwds_version = "1.1.9-2";

    var meta_nwds_ver = document.createElement('meta');
    meta_nwds_ver.name = 'ncbi_nwds_ver';
    meta_nwds_ver.content = nwds_version;
    document.getElementsByTagName('head')[0].appendChild(meta_nwds_ver);

    var meta_nwds = document.createElement('meta');
    meta_nwds.name = 'ncbi_nwds';
    meta_nwds.content = 'yes';
    document.getElementsByTagName('head')[0].appendChild(meta_nwds);

	var alertsUrl = "/core/alerts/alerts.js";
	if (typeof ncbiBaseUrl !== 'undefined') {
		alertsUrl = ncbiBaseUrl + alertsUrl;
	}
  </script>



  
    <!-- JavaScript -->
    <script src="/pmc/static/CACHE/js/output.0f72d6a64937.js"></script>
  
  
    <script src="https://code.jquery.com/jquery-3.5.0.min.js"
          integrity="sha256-xNzN2a4ltkB44Mc/Jz3pT4iU1cmeR0FkXs4pru/JxaQ="
          crossorigin="anonymous">
    </script>
    <script>
        var fallbackJquery = "/pmc/static/base/js/jquery-3.5.0.min.js";
        window.jQuery || document.write("<script src=" + fallbackJquery + ">\x3C/script>")
    </script>
  

  <script src="/pmc/static/CACHE/js/output.a212a9fcf845.js"></script>
<script src="/pmc/static/CACHE/js/output.7999321d1aac.js"></script>
<script src="/pmc/static/CACHE/js/output.7ca436b2ea51.js"></script>
<script src="/pmc/static/CACHE/js/output.f8422046fbe0.js"></script>
<script src="/pmc/static/CACHE/js/output.ff40c7d85ff8.js"></script>
<script src="/pmc/static/CACHE/js/output.a6a84a0ad361.js"></script>

<script type="text/javascript" src="/pmc/static/bundles/base/base.038d36e4e31104b40a19.js" ></script>

    <script type="text/javascript">
        if(typeof jQuery !=='undefined') {
            jQuery.migrateMute = true;
        }
    </script>
    <script type="text/javascript" src="https://code.jquery.com/jquery-migrate-1.4.1.js"></script>
    <script type="text/javascript" src="/core/jig/1.15.2/js/jig.nojquery.min.js">//</script><script type="text/javascript" src="/corehtml/pmc/js/common.min.js?_=3.18">//</script><script type="text/javascript" src="/corehtml/pmc/js/NcbiTagServer.min.js?_=3.18">//</script><script type="text/javascript" src="/corehtml/pmc/js/crb.min.js?_=3.18">//</script><script type="text/javascript" src="/corehtml/pmc/js/jactions.min.js?_=3.18">//</script><script type="text/javascript" src="/core/mathjax/2.7.9/MathJax.js?config=/corehtml/pmc/js/mathjax-config-classic.3.4.js"></script><script type="text/javascript">window.name="mainwindow";</script>

    <script type="text/javascript">var exports = {};</script>
    <script src="/pmc/static/CACHE/js/output.340a3b9cce7f.js"></script>
<script src="/pmc/static/CACHE/js/output.228f96f3298e.js"></script>
    <script type="text/javascript" src="/pmc/static/bundles/article/article.b7dd20e527283dd68f45.js" ></script>
    <script type="text/javascript">
        window.ncbi.pmc.articlePage.init({ pageURL: '/pmc/articles/PMC9649585/', citeCookieName: 'pmc-cf'});
    </script>


  
  
  <script  type="text/javascript" src="https://www.ncbi.nlm.nih.gov/core/pinger/pinger.js"> </script>


  
      
  

</body>
</html>
